
<html lang="en"     class="pb-page"  data-request-id="92e0b4af-c87a-4dc3-bb29-bbfe81a63302"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.8b01561;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design" /></meta><meta name="dc.Creator" content="Amarendar&#xA;Reddy  Maddirala" /></meta><meta name="dc.Creator" content="Roger  Klein" /></meta><meta name="dc.Creator" content="Jerome S.  Pinkner" /></meta><meta name="dc.Creator" content="Vasilios  Kalas" /></meta><meta name="dc.Creator" content="Scott J.  Hultgren" /></meta><meta name="dc.Creator" content="James W.  Janetka" /></meta><meta name="dc.Description" content="The F9/Yde/Fml pilus, tipped with the FmlH adhesin, has been shown to provide uropathogenic Escherichia coli (UPEC) a fitness advantage in urinary tract infections (UTIs). Here, we used X-ray struc..." /></meta><meta name="Description" content="The F9/Yde/Fml pilus, tipped with the FmlH adhesin, has been shown to provide uropathogenic Escherichia coli (UPEC) a fitness advantage in urinary tract infections (UTIs). Here, we used X-ray struc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01561" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01561" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01561" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01561" /></link>
        
    
    

<title>Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01561" /></meta><meta property="og:title" content="Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0012.jpeg" /></meta><meta property="og:description" content="The F9/Yde/Fml pilus, tipped with the FmlH adhesin, has been shown to provide uropathogenic Escherichia coli (UPEC) a fitness advantage in urinary tract infections (UTIs). Here, we used X-ray structure guided design to optimize our previously described ortho-biphenyl Gal and GalNAc FmlH antagonists such as compound 1 by replacing the carboxylate with a sulfonamide as in 50. Other groups which can accept H-bonds were also tolerated. We pursued further modifications to the biphenyl aglycone resulting in significantly improved activity. Two of the most potent compounds, 86 (IC50 = 0.051 μM) and 90 (IC50 = 0.034 μM), exhibited excellent metabolic stability in mouse plasma and liver microsomes but showed only limited oral bioavailability (&lt;1%) in rats. Compound 84 also showed a good pharmacokinetic (PK) profile in mice after IP dosing with compound exposure above the IC50 for 6 h. These new FmlH antagonists represent new antivirulence drugs for UTIs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01561"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01561">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01561&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01561&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01561&amp;href=/doi/10.1021/acs.jmedchem.8b01561" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 467-479</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00909" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01536" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic <i>E. coli</i> (UPEC): Optimization through Iterative Rational Drug Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Amarendar Reddy Maddirala</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amarendar Reddy Maddirala</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amarendar%0AReddy++Maddirala">Amarendar Reddy Maddirala</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0721-1647" title="Orcid link">http://orcid.org/0000-0003-0721-1647</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roger Klein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roger Klein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roger++Klein">Roger Klein</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3216-1792" title="Orcid link">http://orcid.org/0000-0003-3216-1792</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jerome S. Pinkner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jerome S. Pinkner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jerome+S.++Pinkner">Jerome S. Pinkner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vasilios Kalas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vasilios Kalas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vasilios++Kalas">Vasilios Kalas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Scott J. Hultgren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Scott J. Hultgren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div><div class="loa-info-affiliations-info">Center for Women’s Infectious Disease Research, Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Scott+J.++Hultgren">Scott J. Hultgren</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">James W. Janetka</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James W. Janetka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div><div class="loa-info-affiliations-info">Center for Women’s Infectious Disease Research, Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 314-362-0509. Fax: 314-362-7183. E-mail: <a href="/cdn-cgi/l/email-protection#d0bab1beb5a4bbb1ba90a7a5a3a4bcfeb5b4a5"><span class="__cf_email__" data-cfemail="9af0fbf4ffeef1fbf0daedefe9eef6b4fffeef">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Janetka">James W. Janetka</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9888-5411" title="Orcid link">http://orcid.org/0000-0002-9888-5411</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01561&amp;href=/doi/10.1021%2Facs.jmedchem.8b01561" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 467–479</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 October 2018</li><li><span class="item_label"><b>Published</b> online</span>12 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01561</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D467%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAmarendar%250AReddy%2BMaddirala%252C%2BRoger%2BKlein%252C%2BJerome%2BS.%2BPinkner%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01561%26title%3DBiphenyl%2BGal%2Band%2BGalNAc%2BFmlH%2BLectin%2BAntagonists%2Bof%2BUropathogenic%2BE.%2Bcoli%2B%2528UPEC%2529%253A%2BOptimization%2Bthrough%2BIterative%2BRational%2BDrug%2BDesign%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D479%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01561"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1499</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01561" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Amarendar\nReddy&quot;,&quot;last_name&quot;:&quot;Maddirala&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;Klein&quot;},{&quot;first_name&quot;:&quot;Jerome&quot;,&quot;last_name&quot;:&quot;S. Pinkner&quot;},{&quot;first_name&quot;:&quot;Vasilios&quot;,&quot;last_name&quot;:&quot;Kalas&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;J. Hultgren&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Janetka&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;467-479&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01561&quot;},&quot;abstract&quot;:&quot;The F9/Yde/Fml pilus, tipped with the FmlH adhesin, has been shown to provide uropathogenic Escherichia coli (UPEC) a fitness advantage in urinary tract infections (UTIs). Here, we used X-ray structure guided design to optimize our previously described ortho-biphenyl Gal and GalNAc FmlH antagonists such as compound 1 by replacing the carboxylate with a sulfonamide as in 50. Other groups which can accept H-bonds were also tolerated. We pursued further modifications to the biphenyl aglycone resulting in significantly improved activity. Two of the most potent compounds, 86 (IC50 = 0.051 μM) and 90 (IC50 = 0.034 μM), exhibited excellent metabolic stability in mouse plasma and liver microsomes but showed only limited oral bioavailability (&lt;1%) in rats. Compound 84 also showed a good pharmacokinetic (PK) profile in mice after IP dosing with compound exposure above the IC50 for 6 h. These new FmlH antagonists represent new antivirulence drugs for UTIs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01561&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01561" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01561&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01561" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01561&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01561" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01561&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01561&amp;href=/doi/10.1021/acs.jmedchem.8b01561" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01561" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01561" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01561%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DMaddirala%26date%3D2019%26atitle%3DBiphenyl%2BGal%2Band%2BGalNAc%2BFmlH%2BLectin%2BAntagonists%2Bof%2BUropathogenic%2BE.%2Bcoli%2B%2528UPEC%2529%253A%2BOptimization%2Bthrough%2BIterative%2BRational%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D467%26epage%3D479%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The F9/Yde/Fml pilus, tipped with the FmlH adhesin, has been shown to provide uropathogenic <i>Escherichia coli</i> (UPEC) a fitness advantage in urinary tract infections (UTIs). Here, we used X-ray structure guided design to optimize our previously described <i>ortho</i>-biphenyl Gal and GalNAc FmlH antagonists such as compound <b>1</b> by replacing the carboxylate with a sulfonamide as in <b>50</b>. Other groups which can accept H-bonds were also tolerated. We pursued further modifications to the biphenyl aglycone resulting in significantly improved activity. Two of the most potent compounds, <b>86</b> (IC<sub>50</sub> = 0.051 μM) and <b>90</b> (IC<sub>50</sub> = 0.034 μM), exhibited excellent metabolic stability in mouse plasma and liver microsomes but showed only limited oral bioavailability (<1%) in rats. Compound <b>84</b> also showed a good pharmacokinetic (PK) profile in mice after IP dosing with compound exposure above the IC<sub>50</sub> for 6 h. These new FmlH antagonists represent new antivirulence drugs for UTIs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The global rise in infections attributable to multidrug resistant bacteria represents a serious and immediate public health crisis. Globally, 700000 people die each year from infections caused by antibiotic resistant organisms, and by 2050, these infections are predicted to kill up to 10 million people annually with an economic burden of approximately $100 trillion U.S. dollars.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To curb the spread of antibiotic resistance while effectively treating a wide range of bacterial infections, the need for alternative antimicrobial therapeutics has never been greater. Urinary tract infections (UTIs) are one of the most common and costly bacterial infections in the world, affecting approximately 50% of women during their lifetimes and leading to $2.5 billion in healthcare costs annually in the United States alone.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Over 10% of all antibiotic treatment regimens administered to patients in the United States are prescribed for the treatment of UTI.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> The overwhelming majority of community- and hospital-associated UTIs are caused by Gram-negative uropathogenic <i>Escherichia coli</i> (UPEC) strains.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">UPEC encode a variety of virulence factors that facilitate their colonization and persistence of numerous habitats including the gastrointestinal and urinary tracts. One of the most important and well-studied determinants of UPEC urovirulence are chaperone-usher pathway (CUP) pili.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> CUP pili are proteinaceous extracellular fibers expressed by <i>E. coli</i> and other Gram-negative pathogens that are tipped with adhesins, which bind to receptors with stereochemical specificity to mediate colonization, invasion, and biofilm formation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The <i>E. coli</i> pan genome encodes 38 distinct CUP pilus types, and individual <i>E. coli</i> strains can encode between 6 and 16 CUP pili.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The pilus known to be critical in UTI pathogenesis is the type 1 pilus.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> Type 1 pili are tipped with the FimH adhesin that recognizes mannosylated glycoproteins in the gut and in the bladder, an event that is critical for colonization, invasion, and biofilm formation in these various habitats.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Thus, <i>fimH</i> mutants are severely attenuated in virulence and tight-binding FimH inhibitors called biaryl mannosides have been shown to be orally bioavailable and highly efficacious in the treatment and prevention of UTI.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18">(13−18)</a> Fml pili are composed of thousands of repeating FmlA subunits assembled into a rod that is tipped with a two-domain adhesin, FmlH. FmlH recognizes terminal galactose (Gal) and <i>N</i>-acetylgalactosamine (GalNAc) residues found in core-1 and -2 <i>O</i>-glycans decorating glycoproteins in the bladder exposed during chronic inflammation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Fml pili can also recognize Thomsen–Friedenreich (TF) antigen (Galβ1–3GalNAc) on the kidney epithelium to facilitate kidney infection (pyelonephritis).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Cocrystal structures of the FmlH lectin domain (FmlH<sup>LD</sup>) bound to natural and synthetic ligands reveal a solvent-exposed receptor binding pocket composed of three loops at the distal tip of FmlH that confers specificity for the GalNAc receptor.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Loop 1 comprises residues S9-A13, loop 2 comprises residues N44-D53, and loop 3 comprises residues K132–N143 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Deletion of the <i>fml</i> operon from clinical UPEC isolates results in a competitive defect in the bladder and kidney in mouse models of chronic UTI.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. FmlH bound to initial lead compound <b>1</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AS8">6AS8</a>). The COOH group on ring B engages in charge–charge interactions with guanidinium side chain of R142, while a series of direct and water-mediated H-bonds between the acetamide moiety and residue K132. Additionally, phenyl ring A forms edge-to-face π-stacking interactions with Y46.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our previous studies have utilized X-ray crystallography structure-based ligand design and directed organic synthesis to develop high-affinity compounds that can competitively inhibit FmlH binding to inflamed bladder tissue ex vivo.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Using <i>O</i>-nitrophenyl β-galactoside (ONPG) as a basis for further functionalization, compound <b>1</b> was developed. Compound <b>1</b> contains a GalNAc sugar ring attached to an <i>ortho</i>-biphenyl ring substituted with a carboxylic acid moiety in the <i>meta</i> position of the B-ring. The A-ring of the biphenyl aglycone exploits edge-to-face π-stacking interactions with Y46, while the acetamide and the B-ring makes polar contacts with R142 in loop 3 to increase potency (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Compound <b>1</b> achieves 50% inhibition of FmlH binding to serine-TF moieties in an ELISA-based assay at a concentration of 0.64 μM. When tested further in a kinetic binding assay, compound <b>1</b> displayed a dissociation constant (<i>K</i><sub>d</sub>) of 0.089 μM.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Further, compound <b>1</b> was shown to be able to significantly reduce bladder and kidney CFUs in a treatment model of chronic cystitis. Co-administration of FmlH inhibitor <b>1</b> with 4Z269, a potent mannoside inhibitor of FimH, further reduced bacterial titers in both the bladder and kidney. This suggests the possibility for synergistic combination treatment as an antibiotic-sparing therapeutic approach against UTI which has been reviewed recently.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> The structural basis of the affinity of other CUP pili for their cognate ligands has also been determined. For example, the PapG adhesin on the P pilus is known to bind Gal-containing globosides in the kidney. However, the structure and orientation of the PapG binding pocket relative to that of FmlH show little structural or genetic homology.</div><div class="NLM_p last">Herein, we have rationally modified compound <b>1</b> to optimize ligand binding geometry and increase its inhibitory effect on FmlH binding based on the cocrystal structure of compound <b>1</b> bound to FmlH. We then conducted functional and structural studies on these compounds to expand our understanding of the structure–activity relationships (SAR) of these new high-affinity FmlH ligands. Studies evaluating the physical and pharmacokinetic (PK) properties of new lead compounds were also pursued. These compounds represent new and promising antibiotic-sparing drugs for the treatment of chronic UTI.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis of Biphenyl Galactosides and Galactosaminosides</h3><div class="NLM_p">To improve the binding affinity and potency of previous lead biphenyl GalNAc <b>1</b>, we utilized the FmlH-<b>1</b> cocrystal structure (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) as a guide. Initially, we replaced the <i>meta</i> carboxylic acid with a variety of other functional groups to further exploit the charge–charge and hydrogen bonding (H-bonding) interactions with the guanidinium side chain of R142 and K132. The general synthetic routes for these biphenyl GalNAc and Gal analogues are shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The key 2-bromophenyl GalNAc and Gal intermediates, <b>4</b> and <b>5</b>, respectively, were synthesized by Koenig–Knorr type glycosylation reaction.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25">(21−25)</a> Compound <b>4</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A) was synthesized from protected galactosamine chloride <b>2</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> using dichloromethane (DCM), 1N aq. sodium hydroxide (NaOH), tetrabutylammonium bromide (TBAB). and 2-bromophenol at room temperature, whereas compound <b>5</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B) was synthesized from readily available peracetylated galactose bromide <b>3</b> using chloroform (CHCl<sub>3</sub>), 1N aq NaOH, benzyltriethylammonium chloride (TEBAC), and 2-bromophenol at 60 °C in good yield. Next, compounds <b>4</b> and <b>5</b> were subjected to a Suzuki cross-coupling reaction<a onclick="showRef(event, 'ref14 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref27">(14,27)</a> with various phenylboronic acids using Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, and 1,4-dioxane/water (5:1) at 80 °C to generate protected biphenyl intermediates <b>6</b>–<b>28</b>. The target <i>meta</i>-nitro (<b>29</b>), <i>para</i>-methoxy (<b>31</b>) GalNAc, and <i>meta</i>-nitro (<b>30</b>) Gal biphenyl carboxylic acid analogues were then obtained from the dual deprotection and saponification of the esters 8–10. All other compounds <b>32</b>–<b>51</b> were synthesized via treatment with 33% methylamine in absolute ethanol solution from precursors <b>11</b>–<b>28</b>. All final target molecules <b>29</b>–<b>51</b> were purified to by reverse phase preparatory HPLC using a C18 column, resulting in compounds with >95% purity in excellent overall yields.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Biphenyl Glycoside Compounds (<b>29</b>–<b>51</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCM, 1N NaOH, TBAB, 2-bromophenol, rt, 1 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water (5:1), 80 °C, 1 h; (c) NaOH, methanol/water (1:1), rt, overnight for <b>29</b>–<b>31</b> or 33% methylamine in absolute ethanol, rt, 1 h for <b>32</b>–<b>51</b>; (d) CHCl<sub>3</sub>, 1N NaOH, TEBAC, 2-bromophenol, rt, 1 h. See <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for identity of R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup>.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biochemical Analysis of <i>ortho</i>-Biphenyl Gal and GalNAc Compounds <b>29</b>–<b>51</b></h3><div class="NLM_p">The ability of the newly synthesized Gal and GalNAc analogues <b>29</b>–<b>51</b> to inhibit FmlH activity was assessed using our previously described enzyme-linked immunosorbent assay (ELISA).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This competitive binding assay measures the concentration of compound required to inhibit 50% of binding (IC<sub>50</sub>) to desialylated bovine submaxillary mucin, which contains high levels of Gal and GalNAc epitopes. The resultant IC<sub>50</sub> values for each compound are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The majority of compounds (<b>32</b>–<b>42</b>, <b>45</b>–<b>48</b>) had equal or slightly reduced potency relative parent compound <b>1</b>. It is noteworthy that the <i>ortho</i>-methoxy biphenyl GalNAc carboxylic analogue <b>31</b> showed the weakest activity with a 6-fold drop in activity (IC<sub>50</sub>, 3.9 μM) relative to <b>1</b>. It would be tempting to speculate that this could be the result of forced ring twisting of the B-ring due to steric interference from the large ortho substituent. However, changing the carboxylic acid to a smaller phenol in compound <b>34</b> increases the potency (IC<sub>50</sub>, 0.51 μM) back to the level of compound <b>1</b> and is equivalent to the desmethoxy analogue <b>32</b>. The potency was slightly enhanced when the acid is replaced with a reverse amide as in <b>43</b> (IC<sub>50</sub>, 0.31 μM) but decreases in the normal amide <b>47</b> (IC<sub>50</sub>, 3.4 μM). However, the addition of a reverse methyl sulfonamide <b>50</b> resulted in a 3-fold greater potency than <b>1</b> (IC<sub>50</sub> 0.23 μM), but as in amide <b>47</b>, the methyl sulfonamide derivative <b>51</b> showed a loss in activity relative to <b>1</b>. This SAR suggests that distal placement of an H-bond acceptor (i.e., a carbonyl of the reverse amide or S═O bond of the sulfonamide) provides a greater binding benefit than a H-bond donor, presumably due to improved interactions with the Arg142 and/or Lys132 of FmlH. In general, we discovered that groups which can accept an H-bond in the <i>meta</i> position of the B-ring show the best activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Data for Biphenyl Galactosides and Galactosaminosides <b>1</b>, <b>29</b>–<b>51</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0010.gif" alt="" id="gr3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">COOH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">COOH</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center">COOH</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="center">COOH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="center">OSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="center">OSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="center">F</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="center">CN</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="center">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="center">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="center">NHCOMe</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="center">NHCOCF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">NHCO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">CON(Me)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">CONHMe</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">NHSO<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">All the IC<sub>50</sub> values are an average of four or more replicates</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Standard deviations are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a></p></div></div></div><div class="NLM_p last">As with our previously reported FmlH ligands<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> our lead biphenyl GalNAc sulfonamide <b>50</b> is more potent than its matched pair Gal derivative <b>51</b> by about 5-fold. We have demonstrated this trend in all paired analogues hitherto synthesized. However, we observed a reversal of this trend when the potency of compounds <b>29</b> and <b>30</b> were assessed, as the B-ring disubstituted 3-nitro 5-carboxy analogue <b>30</b> (IC<sub>50</sub>, 0.28 μM) was 6-fold more active than the corresponding GalNAc version <b>29</b> (IC<sub>50</sub>, 2.2 μM).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> X-ray Structure Determination of Disubstituted Biphenyl Gal <b>30</b> and GalNAc <b>29</b> Matched Pairs Bound to the FmlH Lectin Domain</h3><div class="NLM_p">To determine the structural basis for the divergent SAR of Gal (<b>30</b>) versus GalNAc (<b>29</b>) and attempt to explain the unfavorable effect on binding from the <i>N</i>-acetyl group on GalNAc <b>29</b> potency relative to Gal <b>30</b>, we obtained cocrystals and solved the X-ray structures of both <b>30</b> and <b>29</b> in complex with FimH<sup>LD</sup> to 1.39 and 1.31 Å resolution, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B). Surprisingly, we found that the nitro group on the biphenyl B-ring, and not the carboxylic acid as previously observed, was bound in the pocket with R142. This contrasts with the FmlH cocrystal structure of <b>1</b>, in which the carboxylic acid occupies that pocket (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In both the <b>29</b> and <b>30</b> structures, the nitro oxygens on the second phenyl ring (B) form two interactions with R142, while the carboxyl oxygens of the carboxylic acid group interact with S2 on the N terminus and the backbone of I11 and G12 in loop 1. In compound <b>29</b>, one nitro oxygen resides within 3.2 Å of the acetamide carbonyl, causing the second phenyl ring to tilt 45° relative to the plane of the first phenyl ring. In contrast, the angular offset between the plane of the two rings is 32.5° in <b>30</b>, altering the position of the carboxylic acid oxygens and attenuating their interaction with loop 1 residues I11 and G12.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of FmlH<sup>LD</sup> in complex with (A) Gal <b>30</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAP">6MAP</a>) and (B) GalNAc <b>29</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAQ">6MAQ</a>) matched pairs. Direct and water-mediated interactions between the <i>N</i>-acetyl group on the galactose ring and the nitro group on the second phenyl ring result in decreased relative potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Substitution of the Reverse Methyl Sulfonamide Scaffold (<b>50</b>) Further Increases Galactoside Potency</h3><div class="NLM_p">To further improve the potency of lead compound <b>50</b>, we explored a series of additional rationally directed modifications. These include substitutions at the <i>meta</i> (R<sup>4</sup>) and <i>para</i> (R<sup>5</sup>)-positions of the biphenyl ring A while keeping the meta-substituted methyl sulfonamide B ring constant (<b>78</b>–<b>85</b>, <b>90</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). We also evaluated different sulfonamides as in <b>86</b>–<b>87</b> and <i>N</i>-substitutions on the GalNAc ring including <b>88</b> and <b>89</b>. This focused library of substituted biphenyl sulfonamide analogues were synthesized as outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> and the <i>N</i>-substituted galactosamine derivatives <b>88</b>–<b>89</b> in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Compounds <b>78</b>–<b>85</b> and <b>90</b> were synthesized following a similar reaction sequence as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. However, sulfonamide analogues <b>86</b> and <b>87</b> were prepared via sulfonylation of intermediate aniline <b>72</b>. As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, GalNAc derivatives <b>88</b> and <b>89</b> were generated first by Koenig–Knorr type glycosylation reaction<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> between 3,4,6-tri-<i>O</i>-acetyl-2-amino-2-deoxy-α-<span class="smallcaps smallerCapital">d</span>-galactopynosyl bromide·HBr<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<b>52</b>) and sodium 2-bromo-3-methylphenolate<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (<b>53</b>) to give bromide intermediate <b>62</b>. Derivatization with trifluoroacetic acid anhydride or methanesulfonyl chloride yielded <i>N</i>-substituted galactosamine intermediates <b>75</b> and <b>76</b>. Subsequent Suzuki cross-coupling reaction with (3-(methylsulfonamido)phenyl)boronic acid followed by treatment with 33% methylamine in absolute ethanol provided the target compounds <b>88</b> and <b>89</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Biphenyl Glycosides to Explore A-Ring Substitution and B-Ring Sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCM, 1N NaOH, TBAB, rt, 1 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water (5:1), 80 °C, 1 h; (c) DCM, cyclopropanesulfonyl chloride/TEA, rt, 2 h, (d) DMF, <i>N</i>,<i>N</i>-dimethylsulfonyl chloride/Cs<sub>2</sub>CO<sub>3</sub>, MW, 80 °C, 2 h; (e) 33% methylamine in absolute ethanol, rt, 1 h; (f) NaOH, methanol/water (1:1), rt, overnight.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Biphenyl Glycosides Evaluating Effect of <i>N</i>-Substitution of GalNAc Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN, 80 °C, 2 h; (b) DCM, (CF<sub>3</sub>CO)<sub>2</sub>O/TEA, rt, 1 h; (c) DCM, MsCl/TEA, rt, 3 h; (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water (5:1), 80 °C, 1 h; (e) 33% methylamine in absolute ethanol, rt, 1 h.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Compounds (<b>78</b>–<b>90</b>) Comparison of Biological Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0011.gif" alt="" id="gr7" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">CN</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">F</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">CO<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">cyclopropyl</td><td class="colsep0 rowsep0">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">N(Me)<sub>2</sub></td><td class="colsep0 rowsep0">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="center">COCF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b></td><td class="colsep0 rowsep0" align="center">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">3500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="center">Ac</td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0">34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All the IC<sub>50</sub> values are an average of four or more replicates</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Standard deviations are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a></p></div></div></div><div class="NLM_p last">The potency of all compounds <b>78</b>–<b>90</b> were assessed using the ELISA assay described above to measure the IC<sub>50</sub>. These values are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. All <i>N</i>-acetyl compounds had excellent activity with an IC<sub>50</sub> of 100 nM or better. We found that all analogues substituted with any of the various functional groups installed at the <i>ortho</i> position (R<sup>4</sup>) of the biphenyl A-ring (relative to the B-ring) further improved IC<sub>50</sub>s relative to lead compound 50 (R<sup>4</sup> = H). It is noteworthy that the cyclopropyl sulfonamide <b>86</b> and the dimethyl sulfonyl urea derivative <b>87</b> retain the same activity as the methyl sulfonamides. Compound <b>90</b>, containing the methyl sulfonamide in the <i>meta</i> position of the biphenyl B-ring and a trifluoromethyl group in the <i>ortho</i> R<sup>4</sup> position on the B-ring, exhibited the highest potency of the compounds tested, with an IC<sub>50</sub> of 34 nM. Even the fused naphthyl A-ring <b>85</b> has excellent potency with an IC<sub>50</sub> of 81 nM. When the sugar acetyl group of compound <b>84</b> is replaced, the trifluoroacetamide retains potent activity (IC<sub>50</sub> 62 nM) while the methyl sulfonamide loses significant activity with an IC<sub>50</sub> of only 3.5 μM.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> X-ray Structure Determination of Biphenyl Sulfonamide GalNAc 90 Bound to the FmlH Lectin Domain</h3><div class="NLM_p">To determine the molecular basis for the high potency exhibited by the biphenyl sulfonamides and the corresponding SAR, we solved an X-ray crystal structure of compound <b>90</b> bound to FmlH<sup>LD</sup>. The cocrystal structure was solved to 1.75 Å resolution (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW">6MAW</a>). As previously observed in the <b>1</b>-FmlH<sup>LD</sup> cocrystal structure (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), the terminal <i>N</i>-acetyl galactosamine ring forms key H-bonds with the amide backbone of F1, as well as the side chains of D45, Y46, and D53 in loop 2 and the side chains of K132 and N140 in loop 3.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The nitrogen of the <i>N</i>-acetylgalactosamine group forms multiple H-bonds with K132 and a water molecule present in the binding pocket. We also observed an additional water-mediated H-bond between the <i>N</i>-acetylglucosamine carbonyl and R142 that had not been previously appreciated. In contrast to the structure of compound <b>1</b> bound to FmlH, in which has the carboxylate group of the biphenyl B-ring faces the <i>N</i>-acetyl group of the sugar and interacts with the pocket formed by R142 and K132, the sulfonamide is interacting in a pocket just opposite from this. This happens to be the same pocket the carboxylate of GalNAc <b>29</b> occupies (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The sulfonamide nitrogen atom of <b>90</b> forms a H-bond with the backbone carbonyl of F1. Additionally, one of the sulfonamide oxygens interacts with the side chain of S2, the side chain of S10 side chain and backbone of I11 in loop 1. The addition of the <i>ortho</i>-trifluoromethyl group to the biphenyl A-ring likely locks the position of the second phenyl ring at a preferred angle relative to the first ring, potentially providing a favorable entropic contribution to binding. Additionally, it is speculated that one of the fluorine atoms interacts directly with D45 and indirectly with S2 through a water molecule.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of FmlH<sup>LD</sup> in complex with <b>90</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW">6MAW</a>). The sulfonyl oxygens form novel contacts with the backbone of S10 and I11 in loop 1 and the backbone of S2 in the <i>N</i>-terminus of the mature protein. Additionally, one fluorine in the trifluoromethyl group interacts with D45.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro Metabolic Stability Studies of Lead FmlH Antagonists</h3><div class="NLM_p">Because of the labile nature of the <i>O</i>-glycosidic linkage of the biphenyl Gal and GalNAc FmlH antagonists, we pursued studies to evaluate their stability. To evaluate their therapeutic potential for advancing into planned animal studies, we assessed the aqueous solubility and in vitro stability of six leading compounds <b>79</b>, <b>80</b>, <b>84</b>, <b>86</b>, <b>88</b>, and <b>90</b> based on their potency and structural diversity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). All compounds tested showed excellent aqueous solubility at pH 7.4 just below 200 μM. These compounds were assessed for their stability in simulated gastric fluid (SGF), simulated intestinal fluid (SIF), mouse liver microsomes, and blood plasma (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). All compounds tested exhibited a high degree of stability, with some variation seen in the plasma stability. These findings are consistent with our earlier characterization of FimH antagonists (mannosides). In these studies, we demonstrated the lability of the <i>O</i>-glycosidic linkage<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> that resulted in the appearance and detection of the phenol product of metabolism in mouse plasma and urine. With these promising results in vitro, we further tested the two most stable analogues, <b>86</b> and <b>90</b>, for their pharmacokinetics (PK) in rats.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Solubility and Metabolic Stability of Select FmlH Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">SGF (% remaining @ 6 h)</th><th class="colsep0 rowsep0" align="center" char=".">SIF (% remaining @ 2 h)</th><th class="colsep0 rowsep0" align="center" char=".">mouse liver microsomes (<i>t</i><sub>1/2</sub> min)</th><th class="colsep0 rowsep0" align="center" char=".">mouse plasma (% remaining @ 2 h)</th><th class="colsep0 rowsep0" align="center" char=".">kinetic solubility (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">>145</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">196</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">>145</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">197</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">>145</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">>145</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">196</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">>145</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">164</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">>145</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">197</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p">We determined the concentration of compounds <b>86</b> and <b>90</b> in rat plasma and urine following either a 10 mg/kg oral dose (PO; circular dots) or a 3 mg/kg intravenous dose (IV; square dots) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Analysis of the rat PK data (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Table S1</a>) revealed that compound <b>86</b> has a longer long life (<i>t</i><sub>1/2</sub> = 1.46 h) and lower plasma clearance rate (Cl = 43.8 mL/min/kg) in plasma than compound <b>90</b> (<i>t</i><sub>1/2</sub> = 1.16 h and Cl = 57.0 mL/min/kg). However, both compounds displayed low renal clearance to the urine (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and an oral bioavailability (<i>F</i>) of less than 1%. Thus, the metabolic stability of these compounds and clearance of these compounds has no relation to the permeability (oral or otherwise) of compounds. The highly polar nature of these molecules containing the sugar GalNAc and multiple polar functionalities precludes their permeability in the gut.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo pharmacokinetics (PK) of <b>86</b> and <b>90</b> in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Urinary excretion of compounds <b>86</b> and <b>90</b> in rats after (A) IV administration and (B) PO administration. R01–R12 rats used for the renal excretion studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine if the improved PK properties of <b>86</b> relative to <b>90</b> are a consequence of the CH<sub>3</sub> versus CF<sub>3</sub> group on the biphenyl A-ring or the cyclopropyl sulfonamide versus methyl sulfonamide of the B-ring, we performed an additional study in mice with compound <b>84</b>, the methyl sulfonamide derivative of <b>86</b>, or the CH<sub>3</sub> derivative of <b>90</b>. This allowed us to determine the isolated effects of a single substitution. These studies were conducted via 20 mg/kg intraperitoneal (IP) injection to inform planned future IP studies in murine studies of chronic UTI, which require a single IP dose of galactoside to persist in the plasma for 6 h prior to measurement of bladder bacterial burdens (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo pharmacokinetic properties of <b>84</b> in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">While not a perfect comparison to <b>86</b> and <b>90</b>, the half-life, <i>t</i><sub>1/2</sub> in the mouse is calculated to be 1.13 h and the clearance rate appears to be slower than either that of <b>86</b> or <b>90</b>. The compound <b>84</b> shows moderate compound exposure at 8 h with a <i>C</i><sub>max</sub> of 7897 ng/mL and a calculated AUC of 6300 ng·h/mL. This compound has an IC<sub>50</sub> of 120 nM, which equates to a concentration of 57.7 ng/mL. At the 4 h time point, the average concentration of <b>84</b> was 79.5 ng/mL. By extrapolating these kinetics, we can infer that the plasma concentration of this compound would likely remain well above the IC<sub>50</sub> for the 6 h, the exact time frame required for our murine model of chronic UTI.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">High-affinity galactose and galactosamine-based ligands of FmlH have been rationally designed and optimized. These low-molecular-weight glycomimetics show great promise in the treatment and prevention of chronic UTI through inhibition of bacterial binding on both inflamed bladder and kidney tissue.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A detailed structural understanding of the FmlH sugar binding pocket and surrounding residues is crucial to the development of high-affinity ligands that utilize multiple intermolecular contacts with the protein to significantly augment binding and potency. In this study, we designed and synthesized optimized FmlH antagonists with significantly increased potency relative to initial lead GalNAc <b>1</b>.</div><div class="NLM_p">We used iterative rounds of X-ray crystallography to design analogues with improved structure–activity relationships. The most potent of these compounds, <b>90</b>, is an <i>ortho</i>-biphenyl which contains a sulfonamide moiety in the <i>meta</i> position on the distal B-ring of the biphenyl aglycone that engages in novel polar contacts with loop 1 with two serines and a phenylalanine of FmlH. Together, these additional interactions confer almost a 20-fold improvement in activity relative to the former lead compound <b>1</b>, resulting in an IC<sub>50</sub> of 34 nM. Interestingly, this structure is very different than that of <b>1</b>, as the <i>meta</i>-carboxylate group of the B-ring, instead of making interactions with loop 1, is making interactions with the R142 and K132 with the acetamide group of the sugar ring. From our SAR analysis, we discovered that reverse sulfonamides like <b>50</b> are ideally suited for interactions in the pocket formed by D45, S2, and S10, while the nitro group as in <b>29</b> and <b>30</b> is prefers to reside in the pocket formed by R142 and K132. This key information will be critical in the further optimization of this series of compounds where both pockets can be exploited to improved galactoside potency. Another aspect of future work will be to assess the selectivity of these compounds toward other Gal and GalNAc recognizing lectins including PapG and mammalian lectins as well. However, because of the extreme structural differences and receptor specificities among these proteins, we do not anticipate significant binding of our compounds to these other lectins.</div><div class="NLM_p last">An evaluation of the metabolic stability and pharmacokinetic properties of several lead compounds has shown relatively good solubility and stability in blood plasma and liver microsomes as well as simulated gut and intestinal fluids. Cyclopropyl sulfonamide GalNAc <b>86</b>, while not the most potent compound, appears to have the best PK profile in rats with a good half-life and moderate clearance. Further, compound <b>84</b> shows an excellent PK profile in mice with compound exposure well above the ELISA IC<sub>50</sub> for 6 h. However, this and other compounds tested still show only <1% oral bioavailability in the rat. Our efforts are now are directed at further lead optimization in identifying new compounds with longer half-life, higher renal clearance to the urine, and oral permeability in the gut prior to conducting additional animal studies of UTI.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Materials and Methods</h3><div class="NLM_p last">Starting materials, reagents, and solvents were purchased from commercial vendors unless otherwise noted. In general, anhydrous solvents are used for carrying out all reactions. <sup>1</sup>H and <sup>13</sup>C NMR spectra were measured on a Varian 400 and 100 MHz NMR spectrometers. The chemical shifts were reported as δ ppm relative to TMS using residual solvent peak as the reference unless otherwise noted. The following abbreviations were used to express the peak multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. High-performance liquid chromatography (HPLC) was carried out on GILSON GX-281 using Waters C18 5 μM, 4.6 mm × 50 mm and Waters Prep C18 5 μM, 19 mm × 150 mm reverse phase columns, eluted with a gradient system of 5:95 to 95:5 acetonitrile:water with a buffer consisting of 0.05–0.1% TFA. Mass spectrometry (MS) was performed on HPLC/MSD using a gradient system of 5:95 to 95:5 acetonitrile:water with a buffer consisting of 0.05–0.1% TFA on a C18 or C8 reversed phased column and electrospray ionization (ESI) for detection. All reactions were monitored by thin layer chromatography (TLC) carried out on either Merck silica gel plates (0.25 mm thick, 60F254) and visualized by using UV (254 nm) or dyes such as 5% H<sub>2</sub>SO<sub>4</sub> in ethanol. Silica gel chromatography was carried out on a Teledyne ISCO CombiFlash purification system using prepacked silica gel columns (4–80 g sizes). All compounds used for biological assays are greater than 95% purity based on NMR and HPLC by absorbance at 220 and 254 nm wavelengths.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Glycosylation Reactions</h4><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Method A</h5><div class="NLM_p last">Synthesis of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-5-acetamido-2-(acetoxymethyl)-6-(2-bromophenoxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (<b>4</b>). 1N aqueous NaOH solution (1 mL) was added into a solution of 2-acetamido-3,4,6,-tri-<i>O</i>-acetyl-1-chloro-1,2-dideoxy-α-<span class="smallcaps smallerCapital">d</span>-galactopyranose <b>2</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (100 mg, 0.273 mmol), tetrabutylammonium bromide (88 mg, 0.273 mmol), and 2-bromophenol (79 mg, 0.546 mmol) in dichloromethane (2 mL) at room temperature. The reaction solution was stirred at the same temperature until the TLC indicates complete disappearance of chloride. Dilute the reaction mass with dichloromethane (10 mL) and washed with water followed by brine. The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated undervacuo.The resulting residue was purified by silica gel chromatography with hexane/ethyl acetate (2:3) combinations as eluent, giving rise to the compound <b>4</b> and followed the same procedure for compounds <b>54</b>–<b>61</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Method B</h5><div class="NLM_p last">(2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>,6<i>S</i>)-2-(Acetoxymethyl)-6-(2-bromophenoxy)tetrahydro-2<i>H</i>-pyran-3,4,5-triyl triacetate (<b>5</b>). 1N aqueous NaOH solution (1 mL) was added into a solution of (2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>,6<i>S</i>)-2-(acetoxymethyl)-6-bromotetrahydro-2<i>H</i>-pyran-3,4,5-triyl triacetate <b>3</b> (200 mg, 0.487 mmol), benzyltriethylammonium chloride (111 mg, 0.0.487 mmol), and 2-bromophenol (79 mg, 0.975 mmol) in chloroform (2 mL) at room temperature. The reaction solution was stirred at 60 °C temperature until the TLC indicates complete disappearance of starting material. The reaction solution was cooled and diluted with the dichloromethane (10 mL) and washed with water followed by brine. The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo. The resulting residue was purified by silica gel chromatography with hexane/ethyl acetate combinations as eluent, giving rise to the desired compound <b>5</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Method C</h5><div class="NLM_p">Procedure 1: Synthesis of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-2-(acetoxymethyl)-5-amino-6-(2-bromo-3-methylphenoxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (<b>62</b>). The solution of 3,4,6-tri-<i>O</i>-acetyl-2-amino-2-deoxy-α-<span class="smallcaps smallerCapital">d</span>-galactopyranosyl bromide·HBr, <b>52</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (550 mg, 1.363 mmol) ,and sodium 2-bromo-3-methyl phenol <b>53</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (570 mg, 2.726 mmol) in acetonitrile (40 mL) was stirred at room temperature for 24 h. The solvent was evaporated under reduced pressure, and the esidue was diluted with DCM (50 mL) and washed with satd NaHCO<sub>3</sub> and brine. The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo, and the resulting residue was purified by silica gel chromatography with hexane/ethyl acetate (2:3) provides the compound <b>62</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Procedure 2: Synthesis of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-2-(acetoxymethyl)-6-(2-bromo-3-methylphenoxy)-5-(methylsulfonamido)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (<b>63</b>). Trifluoroacetic anhydride (0.22 mL, 1.581 mmol) was added into a solution of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-2-(acetoxymethyl)-5-amino-6-(2-bromo-3-methylphenoxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate <b>62</b> (250 mg, 0.527 mmol) and triethylamine (0.22 mL, 1.581 mmol) in dichloromethane (1 mL), and the solution was stirred at room temperature for 15 h. The reaction mass was diluted with dichloromethane (10 mL) and washed with satd NaHCO<sub>3</sub> (5 mL) followed by brine (5 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo. The resulting residue was purified by silica gel chromatography with hexane/ethyl acetate (2:3) combinations as eluent, giving rise to the compound <b>63</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p last">Procedure 3: Synthesis of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-2-(acetoxymethyl)-6-(2-bromo-3-methylphenoxy)-5-(methylsulfonamido)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (<b>64</b>). Methane sulfonyl chloride (119 mg, 1.038 mmol) was added into a solution of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-2-(acetoxymethyl)-5-amino-6-(2-bromo-3-methylphenoxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate <b>62</b> (246 mg, 0.519 mmol) and triethylamine (0.22 mL, 1.556 mmol) in dichloromethane (1 mL), and the solution was stirred at room temperature for 1 h. The reaction mass was diluted with dichloromethane (10 mL) and washed with satd NaHCO<sub>3</sub> (5 mL) followed by brine (5 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo. The resulting residue was purified by silica gel chromatography with hexane/ethyl acetate (2:3) combinations as eluent, giving rise to the compound <b>64</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Method D: Suzuki Reactions</h5><div class="NLM_p">Procedure 1: Under nitrogen atmosphere charge, (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-5-acetamido-2-(acetoxymethyl)-6-(2-bromophenoxy) tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (100 mg, 0.199 mmol), 3-(<i>N</i>-methyl amino carbonyl) phenyl boronic acid (78 mg, 0.298 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (23 mg, 0.0199 mmol), and cesium carbonate (211 mg, 0.597 mmol) in reaction vial and added nitrogen gas bubbled in a 1,4-dioxane/water mixture (5:1, 3.6 mL) was added, and the reaction solution was heated to 80 °C. The reaction mixture was stirred at 80 °C until TLC indicated complete disappearance of staring material (1 h). The reaction solution was cooled to RT and diluted with the dichloromethane (10 mL) and washed with water followed by brine. The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo.The resulting residue was purified by column chromatography with hexane/ethyl acetate (1:3) combinations as eluent, giving rise to the desired products <b>6</b>–<b>28</b>, <b>65</b>–<b>72</b>, and <b>75</b>–<b>77</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Synthesis of compounds <b>73</b>–<b>74</b>.</div><div class="NLM_p">Procedure 2: Synthesis of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-5-acetamido-2-(acetoxymethyl)-6-((3′-(cyclopropanesulfonamido)-6-methyl-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (<b>73</b>). Cyclopropanesulfonyl chloride (54 mg, 0.189 mmol) was added into a solution of amine <b>72</b> (100 mg, 0.378 mmol) and triethyl amine (0.08 mL, 0.567 mmol) in DCM (2.5 mL) at room temperature, and the solution was stirred for 2 h. The solution was diluted with the dichloromethane (10 mL) and washed with water followed by brine. The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo. The resulting residue was purified by column chromatography with hexane/ethyl acetate (3:2), giving rise to the desired products <b>73</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p last">Procedure 3: Synthesis of (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-5-acetamido-2-(acetoxymethyl)-6-((3′-((<i>N</i>,<i>N</i>-dimethylsulfamoyl)amino)-6-methyl-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (<b>74</b>). <i>N</i>,<i>N</i>-Dimethylsulfonyl chloride (54 mg, 0.189 mmol) was added into a solution of amine <b>72</b> (100 mg, 0.378 mmol) and triethylamine (0.08 mL, 0.567 mmol) in DMF (2.5 mL) mixed I and stirred under microwaves at 80 °C for 2 h. The reaction solution was cooled to RT and diluted with the dichloromethane (10 mL) and washed with water followed by brine. The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuo. The resulting residue was purified by column chromatography with hexane/ethyl acetate (4:1) combinations as eluent, giving rise to the desired products <b>74</b> (analytical data in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_2_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Method E. General Procedure for Compounds for <b>29</b>–<b>51</b> and <b>78</b>–<b>90</b></h5><div class="NLM_p">Procedure 1: Synthesis of compounds (<b>29</b>). NaOH (27 mg, 0.66 mmol) was added into a solution of compound <b>6</b> (110 mg, 0.066 mmol) in methanol–water (1:1, 5 mL) at room temperature, stirred (15 h) until the TLC indicated complete disappearance of the staring material. The reaction solution was acidified pH∼2 with 3N aqueous HCl and the product was extracted with ethyl acetate (3 × 10 mL). The organic layers were combined and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was subjected for HPLC purification provided compound <b>29</b> and followed the same procedure for compounds <b>30</b>, <b>31</b>, and <b>82</b>.</div><div class="NLM_p last">Procedure 2: An excess amount of 33% wt methylamine in absolute ethanol solution (5 mL) was added into (2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>)-5-acetamido-2-(acetoxymethyl)-6-(quinolin-8-yloxy)tetrahydro-2<i>H</i>-pyran-3,4-diyl diacetate (50 mg, 0.105 mmol). The reaction solution was stirred at the same temperature (0.5–1 h) until TLC indicated complete disappearance of staring material. Complete evaporation of the solvent provides the desired product compound <b>32</b>, which was subjected for HPLC purification and followed the same procedure for compounds <b>33</b>–<b>51</b>, <b>78</b>–<b>81</b>, and <b>83</b>–<b>90</b>.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Experimental Protocols and Analytical Data of Final Compounds</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2′-(((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-5-nitro-[1,1′-biphenyl]-3-carboxylic Acid (<b>29</b>)</h4><div class="NLM_p last">Followed method E (procedure 1). White solid, 30 mg in 98% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.75 (s, 1H), 8.54 (d, <i>J</i> = 1.6 Hz, 1H), 8.41 (d, <i>J</i> = 1.6 Hz, 1H), 7.47–7.35 (m, 4H), 7.22–7.14 (m, 1H),5.08 (d, <i>J</i> = 8.2 Hz, 1H), 4.03 (t, <i>J</i> = 9.6 Hz, 1H), 3.91–3.74 (m, 3H), 3.73–3.60 (m, 2H), 1.58 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.67, 167.67, 156.07, 149.69, 141.81, 137.16, 133.74, 131.65, 131.54, 129.77, 124.17, 123.83, 117.13, 111.59, 101.67, 77.45, 73.24, 69.78, 62.63, 54.21, 22.69. LCMS (ESI): C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>10</sub>, found [M + Na]<sup>+</sup> 485.2.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-Nitro-2′-(((2<i>S</i>,3<i>R</i>,4S,5<i>R</i>,6<i>R</i>)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-carboxylic Acid (<b>30</b>)</h4><div class="NLM_p last">Followed method E (procedure 1). White solid, 62 mg in 88% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.73 (s, 2 H), 8.58 (s, 1 H), 7.46–7.37 (m, 4 H), 7.21–7.15 (m, 1 H), 5.01 (d, <i>J</i> = 7.4 Hz, 1 H), 3.89 (d, <i>J</i> = 3.5 Hz, 1 H), 3.83–3.74 (m, 2 H), 3.72–3.66 (m, 2 H), 3.56 (dd, <i>J</i> = 9.6, 3.3 Hz, 1 H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 167.88, 156.03, 149.75, 142.10, 137.57, 133.60, 131.57, 129.73, 124.13, 123.66, 117.52, 103.33, 77.27, 75.31, 72.33, 70.3562.51. LCMS (ESI): C<sub>19</sub>H<sub>19</sub>NO<sub>10</sub>, found [M + Na]<sup>+</sup> 444.3.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-6-methoxy-[1,1′-biphenyl]-3-carboxylic Acid (<b>31</b>)</h4><div class="NLM_p last">Followed method E (procedure 1). White solid, 49 mg in 65% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.03 (dd, <i>J</i> = 2.0, 8.6 Hz, 1H), 7.78 (d, <i>J</i> = 2.4 Hz, 1H), 7.36–7.29 (m, 2H), 7.15 (d, <i>J</i> = 7.4 Hz, 1H), 7.10–7.03 (m, 2H), 4.95 (d, <i>J</i> = 8.2 Hz, 1H), 3.96 (dd, <i>J</i> = 8.8, 10.4 Hz, 1H), 3.88–3.83 (m, 1H), 3.82 (s, 3H), 3.80–3.73 (m, 1H), 3.67–3.62 (m, 1H), 3.58 (dd, <i>J</i> = 3.1, 10.6 Hz, 1H), 1.62 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.77, 170.06, 162.78, 156.91, 134.12, 132.47, 132.33, 130.16, 129.56, 129.31, 123.58, 123.31, 116.78, 112.06, 111.59, 101.61, 77.29, 73.49, 69.80, 62.62, 56.50, 54.20, 22.87. LCMS (ESI): C<sub>22</sub>H<sub>25</sub>NO<sub>9</sub>, found [M + Na]<sup>+</sup> 470.3.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-2-((3′-hydroxy-[1,1′-biphenyl]-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>32</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 30 mg in 70% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.36–7.25 (m, 3 H), 7.23–7.10 (m, 2H), 7.09–6.83 (m, 4H), 5.06 (d, <i>J</i> = 8.6 Hz, 1H), 4.11 (dd, <i>J</i> = 10.4, 8.8 Hz, 1H), 3.88 (d, <i>J</i> = 3.1 Hz, 1H), 3.86–3.74 (m, 2H), 3.72–3.60 (m, 2H), 1.73 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.31, 158.05, 156.13, 140.97, 132.87, 131.78, 129.79, 123.74, 122.35, 117.86, 117.09, 115.08, 101.44, 77.35, 73.63, 69.81, 62.63, 54.36, 22.96. LCMS (ESI): C<sub>20</sub>H<sub>23</sub>NO<sub>7</sub>, found [M + Na]<sup>+</sup> 412.3.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-yl methanesulfonate (<b>33</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 30 mg in 94% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.51–7.46 (m, 2H), 7.38–7.32 (m, 2H), 7.32–7.27 (m, 1H), 7.16–7.10 (m, 1H), 5.15 (d, <i>J</i> = 8.2 Hz, 1H), 4.05 (dd, <i>J</i> = 8.4, 10.8 Hz, 1H), 3.89 (d, <i>J</i> = 3.3 Hz, 1H), 3.84–3.75 (m, 2H), 3.73–3.66 (m, 2H), 3.29 (s, 3H), 1.71 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.98, 156.04, 150.72, 141.82, 131.81, 131.30, 130.72, 129.89, 124.60, 124.02, 121.79, 117.10, 101.35, 77.43, 73.27, 69.79, 62.61, 54.47, 37.77, 22.96. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>NO<sub>9</sub>S, found [M + Na]<sup>+</sup> 490.3.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-2-((5′-hydroxy-2′-methoxy-[1,1′-biphenyl]-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>34</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 21 mg in 91% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.14 (dd, <i>J</i> = 7.4, 1.2 Hz, 1H), 7.03 (t, <i>J</i> = 6.8 Hz, 1H), 6.86 (d, <i>J</i> = 9.0 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.9 Hz, 1H), 6.60 (d, <i>J</i> = 3.1 Hz, 1H), 4.95 (d, <i>J</i> = 8.2 Hz, 1H), 4.00 (dd, <i>J</i> = 10.6, 8.6 Hz, 1H), 3.86 (d, <i>J</i> = 2.7 Hz, 1H), 3.84–3.80 (m, 1H), 3.79–3.74 (m, 1H), 3.66 (s, 3H), 3.64–3.61 (m, 1H), 3.61–3.56 (m, 2H), 1.73 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.15, 156.75, 152.19, 151.93, 132.55, 130.44, 129.68, 123.21, 119.49, 117.10, 115.98, 114.77, 101.70, 77.25, 73.62, 69.80, 62.61, 57.44, 54.32, 23.02. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>NO<sub>8</sub>, found [M + Na]<sup>+</sup> 442.3.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-6-methoxy-[1,1′-biphenyl]-3-yl Methanesulfonate (<b>35</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 13 mg in 82% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.34–7.25 (m, 3H), 7.20 (d, <i>J</i> = 7.4 Hz, 1H), 7.14 (d, <i>J</i> = 2.7 Hz, 1H), 7.10–7.02 (m, 2H), 5.01 (d, <i>J</i> = 8.2 Hz, 1H), 4.01–3.93 (m, 1H), 3.89–3.83 (m, 1H), 3.83–3.79 (m, 1H), 3.74 (s, 1H), 3.64 (t, <i>J</i> = 6.1 Hz, 2H), 3.23 (s, 3H), 1.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.87, 156.47, 143.93, 132.69, 128.77, 126.45, 123.27, 116.95, 113.58, 101.39, 77.30, 73.34, 69.75, 62.59, 56.79, 54.31, 37.38, 23.05. LCMS (ESI): C<sub>22</sub>H<sub>27</sub>NO<sub>10</sub>S, found [M + Na]<sup>+</sup> 520.2.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-((3′-Fluoro-[1,1′-biphenyl]-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>36</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 32 mg in 85% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.41–7.24 (m, 5H), 7.20 (dd, <i>J</i> = 10.4, 1.8 Hz, 1H), 7.14–7.07 (m, 1H), 7.07–7.00 (m, 1H), 5.06 (d, <i>J</i> = 8.2 Hz, 1H), 4.19–4.10 (m, 1H), 3.89 (d, <i>J</i> = 3.1 Hz, 1H), 3.87–3.75 (m, 2H), 3.72–3.67 (m, 1H), 3.61 (dd, <i>J</i> = 11.0, 3.1 Hz, 1H), 1.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.95, 165.19, 162.76, 156.03, 141.98, 131.78, 131.54, 130.82, 130.74, 130.47, 126.70, 126.67, 123.85, 117.70, 117.48, 116.99, 114.82, 114.61, 101.42, 77.41, 73.74, 69.81, 62.62, 54.12, 22.83. LCMS (ESI): C<sub>20</sub>H<sub>22</sub>FNO<sub>6</sub>, found [M + Na]<sup>+</sup> 414.3.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-methoxy-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>37</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 20 mg in 87% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.39–7.34 (m, 1H), 7.33–7.22 (m, 4H), 7.12–7.00 (m, 3H), 6.86 (d, <i>J</i> = 8.2 Hz, 1H), 5.03 (d, <i>J</i> = 8.2 Hz, 1H), 4.12 (t, <i>J</i> = 9.8 Hz, 1H), 3.91–3.85 (m, 1H), 3.83 (s, 3H), 3.81–3.74 (m, 1H), 3.71–3.64 (m, 1H), 3.60 (dd, <i>J</i> = 10.6, 2.3 Hz, 1H), 2.55 (s, 1H), 1.65 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.07, 160.81, 156.24, 141.06, 132.95, 131.84, 129.96, 123.85, 123.23, 117.29, 116.47, 113.80, 101.85, 77.40, 73.79, 69.82, 62.64, 55.83, 54.25, 22.80. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>NO<sub>7</sub>, found [M + Na]<sup>+</sup> 426.3.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-nitro-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>38</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 35 mg in 91% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.33 (s, 1H), 8.19 (d, <i>J</i> = 8.2 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.62 (t, <i>J</i> = 8.0 Hz, 1H), 7.41–7.35 (m, 3H), 7.18–7.13 (m, 1H), 5.07 (d, <i>J</i> = 8.6 Hz, 1H), 4.14–4.08 (m, 1H), 3.89 (d, <i>J</i> = 2.7 Hz, 1H), 3.87–3.75 (m, 3H), 3.73–3.67 (m, 1H), 3.61 (dd, <i>J</i> = 10.6, 3.1 Hz, 1H), 2.55 (s, 1H), 1.63 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.74, 156.05, 149.62, 141.30, 137.07, 131.66, 131.20, 130.38, 125.60, 124.06, 122.87, 117.01, 101.51, 77.43, 73.50, 69.77, 62.62, 54.04, 22.77. LCMS (ESI): C<sub>20</sub>H<sub>22</sub>N<sub>2</sub>O<sub>8</sub>, found [M + Na]<sup>+</sup> 441.3.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-((3′-Cyano-[1,1′-biphenyl]-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>39</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 16 mg in 84% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.82–7.77 (m, 2H), 7.67 (d, <i>J</i> = 9.00 Hz, 1H), 7.59–7.53 (m, 1H), 7.40–7.31 (m, 3H), 7.17–7.10 (m, 1H), 5.07 (d, <i>J</i> = 8.2 Hz, 1H), 4.18–4.10 (m, 1H), 3.90 (d, <i>J</i> = 3.1 Hz, 1H), 3.87–3.74 (m, 2H), 3.73–3.67 (m, 1H), 3.61 (dd, <i>J</i> = 2.5, 10.8 Hz, 1H), 1.70 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.77, 155.97, 141.05, 135.62, 134.28, 131.72, 131.03, 130.36, 123.99, 120.08, 116.88, 113.37, 101.38, 77.42, 73.58, 69.77, 62.61, 54.01, 22.87. LCMS (ESI): C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub>, found [M + Na]<sup>+</sup> 421.3.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>40</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 14 mg in 86% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.78 (d, <i>J</i> = 7.4 Hz, 1H), 7.68 (s, 1H), 7.63–7.53 (m, 2H), 7.39–7.36 (m, 2H), 7.36–7.30 (m, 1H), 7.17–7.11 (m, 1H), 5.07 (d, <i>J</i> = 8.6 Hz, 1H), 4.11 (dd, <i>J</i> = 10.4, 8.8 Hz, 1H), 3.89 (br s, 1H), 3.86–3.75 (m, 2H), 3.73–3.66 (m, 1H), 3.61 (dd, <i>J</i> = 10.8, 3.3 Hz, 1H), 1.63 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.39, 156.11, 140.70, 135.02, 131.74, 131.33, 130.81, 129.92, 126.95, 124.75, 117.02, 101.53, 77.44, 73.72, 69.78, 62.62, 54.13, 22.73. LCMS (ESI): C<sub>21</sub>H<sub>22</sub>F<sub>3</sub>NO<sub>6</sub>, found [M + Na]<sup>+</sup> 464.3.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-(methylsulfonyl)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>41</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 14 mg in 60% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.10 (s, 1H), 7.90 (d, <i>J</i> = 7.8 Hz, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.69–7.62 (m, 1H), 7.42–7.34 (m, 3H), 7.18–7.12 (m, 1H), 5.14 (d, <i>J</i> = 8.2 Hz, 1H), 4.06 (dd, <i>J</i> = 10.6, 8.6 Hz, 1H), 3.89 (d, <i>J</i> = 3.1 Hz, 1H), 3.87–3.75 (m, 3H), 3.71–3.63 (m, 2H), 3.24 (s, 2H), 1.68 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.81, 156.05, 141.91, 141.01, 136.05, 131.77, 131.06, 130.44, 129.69, 126.80, 124.10, 116.95, 101.46, 77.44, 73.41, 69.77, 62.61, 54.27, 44.65, 22.93. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>NO<sub>8</sub>S, found [M + Na]<sup>+</sup> 474.3.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-(hydroxymethyl)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>42</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 33 mg in 87% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.53 (s, 1H), 7.40–7.27 (m, 6H), 7.12–7.06 (m, 1H), 4.97 (d, <i>J</i> = 8.6 Hz, 1H), 4.63 (s, 2H), 4.18 (dd, <i>J</i> = 8.6, 10.6 Hz, 1H), 3.88 (d, <i>J</i> = 3.5 Hz, 1H), 3.86–3.82 (m, 1H), 3.81–3.76 (m, 1H), 3.71–3.66 (m, 1H), 3.59 (dd, <i>J</i> = 3.1, 10.6 Hz, 1H), 1.54 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.24, 156.32, 142.22, 132.65, 131.80, 130.32, 129.99, 129.65, 129.33, 127.18, 123.90, 117.10, 101.91, 77.42, 73.47, 69.82, 65.84, 62.68, 54.09, 22.70. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>NO<sub>7</sub>, found [M + Na]<sup>+</sup> 426.3.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-yl)acetamide (<b>43</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 38 mg in 96% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.63 (t, <i>J</i> = 1.8 Hz, 1H), 7.56 (d, <i>J</i> = 9.0 Hz, 1H), 7.36–7.28 (m, 5H), 7.23 (s, 1H), 7.09 (td, <i>J</i> = 7.2, 1.6 Hz, 1H), 5.11 (d, <i>J</i> = 8.6 Hz, 1H), 4.13 (dd, <i>J</i> = 10.6, 8.6 Hz, 1H), 3.89 (d, <i>J</i> = 3.1 Hz, 1H), 3.85–3.74 (m, 2H), 3.70–3.65 (m, 2H), 2.16 (s, 3H),1.70 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.17, 171.86, 155.99, 140.15, 139.38, 132.16, 131.78, 130.08, 129.58, 126.81, 132.83, 123.23, 120.35, 116.84, 101.05, 77.32, 73.37, 69.80, 62.63, 54.32, 24.01, 23.02. LCMS (ESI): C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>7</sub>, found [M + Na]<sup>+</sup> 453.3.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(2′-(((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-yl)-2,2,2-trifluoroacetamide (<b>44</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 20 mg in 63% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.70–7.65 (m, 2H), 7.44–7.38 (m, 1H), 7.38–7.31 (m, 4H), 7.13–7.08 (m, 1H), 5.10 (d, <i>J</i> = 8.2 Hz,1H), 4.18 (dd, <i>J</i> = 8.6, 10.6 Hz, 1H), 3.89 (d, <i>J</i> = 3.1 Hz, 1H), 3.85–3.73 (m, 2H), 3.72–3.61 (m, 2H), 1.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.09, 155.88, 140.47, 137.15, 131.80, 130.33, 129.85, 128.45, 124.18, 123.80, 121.26, 116.52, 100.88, 77.31, 73.38, 69.76, 62.59, 54.06, 22.94. LCMS (ESI): C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>2</sub>O<sub>7</sub>, found [M + Na]<sup>+</sup> 507.4.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl (2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-yl)carbamate (<b>45</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 34 mg in 87% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.53 (br s, 1H), 7.41 (d, <i>J</i> = 8.6 Hz, 1H), 7.35–7.27 (m, 4H), 7.16 (d, <i>J</i> = 7.8 Hz, 1H), 7.11–7.06 (m, 1H), 5.11 (d, <i>J</i> = 8.6 Hz, 1H), 4.09 (dd, <i>J</i> = 8.6, 10.6 Hz, 1H), 3.88 (d, <i>J</i> = 3.1 Hz, 1H), 3.85–3.77 (m, 2H), 3.74 (s, 3H), 3.68 (dd, <i>J</i> = 3.1, 10.6 Hz, 2H), 1.70 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.17, 156.01, 140.27, 132.46, 131.85, 130.00, 129.57, 125.88, 123.39, 116.89, 101.08, 77.32, 73.34, 69.83, 62.61, 54.42, 52.67, 22.96. LCMS (ESI): C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>8</sub>, found [M + Na]<sup>+</sup>, 469.2.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-<i>N</i>,<i>N</i>-dimethyl-[1,1′-biphenyl]-3-carboxamide (<b>46</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 29 mg in 86% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.60–7.55 (m, 2H), 7.47 (t, <i>J</i> = 7.8 Hz, 1H), 7.39–7.29 (m, 4H), 7.14–7.08 (m, 1H), 5.17 (d, <i>J</i> = 8.2 Hz, 1H), 4.06–3.98 (m, 1H), 3.89 (d, <i>J</i> = 2.7 Hz, 1H), 3.84–3.73 (m, 2H), 3.73–3.65 (m, 2H), 3.12 (d, <i>J</i> = 5.1 Hz, 6H), 1.74 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.94, 156.03, 140.15, 136.96, 132.31, 131.84, 130.44, 129.66, 129.41, 126.62, 123.90, 116.88, 101.05, 77.35, 73.42, 69.77, 62.63, 54.49, 40.58, 35.88, 23.01. LCMS (ESI): C<sub>23</sub>H<sub>28</sub>N<sub>2</sub>O<sub>7</sub>, found [M + Na]<sup>+</sup> 445.3.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-<i>N</i>-methyl-[1,1′-biphenyl]-3-carboxamide (<b>47</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 62 mg in 73% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.93 (d, <i>J</i> = 3.91 Hz, 1H), 7.73 (t, <i>J</i> = 5.09 Hz, 1H), 7.65 (t, <i>J</i> = 5.87 Hz, 1H), 7.50–7.44 (m, 1H), 7.36 (d, <i>J</i> = 4.70 Hz, 3H), 7.16–7.09 (m, 1H), 5.13–5.07 (m, 1H),4.17- 4.10 (m, 1H), 3.93–3.74 (m, 3H), 3.73–3.64 (m, 2H), 2.96 (d, <i>J</i> = 5.1 Hz, 3H),1.64 (d, <i>J</i> = 4.7 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.03, 156.12, 140.03, 135.80, 133.90, 131.92, 130.44, 129.54, 126.83, 123.96, 116.96, 101.53, 77.41, 73.27, 69.79, 62.64, 54.23, 27.12, 22.82. LCMS (ESI): C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>7</sub>, found [M + Na]<sup>+</sup> 453.3.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2′-(((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-carboxamide (<b>48</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 13 mg in 85% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.99 (s, 1H), 7.79 (d, <i>J</i> = 7.83 Hz, 1H), 7.68 (d, <i>J</i> = 7.83 Hz, 1H), 7.50–7.45 (m, 1H), 7.39–7.31 (m, 4H), 7.12 (t, <i>J</i> = 6.9 Hz, 1H), 5.11 (d, <i>J</i> = 8.2 Hz, 1H), 4.10 (dd, <i>J</i> = 8.8, 10.4 Hz, 1H), 3.89 (d, <i>J</i> = 3.13 Hz, 1H), 3.87–3.75 (m, 3H), 3.72–3.64 (m, 3H), 1.64 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.01, 172.99, 156.13, 140.02, 135.11, 134.37, 131.91, 130.44, 129.96, 129.41, 127.24, 123.97, 117.00, 101.50, 77.41, 73.26, 62.63, 54.32, 22.82. LCMS (ESI): C<sub>21</sub>H<sub>24</sub>N<sub>2</sub>O<sub>7</sub>, found [M + Na]<sup>+</sup> 439.3.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>49</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 34 g in 96% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.40 (s, 1H), 7.36 (s, 1H), 7.32 (d, <i>J</i> = 5.9 Hz, 3H), 7.29–7.22 (m, 2H), 7.12–7.07 (m, 1H), 5.12 (d, <i>J</i> = 8.6 Hz, 1H), 4.11 (dd, <i>J</i> = 8.6, 10.6 Hz, 1H), 3.89 (d, <i>J</i> = 3.1 Hz, 1H), 3.85–3.73 (m, 2H), 3.71–3.63 (m, 2H), 3.03 (s, 3H), 1.73 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm174.06, 155.99, 140.93, 139.06, 131.97, 130.27, 127.25, 123.82, 120.68, 116.69, 101.09, 77.35, 73.46, 62.60, 54.24, 39.58, 23.04. LCMS (ESI): C<sub>21</sub>H<sub>26</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 489.2.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-((trifluoromethyl)sulfonamido)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>50</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 25 mg in 63% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.70–7.65 (m, 2H), 7.44–7.38 (m, 1H), 7.38–7.31 (m, 4H), 7.13–7.08 (m, 1H), 5.10 (d, <i>J</i> = 8.2 Hz,1H), 4.18 (dd, <i>J</i> = 8.6, 10.6 Hz, 1H), 3.89 (d, <i>J</i> = 3.1 Hz, 1H), 3.85–3.73 (m, 2H), 3.72–3.61 (m, 2H), 1.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 174.09, 155.88, 140.47, 137.15, 131.80, 130.33, 129.85, 128.45, 124.18, 123.80, 121.26, 116.52, 100.88, 77.31, 73.38, 69.76, 62.59, 54.06, 22.94 . LCMS (ESI): C<sub>21</sub>H<sub>23</sub>F<sub>3</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 543.2.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(2′-(((2<i>S</i>,3<i>R</i>,4S,5<i>R</i>,6<i>R</i>)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-[1,1′-biphenyl]-3-yl)methanesulfonamide (<b>51</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 33 mg in 93% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.54 (s, 1 H), 7.39–7.27 (m, 5 H), 7.26–7.19 (m, 1 H), 7.12–7.06 (m, 1 H), 5.06 (d, <i>J</i> = 7.8 Hz, 1 H),3.89 (d, <i>J</i> = 3.1 Hz, 1 H), 3.77–3.72 (m, 2 H), 3.72–3.66 (m, 2 H), 3.57 (dd, <i>J</i> = 9.6, 3.3 Hz, 1 H), 3.01 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 153.37, 141.09, 138.77, 131.72, 129.98, 127.19, 123.71, 123.36, 120.63, 116.29, 101.96, 76.91, 75.02, 72.17, 70.15, 62.2739.16. LCMS (ESI): C<sub>19</sub>H<sub>23</sub>NO<sub>8</sub>S, C<sub>19</sub>H<sub>23</sub>NO<sub>8</sub>S, found [M + Na]<sup>+</sup> 448.2.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-(methylsulfonamido)-6-nitro-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>78</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 30 mg in 94% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.63–7.58 (m, 1H), 7.57–7.49 (m, 3H), 7.39–7.33 (m, 1H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.16 (s, 1H), 6.98(d, <i>J</i> = 7.4 Hz, 1H), 5.11 (d, <i>J</i> = 8.6 Hz, 1H), 3.97 (t, <i>J</i> = 9.6 Hz, 1H), 3.87 (d, <i>J</i> = 2.4 Hz, 1H), 3.85–3.73 (m, 2H), 3.73–3.67 (m, 1H), 3.63(dd, <i>J</i> = 2.4, 10.6 Hz, 1H), 3.00 (s, 3H), 1.78 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.81, 156.82, 152.49, 139.54, 135.32, 130.82, 130.48, 126.29, 121.27, 120.33, 118.20, 101.19, 77.60, 73.35, 69.74, 62.63, 53.92, 39.34, 23.16. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>10</sub>S, found [M + H]<sup>+</sup> 512.3.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-2-((6-Cyano-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>79</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 25 mg in 88% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.64 (dd, <i>J</i> = 2.9, 6.46 Hz, 1H), 7.53–7.47 (m, 2H), 7.45–7.39 (m, 1H), 7.34–7.26 (m, 2H), 7.14 (d, <i>J</i> = 7.4 Hz, 1H), 5.09 (d, <i>J</i> = 8.6 Hz, 1H), 4.03–3.96 (m, 1H), 3.87 (d, <i>J</i> = 2.7 Hz, 1H), 3.83–3.73 (m, 2H), 3.72–3.66 (m, 1H), 3.65–3.60 (m,1H), 3.05 (s, 3H), 1.78 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.83, 156.43, 139.53, 136.87, 135.97, 131.11, 130.50, 128.08, 127.49, 121.62, 119.11, 114.82, 101.08, 77.57, 73.29, 69.74, 62.63, 53.95, 39.60, 23.11. LCMS (ESI): C<sub>22</sub>H<sub>25</sub>N<sub>3</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 514.2.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-((6-Fluoro-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>80</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 7 mg in 59% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.40–7.28 (m, 2H), 7.25 (br s, 2H), 7.14 (dd, <i>J</i> = 8.0, 12.3 Hz, 2H), 6.88 (t, <i>J</i> = 9.0 Hz, 1H), 5.10 (d, <i>J</i> = 8.2 Hz, 1H), 4.00 (t, <i>J</i> = 9.6 Hz, 1H), 3.87 (d, <i>J</i> = 2.4 Hz, 1H), 3.84–3.73 (m, 2H), 3.71–3.60 (m, 2H), 3.03 (s, 3H), 1.77 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.91, 139.12, 133.95, 130.61, 130.01, 128.28, 124.36, 121.10, 112.25, 110.79, 110.56, 101.05, 77.42, 73.40, 69.74, 62.59, 54.09, 39.50, 23.11. LCMS (ESI): C<sub>21</sub>H<sub>25</sub>FN<sub>2</sub>O<sub>8</sub>S, found [M + H]<sup>+</sup> 485.3.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Benzyl 6-(((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-carboxylate (<b>81</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 37 mg in 90% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.52–7.45 (m, 1H), 7.45–7.40 (m, 2H), 7.30–7.23 (m, 3H), 7.18–7.10 (m, 2H), 7.06–7.00 (m, 2H), 6.94 (d, <i>J</i> = 8.2 Hz, 1H), 5.06 (d, <i>J</i> = 8.2 Hz, 1H), 5.00 (s, 2H), 4.01–3.93 (m, 1H), 3.85 (d, <i>J</i> = 2.7 Hz, 1H), 3.84–3.71 (m, 2H), 3.70–3.64 (m,1H), 3.60 (dd, <i>J</i> = 3.1, 10.6 Hz, 1H), 2.90 (s, 3H), 1.76 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 170.06, 156.30, 139.07, 138.98, 134.93, 131.98, 130.13, 129.62, 129.30, 124.27, 123.41, 120.80, 119.40, 101.05, 77.43, 73.54, 69.75, 68.27, 62.62, 54.02, 39.46, 23.15. LCMS (ESI): C<sub>29</sub>H<sub>32</sub>N<sub>2</sub>O<sub>10</sub>S, found [M + H]<sup>+</sup> 601.3.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-(((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-2-yl)oxy)-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-carboxylic Acid (<b>82</b>)</h4><div class="NLM_p last">Followed method E (procedure 1). White solid, 22 mg in 92% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm7.49–7.37 (m, 3H), 7.33–7.27 (m, 1H), 7.19–7.13 (m, 2H), 7.00 (d, <i>J</i> = 7.4 Hz, 1H), 5.06 (d, <i>J</i> = 8.6 Hz, 1H), 4.00–3.91 (m, 1H), 3.86 (d, <i>J</i> = 2.7 Hz, 1H), 3.83–3.72 (m, 2H), 3.71–3.65 (m, 1H), 3.61 (dd, <i>J</i> = 3.1, 10.6 Hz, 1H), 2.99 (s, 3H),1.78 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.87, 171.76, 156.34, 139.18, 138.89, 135.62, 132.08, 129.79, 124.11, 120.69, 119.15, 101.09, 77.41, 73.55, 69.77, 62.63, 54.07, 39.29, 23.18. LCMS (ESI): C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>10</sub>S, found [M + H]<sup>+</sup> 511.2.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((6-methoxy-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>83</b>)</h4><div class="NLM_p last">Followed method E (procedure 2)., White solid, 13 mg in 93% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.28 (q, <i>J</i> = 8.4 Hz, 2H), 7.18–7.14 (m, 2H), 7.04 (d, <i>J</i> = 7.8 Hz, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 1H), 6.77(d, <i>J</i> = 8.2 Hz, 1H), 5.06 (d, <i>J</i> = 8.6 Hz, 1H), 3.93 (dd, <i>J</i> = 8.6, 10.6 Hz, 1H), 3.86 (d, <i>J</i> = 3.1 Hz, 1H), 3.82–3.73 (m, 2H), 3.71 (s, 3H), 3.68–3.59 (m, 2H), 3.02 (s, 3H), 1.78 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.90, 159.07, 156.88, 138.65, 136.71, 130.33, 129.54, 128.81, 124.94, 120.47, 109.18, 106.85, 100.95, 77.27, 73.56, 69.75, 62.58, 56.49, 54.21, 39.35, 23.16. LCMS (ESI): C<sub>22</sub>H<sub>28</sub>N<sub>2</sub>O<sub>9</sub>S, found [M + Na]<sup>+</sup> 519.3.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((6-methyl-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>84</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 31 mg in 97% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.35 (t, <i>J</i> = 7.0 Hz, 1H), 7.23–7.16 (m, 2H), 7.15–7.10 (m, 1H), 7.07 (s, 1H), 6.95 (d, <i>J</i> = 7.4 Hz, 2H),5.01 (d, <i>J</i> = 8.6 Hz, 1H), 3.94–3.71 (m, 4H), 3.68–3.56 (m, 2H), 3.01 (s, 3H), 2.05 (s, 3H), 1.81 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 171.92, 140.15, 138.68, 132.35, 130.18, 129.51, 125.15, 100.98, 77.21, 69.75, 62.58, 54.15, 39.46, 23.24, 20.79. LCMS (ESI): C<sub>22</sub>H<sub>28</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + H]<sup>+</sup> 481.4.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((1-(3-(methylsulfonamido)phenyl)naphthalen-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>85</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 54 mg in 97% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.92–7.82 (m, 2H), 7.65–7.59 (m, 1H), 7.47–7.41 (m, 2H), 7.39–7.26 (m, 3H), 7.21 (d, <i>J</i> = 12.9 Hz, 1H), 7.03 (d, <i>J</i> = 7.0 Hz, 1H), 5.15 (d, <i>J</i> = 8.6 Hz, 1H), 4.02–3.94 (m, 1H), 3.87 (br s, 1H), 3.86–3.76 (m, 2H), 3.73–3.58 (m, 2H), 3.07 (s, 3H), 1.80 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.36, 139.64, 138.87, 130.63, 130.41, 129.10, 128.02, 127.62, 126.97, 126.39, 125.34, 124.61, 124.44, 120.75, 120.40, 118.19, 117.73, 101.57, 101.40, 39.59.23.25. LCMS (ESI): C<sub>25</sub>H<sub>28</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 517.3.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-((3′-(Cyclopropanesulfonamido)-6-methyl-[1,1′-biphenyl]-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>86</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 22 mg in 93% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.31–7.38 (m, 1H), 7.26–7.16 (m, 2H), 7.11 (d, <i>J</i> = 9.8 Hz, 2H), 6.95 (d, <i>J</i> = 7.4 Hz, 2H), 5.03 (d, <i>J</i> = 8.2 Hz, 1H), 3.91–3.81 (m, 2H), 3.80–3.71 (m, 2H), 3.67–3.56 (m, 2H), 2.65–2.53 (m, 1H), 2.05 (s, 3H, 1.83 (s, 3H), 1.07–0.95 (m, 4H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 156.23, 139.99, 138.70, 132.40, 129.98, 125.10, 124.87, 100.85, 77.18, 69.73, 62.60, 54.22, 30.52, 23.24, 20.81, 6.06. LCMS (ESI): C<sub>24</sub>H<sub>30</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 529.3.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-2-((3′-((<i>N</i>,<i>N</i>-Dimethylsulfamoyl)amino)-6-methyl-[1,1′-biphenyl]-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>87</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 21 mg in 89% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.77 (br s, 1H), 7.56(d, <i>J</i> = 7.8 Hz, 1H), 7.28–7.17 (m, 2H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 7.02 (d, <i>J</i> = 8.2 Hz, 1H), 6.82 (d, <i>J</i> = 7.4 Hz, 1H), 4.93 (d, <i>J</i> = 8.6 Hz, 1H), 3.79–3.69 (m, 1H), 3.66 (br s, 1H), 3.57–3.47 (m, 3H), 3.47–3.40 (m, 1H), 2.70 (s, 6H), 1.99 (s, 3H), 1.74 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 171.99, 155.37, 135.52, 128.92, 128.12, 126.42, 125.47, 118.37, 99.26, 99.08, 75.89, 72.05, 71.74, 68.16, 61.03, 52.29, 37.60, 21.68. LCMS (ESI): C<sub>23</sub>H<sub>31</sub>N<sub>3</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 532.3.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((6-methyl-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)-2,2,2-trifluoroacetimidic Acid (<b>88</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 6 mg in 23% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.93 (d, <i>J</i> = 9.4 Hz, 1H), 7.29 (t, <i>J</i> = 6.5 Hz, 1H), 7.22 (br s, 2H), 7.08–6.98 (m, 2H), 6.95 (d, <i>J</i> = 7.4 Hz, 1H), 6.83 (br s, 1H), 5.11 (d, <i>J</i> = 8.6 Hz, 1H), 4.05–3.95 (m, 1H), 3.87 (d, <i>J</i> = 2.4 Hz, 1H), 3.83–3.72 (m, 2H), 3.66 (d, <i>J</i> = 9.4 Hz, 2H),3.02 (br s, 3H), 2.04 (s, 3H) (Note: <sup>13</sup>C NMR not provide due to due to insufficient quantity). LCMS (ESI): C<sub>22</sub>H<sub>25</sub>F<sub>3</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + Na]<sup>+</sup> 557.3.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-((2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((6-methyl-3′-(methylsulfonamido)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)methanesulfonamide (<b>89</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 39 mg in 97% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.40–7.35 (m, 1H), 7.28–7.19 (m, 2H), 7.14 (d, <i>J</i> = 9.8 Hz, 1H), 7.09–6.94 (m, 3H), 5.08 (d, <i>J</i> = 16.8 Hz, 1H), 3.89 (br s, 1H), 3.73 (d, <i>J</i> = 5.9 Hz, 2H), 3.64–3.60 (m, 1H), 3.55–3.50 (m, 1H), 3.48–3.37 (m, 1H), 2.59–2.39 (m, 3H), 2.08 (br s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 149.33, 130.37, 129.45, 125.22, 77.05, 69.81, 62.34, 57.85, 41.92, 39.63, 20.94. LCMS (ESI): C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>9</sub>S<sub>2</sub>, found [M + Na]<sup>+</sup> 539.3.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-4,5-Dihydroxy-6-(hydroxymethyl)-2-((3′-(methylsulfonamido)-6-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)oxy)tetrahydro-2<i>H</i>-pyran-3-yl)acetamide (<b>90</b>)</h4><div class="NLM_p last">Followed method E (procedure 2). White solid, 20 mg in 84% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.57–7.48 (m, 2H), 7.46–7.41 (m, 1H), 7.37–7.30 (m, 1H), 7.27–7.21 (m, 1H), 7.21–7.14 (m, 1H), 7.10 (s, 3H), 6.98–6.89 (m, 1H), 5.06 (d, <i>J</i> = 8.0, 1H), 3.91–3.83 (m, 2H), 3.83–3.72 (m, 2H), 3.68 (t, <i>J</i> = 6.1 Hz, 1H), 3.65–3.55 (m, 1H), 2.99 (s, 3H), 1.83 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 173.60, 157.18, 139.04, 137.11, 130.51, 129.72, 120.90, 120.39, 120.30, 119.97, 100.84, 77.48, 73.64, 73.34, 69.76, 62.63, 53.89, 39.20, 39.13, 23.28. LCMS (ESI): C<sub>22</sub>H<sub>25</sub>F<sub>3</sub>N<sub>2</sub>O<sub>8</sub>S, found [M + H]<sup>+</sup> 535.3.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> FmlH Protein Expression and Purification</h3><div class="NLM_p last">FmlH protein used in crystallographic studies was expressed and purified as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Briefly, protein was expressed in the periplasm of <i>E. coli</i> C600 cells containing pTRC99a encoding the first 182 amino acids of the CFT073 FmlH protein (corresponding to the signal sequence and lectin domain) and a C-terminal 6x-his tag. Periplasmic isolates were prepared as previously described and were washed over a cobalt affinity column (GoldBio) and eluted in 20 mM Tris 8.0 + 250 mM imidazole. Fractions containing protein of the expected molecular weight were then diluted 5-fold in 20 mM Tris 8.0 to a final concentration of 50 mM Imidazole, washed over an anion exchange column (GE Healthcare Mono Q) with 20 mM Tris 8.0, and eluted in 20 mM Tris 8.0 + 250 mM NaCl. Resulting fractions were pooled and dialyzed in 1 mM HEPES pH 7.5 + 50 mM NaCl and concentrated as needed for further study. Protein used in ELISA assays was biotinylated using anNHS-PEG4-Biotin and Biotinylation Kits (ThermoFisher).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> ELISA Assay and Determination of IC<sub>50</sub> Values</h3><div class="NLM_p last">Enzyme-linked immunosorbent assays (ELISAs) were used to quantify the IC<sub>50</sub> of different Gal and GalNAc compounds as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Briefly, 1 μg of bovine submaxillary mucin (Sigma) in 100 μL of PBS were incubated with Immulon 4HBX 96-well plates overnight prior to treatment with 1 mU <i>Arthrobacter ureafaciens</i> sialidase for 1 h at 37 °C to remove terminal sialic acid sugars. Wells were then blocked with 200 μL PBS + 1% BSA for 2 h at room temperature. Biotinylated FmlH<sup>LD</sup> was diluted to 20 μg/mL in blocking buffer and incubated in the presence or absence of compounds serially diluted 2× down eight rows for 1 h at room temperature. Wells were washed three times with PBS 0.05% TWEEN-20 then incubated with 100 μL of streptavidin-HRP conjugate (BD Biosciences; 1:2000 dilution in blocking buffer) for one hour. After three additional PBS + 0.05% TWEEN washes, plates were developed with 100 μL of tetramethylbenzidine (BD Biosciences) substrate and quenched with 50 μL of 1 M H<sub>2</sub>SO<sub>4</sub>. Total bound portion concentration was measured by the absorbance at 450 nm. IC<sub>50</sub>s were determined using the Graphpad Prism software.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> X-ray Crystallography Studies</h3><div class="NLM_p">All protein solutions were generated by adding 10 μL of 50 mM compound dissolved in 100% DMSO to FmlH in 10 mM HEPES pH 7.5 + 50 mM NaCl immediately before setting up drops for a final concentration of 9 mg/mL FmlD<sup>LD</sup>, 5 mM compound, and 10% DMSO. Cocrystals of FmlH-<b>90</b> were grown by mixing 1 μL of protein solution with 1 μL of mother liquor containing 0.7 M LiSO<sub>4</sub> + 20% PEG 8000 on a glass coverslip over 1 mL of mother liquor. Thin, needle-like crystals appeared after approximately 72 h. Crystals were cryoprotected in 1 M LiSO4 + 20% PEG 8000 + 25% glycerol for 10 s before and flash-freezing in liquid nitrogen. Crystals of FmlH-<b>29</b> were grown by mixing 1 μL of protein solution (9 mM FmlH<sup>LD</sup>, 5 mM compound <b>29</b>, 9 mM HEPES pH 7.5, 45 mM NaCl) with 1 μL of 0.1 M Tris 8.0 + 0.8 M AmSO<sub>4</sub> using the hanging drop vapor diffusion method. Square pyramidal crystals began appearing after approximately 24 h and continued to grow for up to 7 days. Crystals were harvested after 10 days, cryoprotected in a solution containing 0.1 M Tris 8.0, 0.8 M AmSO<sub>4</sub>, and 30% glycerol for 10 s, and flash-frozen in liquid nitrogen.</div><div class="NLM_p">To generate crystals of FmlH-<b>30</b>, drops containing 9 mg/mL FmlH, 2.5 mM <b>30</b>, 10% DSMO, 0.1 M Tris 8.0, and 0.8 M AmSO<sub>4</sub> were allowed to equilibrate over a 1 M well solution of 0.1 M Tris 8.0 + 0.8 M AmSO4 for 2 days. FmlH-<b>29</b> cocrystals were then transferred the pre-equilibrated drops and allowed to soak for 48 h before cryoprotection in 0.1 M Tris 8.0, 0.8 M AmSO<sub>4</sub>, and 30% and flash-freezing in liquid nitrogen.</div><div class="NLM_p last">All data were collected on ALS Beamline 4.2.2 at an X-ray wavelength of 1.00 Å. Raw data were processed using XDS, Aimless, and Pointles.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> The phase problem was solved using Phaser-MR in the Phenix suite using the apo FmlHLD structure (PDBID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AOW">6AOW</a>) as a search model.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Iterative rounds of Phenix. Refine, and Coot<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> were used to refine the final model. Guided ligand replacement was performed using Phenix. Space group, collection, and refinement statistics for each cocrystal are listed in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">Table S3</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01561" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01561" class="ext-link">10.1021/acs.jmedchem.8b01561</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC, MS, <sup>1</sup>H, and <sup>13</sup>C NMR spectra of all final tested compounds and intermediates as well as the detailed protocol and data for the rat and mouse pharmacokinetic studies performed by WuXi AppTec (Shanghai) Co., Ltd. (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf">jm8b01561_si_001.pdf (7.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_002.csv">jm8b01561_si_002.csv (3.27 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB IDs of X-ray structures/homology models: novel protein structures have been deposited into the PDB; FmlH-30, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAP">6MAP</a>; FmlH-29, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAQ">6MAQ</a>; FmlH-90, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW">6MAW</a>.  Authors will release the atomic coordinates upon article publication. Homology modeling was performed using the apo FimHLD structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AOW">6AOW</a>) as a search model.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01561" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Janetka</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Women’s Infectious Disease Research, Department of Molecular
Microbiology, Washington University School
of Medicine, St. Louis, Missouri 63110, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9888-5411" title="Orcid link">http://orcid.org/0000-0002-9888-5411</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4e242f202b3a252f240e393b3d3a22602b2a3b"><span class="__cf_email__" data-cfemail="066c676863726d676c46717375726a28636273">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amarendar
Reddy Maddirala</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0721-1647" title="Orcid link">http://orcid.org/0000-0003-0721-1647</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger Klein</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3216-1792" title="Orcid link">http://orcid.org/0000-0003-3216-1792</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerome S. Pinkner</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vasilios Kalas</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott J. Hultgren</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Women’s Infectious Disease Research, Department of Molecular
Microbiology, Washington University School
of Medicine, St. Louis, Missouri 63110, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.R.M. and R.K. contributed equally. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): JWJ and SJH are co-founders and owners of Fimbrion Therapeutics company stock who are commercializing mannoside FimH antagonists as new drugs for UTIs.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the National Institutes of Health (NIH) for funding awarded by the NIDDK, R01DK10884.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">aq</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethyl amine</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">°C</td><td class="NLM_def"><p class="first last">degrees Celsius</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">not applicable</p></td></tr><tr><td class="NLM_term">Å</td><td class="NLM_def"><p class="first last">Angstrom(s)</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">SIF</td><td class="NLM_def"><p class="first last">simulated intestinal fluid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adeyi, O. O.</span>; <span class="NLM_string-name">Baris, E.</span>; <span class="NLM_string-name">Jonas, O.
B.</span>; <span class="NLM_string-name">Irwin, A.</span>; <span class="NLM_string-name">Berthe, F. C. J.</span>; <span class="NLM_string-name">Le Gall, F. G.</span>; <span class="NLM_string-name">Marquez, P. V.</span>; <span class="NLM_string-name">Nikolic, I. A.</span>; <span class="NLM_string-name">Plante, C. A.</span>; <span class="NLM_string-name">Schneidman, M.</span>; <span class="NLM_string-name">Shriber, D. E.</span>; <span class="NLM_string-name">Thiebaud, A.</span></span> <span> </span><span class="NLM_article-title">Drug-resistant infections: a threat to our economic future</span>. <span class="NLM_publisher-name">The World Bank</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=O.+O.+Adeyi&author=E.+Baris&author=O.%0AB.+Jonas&author=A.+Irwin&author=F.+C.+J.+Berthe&author=F.+G.+Le+Gall&author=P.+V.+Marquez&author=I.+A.+Nikolic&author=C.+A.+Plante&author=M.+Schneidman&author=D.+E.+Shriber&author=A.+Thiebaud&title=Drug-resistant+infections%3A+a+threat+to+our+economic+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAdeyi%26aufirst%3DO.%2BO.%26atitle%3DDrug-resistant%2520infections%253A%2520a%2520threat%2520to%2520our%2520economic%2520future%26pub%3DThe%2520World%2520Bank%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebling, T. L.</span></span> <span> </span><span class="NLM_article-title">Urologic diseases in America project: trends in resource use for urinary tract infections in women</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1287</span>, <span class="refDoi"> DOI: 10.1097/01.ju.0000155596.98780.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1097%2F01.ju.0000155596.98780.82" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=15758783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A280%3ADC%252BD2M7isl2gsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2005&pages=1281-1287&author=T.+L.+Griebling&title=Urologic+diseases+in+America+project%3A+trends+in+resource+use+for+urinary+tract+infections+in+women&doi=10.1097%2F01.ju.0000155596.98780.82"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Urologic diseases in America project: trends in resource use for urinary tract infections in women</span></div><div class="casAuthors">Griebling Tomas L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1281-7</span>
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    </div><div class="casAbstract">PURPOSE:  Urinary tract infection (UTI) is one of the most common clinical diagnoses in women.  In this study we examined epidemiological, economic and health care use trends for UTI in women in the United States.  MATERIALS AND METHODS:  The analytical methods used to generate these results have been described previously.  RESULTS:  The lifetime risk for UTI in women is high (greater than 50%).  Between 1988 and 1994 the overall lifetime prevalence of UTI was estimated to be 53,067/100,000 women.  Prescribing patterns demonstrated an increase in the trend toward using fluoroquinolones as first line therapy for UTI, which was associated with increased costs.  Composite data revealed that overall expenditures for the treatment of UTIs in women in the United States, excluding spending on outpatient prescriptions, were approximately 2.47 billion dollars in 2000.  Diagnosis and treatment of UTI in women is performed in various clinical settings.  Inpatient hospitalization for UTI care has generally decreased in younger women but increased in elderly women.  There has been a sharp increase in emergency room use by younger women, which may reflect disparities in access to health insurance or primary care providers.  Most outpatient care of women with UTIs is performed in physician offices.  CONCLUSIONS:  Analysis of health care use and economic data on UTIs in women revealed various interesting trends.  These findings will help shape understanding of UTI treatment in relation to other urological disorders in women.  The results raise various important future research questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_KjH_H4Mito2y4bB4mnvYfW6udTcc2eYkvngYLqP84Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7isl2gsA%253D%253D&md5=39cb45fc4889b96a53683010c8801d5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000155596.98780.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000155596.98780.82%26sid%3Dliteratum%253Aachs%26aulast%3DGriebling%26aufirst%3DT.%2BL.%26atitle%3DUrologic%2520diseases%2520in%2520America%2520project%253A%2520trends%2520in%2520resource%2520use%2520for%2520urinary%2520tract%2520infections%2520in%2520women%26jtitle%3DJ.%2520Urol.%26date%3D2005%26volume%3D173%26spage%3D1281%26epage%3D1287%26doi%3D10.1097%2F01.ju.0000155596.98780.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schappert, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechtsteiner, E. A.</span></span> <span> </span><span class="NLM_article-title">Ambulatory medical care utilization estimates for 2007</span>. <i>Vital Health Stat.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1-38&author=S.+M.+Schappertauthor=E.+A.+Rechtsteiner&title=Ambulatory+medical+care+utilization+estimates+for+2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchappert%26aufirst%3DS.%2BM.%26aulast%3DRechtsteiner%26aufirst%3DE.%2BA.%26atitle%3DAmbulatory%2520medical%2520care%2520utilization%2520estimates%2520for%25202007%26jtitle%3DVital%2520Health%2520Stat.%26date%3D2011%26volume%3D13%26spage%3D1%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavia, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersh, A. L.</span></span> <span> </span><span class="NLM_article-title">Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1093/jac/dkt301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1093%2Fjac%2Fdkt301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=23887867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=234-240&author=D.+J.+Shapiroauthor=L.+A.+Hicksauthor=A.+T.+Paviaauthor=A.+L.+Hersh&title=Antibiotic+prescribing+for+adults+in+ambulatory+care+in+the+USA%2C+2007%E2%80%9309&doi=10.1093%2Fjac%2Fdkt301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09</span></div><div class="casAuthors">Shapiro, Daniel J.; Hicks, Lauri A.; Pavia, Andrew T.; Hersh, Adam L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">234-240</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives To det. patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum vs. narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors assocd. with broad-spectrum antibiotic prescribing.  Methods We used data for patients aged ≥18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09).  These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits.  We detd. the types of antibiotics prescribed, including the use of broad-spectrum vs. narrow-spectrum antibiotics, and examd. prescribing patterns by diagnoses.  We used multivariable logistic regression to identify factors assocd. with broad-spectrum antibiotic prescribing.  Results Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits.  Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed.  The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%).  Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%).  In multivariable anal., among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥60 years.  Conclusions Broad-spectrum agents constitute the majority of antibiotics in ambulatory care.  More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated.  Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi7XJv16JahrVg90H21EOLACvtfcHk0liBkj8sVVCgaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrjJ&md5=9ee4d6124a1852984ce9eef7052c9091</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt301%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DD.%2BJ.%26aulast%3DHicks%26aufirst%3DL.%2BA.%26aulast%3DPavia%26aufirst%3DA.%2BT.%26aulast%3DHersh%26aufirst%3DA.%2BL.%26atitle%3DAntibiotic%2520prescribing%2520for%2520adults%2520in%2520ambulatory%2520care%2520in%2520the%2520USA%252C%25202007%25E2%2580%259309%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D234%26epage%3D240%26doi%3D10.1093%2Fjac%2Fdkt301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fridkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malpiedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slayton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khader, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samore, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumyati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodds-Ashley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousey-Hindes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shehab, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, A.</span></span> <span> </span><span class="NLM_article-title">Vital signs: improving antibiotic use among hospitalized patients</span>. <i>Morb. Mortal. Wkly. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=24598596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A280%3ADC%252BC2crgs1Sjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=194-200&author=S.+Fridkinauthor=J.+Baggsauthor=R.+Faganauthor=S.+Magillauthor=L.+A.+Pollackauthor=P.+Malpiediauthor=R.+Slaytonauthor=K.+Khaderauthor=M.+A.+Rubinauthor=M.+Jonesauthor=M.+H.+Samoreauthor=G.+Dumyatiauthor=E.+Dodds-Ashleyauthor=J.+Meekauthor=K.+Yousey-Hindesauthor=J.+Jerniganauthor=N.+Shehabauthor=R.+Herreraauthor=C.+L.+McDonaldauthor=A.+Schneiderauthor=A.+Srinivasan&title=Vital+signs%3A+improving+antibiotic+use+among+hospitalized+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Vital signs: improving antibiotic use among hospitalized patients</span></div><div class="casAuthors">Fridkin Scott; Baggs James; Fagan Ryan; Magill Shelley; Pollack Lori A; Malpiedi Paul; Slayton Rachel; Khader Karim; Rubin Michael A; Jones Makoto; Samore Matthew H; Dumyati Ghinwa; Dodds-Ashley Elizabeth; Meek James; Yousey-Hindes Kimberly; Jernigan John; Shehab Nadine; Herrera Rosa; McDonald Clifford L; Schneider Amy; Srinivasan Arjun</div><div class="citationInfo"><span class="NLM_cas:title">MMWR. Morbidity and mortality weekly report</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">194-200</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Antibiotics are essential to effectively treat many hospitalized patients.  However, when antibiotics are prescribed incorrectly, they offer little benefit to patients and potentially expose them to risks for complications, including Clostridium difficile infection (CDI) and antibiotic-resistant infections.  Information is needed on the frequency of incorrect prescribing in hospitals and how improved prescribing will benefit patients.  METHODS:  A national administrative database (MarketScan Hospital Drug Database) and CDC's Emerging Infections Program (EIP) data were analyzed to assess the potential for improvement of inpatient antibiotic prescribing.  Variability in days of therapy for selected antibiotics reported to the National Healthcare Safety Network (NHSN) antimicrobial use option was computed.  The impact of reducing inpatient antibiotic exposure on incidence of CDI was modeled using data from two U.S. hospitals.  RESULTS:  In 2010, 55.7% of patients discharged from 323 hospitals received antibiotics during their hospitalization.  EIP reviewed patients' records from 183 hospitals to describe inpatient antibiotic use; antibiotic prescribing potentially could be improved in 37.2% of the most common prescription scenarios reviewed.  There were threefold differences in usage rates among 26 medical/surgical wards reporting to NHSN.  Models estimate that the total direct and indirect effects from a 30% reduction in use of broad-spectrum antibiotics will result in a 26% reduction in CDI.  CONCLUSIONS:  Antibiotic prescribing for inpatients is common, and there is ample opportunity to improve use and patient safety by reducing incorrect antibiotic prescribing.  Implications for Public Health: Hospital administrators and health-care providers can reduce potential harm and risk for antibiotic resistance by implementing formal programs to improve antibiotic prescribing in hospitals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiD0byK_MmNP3jf77P2BG3fW6udTcc2eYkvngYLqP84Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crgs1Sjug%253D%253D&md5=82865a2bdd6101314aec17865ca73936</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFridkin%26aufirst%3DS.%26aulast%3DBaggs%26aufirst%3DJ.%26aulast%3DFagan%26aufirst%3DR.%26aulast%3DMagill%26aufirst%3DS.%26aulast%3DPollack%26aufirst%3DL.%2BA.%26aulast%3DMalpiedi%26aufirst%3DP.%26aulast%3DSlayton%26aufirst%3DR.%26aulast%3DKhader%26aufirst%3DK.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DSamore%26aufirst%3DM.%2BH.%26aulast%3DDumyati%26aufirst%3DG.%26aulast%3DDodds-Ashley%26aufirst%3DE.%26aulast%3DMeek%26aufirst%3DJ.%26aulast%3DYousey-Hindes%26aufirst%3DK.%26aulast%3DJernigan%26aufirst%3DJ.%26aulast%3DShehab%26aufirst%3DN.%26aulast%3DHerrera%26aufirst%3DR.%26aulast%3DMcDonald%26aufirst%3DC.%2BL.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DA.%26atitle%3DVital%2520signs%253A%2520improving%2520antibiotic%2520use%2520among%2520hospitalized%2520patients%26jtitle%3DMorb.%2520Mortal.%2520Wkly.%2520Rep.%26date%3D2014%26volume%3D63%26spage%3D194%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Mireles, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caparon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Urinary tract infections: epidemiology, mechanisms of infection and treatment options</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1038%2Fnrmicro3432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=25853778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtVaqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=269-284&author=A.+L.+Flores-Mirelesauthor=J.+N.+Walkerauthor=M.+Caparonauthor=S.+J.+Hultgren&title=Urinary+tract+infections%3A+epidemiology%2C+mechanisms+of+infection+and+treatment+options&doi=10.1038%2Fnrmicro3432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary tract infections: epidemiology, mechanisms of infection and treatment options</span></div><div class="casAuthors">Flores-Mireles, Ana L.; Walker, Jennifer N.; Caparon, Michael; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-284</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus.  High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections.  In this Review, we discuss how basic science studies are elucidating the mol. details of the crosstalk that occurs at the host-pathogen interface, as well as the consequences of these interactions for the pathophysiol. of UTIs.  We also describe current efforts to translate this knowledge into new clin. treatments for UTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokqDEu5P1QX7Vg90H21EOLACvtfcHk0lji17OJ-acp0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtVaqs78%253D&md5=b81a25f1f4ab04770982ee01b41b2427</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3432%26sid%3Dliteratum%253Aachs%26aulast%3DFlores-Mireles%26aufirst%3DA.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BN.%26aulast%3DCaparon%26aufirst%3DM.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DUrinary%2520tract%2520infections%253A%2520epidemiology%252C%2520mechanisms%2520of%2520infection%2520and%2520treatment%2520options%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2015%26volume%3D13%26spage%3D269%26epage%3D284%26doi%3D10.1038%2Fnrmicro3432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spaulding, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Adhesive pili in UTI pathogenesis and drug development</span>. <i>Pathogens</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30</span>, <span class="refDoi"> DOI: 10.3390/pathogens5010030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.3390%2Fpathogens5010030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=30&author=C.+N.+Spauldingauthor=S.+J.+Hultgren&title=Adhesive+pili+in+UTI+pathogenesis+and+drug+development&doi=10.3390%2Fpathogens5010030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fpathogens5010030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpathogens5010030%26sid%3Dliteratum%253Aachs%26aulast%3DSpaulding%26aufirst%3DC.%2BN.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DAdhesive%2520pili%2520in%2520UTI%2520pathogenesis%2520and%2520drug%2520development%26jtitle%3DPathogens%26date%3D2016%26volume%3D5%26spage%3D30%26doi%3D10.3390%2Fpathogens5010030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waksman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural biology of the chaperone-usher pathway of pilus biogenesis</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1038%2Fnrmicro2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=19820722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cmu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=765-774&author=G.+Waksmanauthor=S.+J.+Hultgren&title=Structural+biology+of+the+chaperone-usher+pathway+of+pilus+biogenesis&doi=10.1038%2Fnrmicro2220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of the chaperone-usher pathway of pilus biogenesis</span></div><div class="casAuthors">Waksman, Gabriel; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">765-774</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The chaperone-usher (CU) pathway of pilus biogenesis is the most widespread of the 5 pathways that assemble adhesive pili at the surface of Gram-neg. bacteria.  Recent progress in the study of the structural biol. of the CU pathway has unravelled the mol. basis of chaperone function and elucidated the mechanisms of fiber assembly at the outer membrane, leading to a comprehensive description of each step in the biogenesis pathway.  Other studies have provided the mol. basis of host recognition by CU pili.  The knowledge that has been gathered about both the assembly of and host recognition by CU pili has been harnessed to design promising antibiotic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEpAKySGeLiLVg90H21EOLACvtfcHk0lji17OJ-acp0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cmu7%252FK&md5=2ee8b6520f089e50e037bf4addfa8a43</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2220%26sid%3Dliteratum%253Aachs%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520biology%2520of%2520the%2520chaperone-usher%2520pathway%2520of%2520pilus%2520biogenesis%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2009%26volume%3D7%26spage%3D765%26epage%3D774%26doi%3D10.1038%2Fnrmicro2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wurpel, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totsika, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petty, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schembri, M. A.</span></span> <span> </span><span class="NLM_article-title">Chaperone-usher fimbriae of Escherichia coli</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e52835</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0052835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1371%2Fjournal.pone.0052835" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=D.+J.+Wurpelauthor=S.+A.+Beatsonauthor=M.+Totsikaauthor=N.+K.+Pettyauthor=M.+A.+Schembri&title=Chaperone-usher+fimbriae+of+Escherichia+coli&doi=10.1371%2Fjournal.pone.0052835"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0052835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0052835%26sid%3Dliteratum%253Aachs%26aulast%3DWurpel%26aufirst%3DD.%2BJ.%26aulast%3DBeatson%26aufirst%3DS.%2BA.%26aulast%3DTotsika%26aufirst%3DM.%26aulast%3DPetty%26aufirst%3DN.%2BK.%26aulast%3DSchembri%26aufirst%3DM.%2BA.%26atitle%3DChaperone-usher%2520fimbriae%2520of%2520Escherichia%2520coli%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0052835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouckaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFusco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auguste, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waksman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02915.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1046%2Fj.1365-2958.2002.02915.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=12010488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2002&pages=903-915&author=C.+S.+Hungauthor=J.+Bouckaertauthor=D.+Hungauthor=J.+Pinknerauthor=C.+Widbergauthor=A.+DeFuscoauthor=C.+G.+Augusteauthor=R.+Strouseauthor=S.+Langermannauthor=G.+Waksmanauthor=S.+J.+Hultgren&title=Structural+basis+of+tropism+of+Escherichia+coli+to+the+bladder+during+urinary+tract+infection&doi=10.1046%2Fj.1365-2958.2002.02915.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span></div><div class="casAuthors">Hung, Chia-Suei; Bouckaert, Julie; Hung, Danielle; Pinkner, Jerome; Widberg, Charlotte; DeFusco, Anthony; Auguste, C. Gale; Strouse, Robert; Langermann, Solomon; Waksman, Gabriel; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">903-915</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The first step in the colonization of the human urinary tract by pathogenic Escherichia coli is the mannose-sensitive binding of FimH, the adhesin present at the tip of type 1 pili, to the bladder epithelium.  We elucidated crystallog. the interactions of FimH with D-mannose.  The unique site binding pocket occupied by D-mannose was probed using site-directed mutagenesis.  All but one of the mutants examd. had greatly diminished mannose-binding activity and had also lost the ability to bind human bladder cells.  The binding activity of the monosaccharide D-mannose was delineated from this of mannotriose (Man(α1-3)[Man(α1-6)]Man) by generating mutants that abolished D-mannose binding but retained mannotriose binding activity.  Our structure/function anal. demonstrated that the binding of the monosaccharide α-D-mannose is the primary bladder cell receptor for uropathogenic E. coli and that this event requires a highly conserved FimH binding pocket.  The residues in the FimH mannose-binding pocket were sequenced and found to be invariant in over 200 uropathogenic strains of E. coli.  Only enterohemorrhagic E. coli (EHEC) possess a sequence variation within the mannose-binding pocket of FimH, suggesting a naturally occurring mechanism of attenuation in EHEC bacteria that would prevent them from being targeted to the urinary tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoljy6DS5GA8bVg90H21EOLACvtfcHk0lji17OJ-acp0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D&md5=b2d31ffbc2540d4be1bfff9d4036f5eb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02915.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02915.x%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DHung%26aufirst%3DD.%26aulast%3DPinkner%26aufirst%3DJ.%26aulast%3DWidberg%26aufirst%3DC.%26aulast%3DDeFusco%26aufirst%3DA.%26aulast%3DAuguste%26aufirst%3DC.%2BG.%26aulast%3DStrouse%26aufirst%3DR.%26aulast%3DLangermann%26aufirst%3DS.%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520tropism%2520of%2520Escherichia%2520coli%2520to%2520the%2520bladder%2520during%2520urinary%2520tract%2520infection%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D44%26spage%3D903%26epage%3D915%26doi%3D10.1046%2Fj.1365-2958.2002.02915.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conover, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taganna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Greve, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Inflammation-induced adhesin-receptor interaction provides a fitness advantage to uropathogenic E. coli during chronic infection</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2016.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1016%2Fj.chom.2016.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=27667696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGru7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=482-492&author=M.+S.+Conoverauthor=S.+Ruerauthor=J.+Tagannaauthor=V.+Kalasauthor=H.+De+Greveauthor=J.+S.+Pinknerauthor=K.+W.+Dodsonauthor=H.+Remautauthor=S.+J.+Hultgren&title=Inflammation-induced+adhesin-receptor+interaction+provides+a+fitness+advantage+to+uropathogenic+E.+coli+during+chronic+infection&doi=10.1016%2Fj.chom.2016.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection</span></div><div class="casAuthors">Conover, Matt S.; Ruer, Segolene; Taganna, Joemar; Kalas, Vasilios; De Greve, Henri; Pinkner, Jerome S.; Dodson, Karen W.; Remaut, Han; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-492</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Uropathogenic E. coli (UPEC) is the dominant cause of urinary tract infections, clin. described as cystitis.  UPEC express CUP pili, which are extracellular fibers tipped with adhesins that bind mucosal surfaces of the urinary tract.  Here we identify the role of the F9/Yde/Fml pilus for UPEC persistence in the inflamed urothelium.  The Fml adhesin FmlH binds galactose β1-3 N-acetylgalactosamine found in core-1 and -2 O-glycans.  Deletion of fmlH had no effect on UPEC virulence in an acute mouse model of cystitis.  However, FmlH provided a fitness advantage during chronic cystitis, which is manifested as persistent bacteriuria, high bladder bacterial burdens, and chronic inflammation.  In situ binding confirmed that FmlH bound avidly to the inflamed, but not the naive bladder.  In accordance with its pathogenic profile, vaccination with FmlH significantly protected mice from chronic cystitis.  Thus, UPEC employ sep. CUP pili to adapt to the rapidly changing niche during bladder infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8JDlQpjGVFLVg90H21EOLACvtfcHk0lhvnZMaz0WZSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGru7zJ&md5=35fb7d5f61cdb451f9104dcf4c3e072d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2016.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2016.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DConover%26aufirst%3DM.%2BS.%26aulast%3DRuer%26aufirst%3DS.%26aulast%3DTaganna%26aufirst%3DJ.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DDe%2BGreve%26aufirst%3DH.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DDodson%26aufirst%3DK.%2BW.%26aulast%3DRemaut%26aufirst%3DH.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DInflammation-induced%2520adhesin-receptor%2520interaction%2520provides%2520a%2520fitness%2520advantage%2520to%2520uropathogenic%2520E.%2520coli%2520during%2520chronic%2520infection%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2016%26volume%3D20%26spage%3D482%26epage%3D492%26doi%3D10.1016%2Fj.chom.2016.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbing, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddirala, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conover, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E2819</span>– <span class="NLM_lpage">E2828</span>, <span class="refDoi"> DOI: 10.1073/pnas.1720140115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1073%2Fpnas.1720140115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=29507247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Chs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E2819-E2828&author=V.+Kalasauthor=M.+E.+Hibbingauthor=A.+R.+Maddiralaauthor=R.+Chuganiauthor=J.+S.+Pinknerauthor=L.+K.+Mydock-McGraneauthor=M.+S.+Conoverauthor=J.+W.+Janetkaauthor=S.+J.+Hultgren&title=Structure-based+discovery+of+glycomimetic+FmlH+ligands+as+inhibitors+of+bacterial+adhesion+during+urinary+tract+infection&doi=10.1073%2Fpnas.1720140115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection</span></div><div class="casAuthors">Kalas, Vasilios; Hibbing, Michael E.; Maddirala, Amarendar Reddy; Chugani, Ryan; Pinkner, Jerome S.; Mydock-McGrane, Laurel K.; Conover, Matt S.; Janetka, James W.; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">E2819-E2828</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Treatment of bacterial infections is becoming a serious clin. challenge due to the global dissemination of multidrug antibiotic resistance, necessitating the search for alternative treatments to disarm the virulence mechanisms underlying these infections.  Uropathogenic Escherichia coli (UPEC) employs multiple chaperone-usher pathway pili tipped with adhesins with diverse receptor specificities to colonize various host tissues and habitats.  For example, UPEC F9 pili specifically bind galactose or N-acetylgalactosamine epitopes on the kidney and inflamed bladder.  Using x-ray structure-guided methods, virtual screening, and multiplex ELISA arrays, the authors rationally designed aryl galactosides and N-acetylgalactosaminosides that inhibit the F9 pilus adhesin FmlH.  The lead compd., 29β-NAc, is a biphenyl N-acetyl-β-galactosaminoside with a Ki of ∼90 nM, representing a major advancement in potency relative to the characteristically weak nature of most carbohydrate-lectin interactions. 29β-NAc binds tightly to FmlH by engaging the residues Y46 through edge-to-face p-stacking with its A-Ph ring, R142 in a salt-bridge interaction with its carboxylate group, and K132 through water-mediated hydrogen bonding with its N-acetyl group.  Administration of 29β-NAc in a mouse urinary tract infection (UTI) model significantly reduced bladder and kidney bacterial burdens, and coadministration of 29β-NAc and mannoside 4Z269, which targets the type 1 pilus adhesin FimH, resulted in greater elimination of bacteria from the urinary tract than either compd. alone.  Moreover, FmlH specifically binds healthy human kidney tissue in a 29β-NAc-inhibitable manner, suggesting a key role for F9 pili in human kidney colonization.  Thus, these glycoside antagonists of FmlH represent a rational antivirulence strategy for UPEC-mediated UTI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQALa-bUsUlrVg90H21EOLACvtfcHk0lhvnZMaz0WZSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Chs7nE&md5=e686b5b852add750b184b3f0ca8358d0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1720140115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1720140115%26sid%3Dliteratum%253Aachs%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DHibbing%26aufirst%3DM.%2BE.%26aulast%3DMaddirala%26aufirst%3DA.%2BR.%26aulast%3DChugani%26aufirst%3DR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DConover%26aufirst%3DM.%2BS.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructure-based%2520discovery%2520of%2520glycomimetic%2520FmlH%2520ligands%2520as%2520inhibitors%2520of%2520bacterial%2520adhesion%2520during%2520urinary%2520tract%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE2819%26epage%3DE2828%26doi%3D10.1073%2Fpnas.1720140115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">109ra115</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1126%2Fscitranslmed.3003021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=22089451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=109ra115&author=C.+K.+Cusumanoauthor=J.+S.+Pinknerauthor=Z.+Hanauthor=S.+E.+Greeneauthor=B.+A.+Fordauthor=J.+R.+Crowleyauthor=J.+P.+Hendersonauthor=J.+W.+Janetkaauthor=S.+J.+Hultgren&title=Treatment+and+prevention+of+urinary+tract+infection+with+orally+active+FimH+inhibitors&doi=10.1126%2Fscitranslmed.3003021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span></div><div class="casAuthors">Cusumano Corinne K; Pinkner Jerome S; Han Zhenfu; Greene Sarah E; Ford Bradley A; Crowley Jan R; Henderson Jeffrey P; Janetka James W; Hultgren Scott J</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">109</span>),
    <span class="NLM_cas:pages">109ra115</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic and recurrent urinary tract infections pose a serious medical problem because there are few effective treatment options.  Patients with chronic urinary tract infections are commonly treated with long-term prophylactic antibiotics that promote the development of antibiotic-resistant forms of uropathogenic Escherichia coli (UPEC), further complicating treatment.  We developed small-molecular weight compounds termed mannosides that specifically inhibit the FimH type 1 pilus lectin of UPEC, which mediates bacterial colonization, invasion, and formation of recalcitrant intracellular bacterial communities in the bladder epithelium.  Here, we optimized these compounds for oral bioavailability and demonstrated their fast-acting efficacy in treating chronic urinary tract infections in a preclinical murine model.  These compounds also prevented infection in vivo when given prophylactically and strongly potentiated the activity of the current standard of care therapy, trimethoprim-sulfamethoxazole, against clinically resistant PBC-1 UPEC bacteria.  These compounds have therapeutic efficacy after oral administration for the treatment of established urinary tract infections in vivo.  Their unique mechanism of action-targeting the pilus tip adhesin FimH-circumvents the conventional requirement for drug penetration of the outer membrane, minimizing the potential for the development of resistance.  The small-molecular weight compounds described herein promise to provide substantial benefit to women suffering from chronic and recurrent urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJjBsZZFqz29j_Vg2vObihfW6udTcc2eY8-KsLRI5P5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D&md5=253b506b7485c2cf042cb5665c518277</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003021%26sid%3Dliteratum%253Aachs%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DGreene%26aufirst%3DS.%2BE.%26aulast%3DFord%26aufirst%3DB.%2BA.%26aulast%3DCrowley%26aufirst%3DJ.%2BR.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DTreatment%2520and%2520prevention%2520of%2520urinary%2520tract%2520infection%2520with%2520orally%2520active%2520FimH%2520inhibitors%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D109ra115%26doi%3D10.1126%2Fscitranslmed.3003021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostakioti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Antivirulence C-mannosides as antibiotic-sparing, oral therapeutics for urinary tract infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9390</span>– <span class="NLM_lpage">9408</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00948</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00948" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9390-9408&author=L.+Mydock-McGraneauthor=Z.+Cusumanoauthor=Z.+Hanauthor=J.+Binkleyauthor=M.+Kostakiotiauthor=T.+Hannanauthor=J.+S.+Pinknerauthor=R.+Kleinauthor=V.+Kalasauthor=J.+Crowleyauthor=N.+P.+Rathauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Antivirulence+C-mannosides+as+antibiotic-sparing%2C+oral+therapeutics+for+urinary+tract+infections&doi=10.1021%2Facs.jmedchem.6b00948"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00948%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DCusumano%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DBinkley%26aufirst%3DJ.%26aulast%3DKostakioti%26aufirst%3DM.%26aulast%3DHannan%26aufirst%3DT.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DCrowley%26aufirst%3DJ.%26aulast%3DRath%26aufirst%3DN.%2BP.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DAntivirulence%2520C-mannosides%2520as%2520antibiotic-sparing%252C%2520oral%2520therapeutics%2520for%2520urinary%2520tract%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9390%26epage%3D9408%26doi%3D10.1021%2Facs.jmedchem.6b00948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Antivirulence isoquinolone mannosides: Optimization of the biaryl aglycone for FimH lectin binding affinity and efficacy in the treatment of chronic UTI</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1002%2Fcmdc.201600006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=367-373&author=C.+Jarvisauthor=Z.+Hanauthor=V.+Kalasauthor=R.+Kleinauthor=J.+S.+Pinknerauthor=B.+Fordauthor=J.+Binkleyauthor=C.+K.+Cusumanoauthor=Z.+Cusumanoauthor=L.+Mydock-McGraneauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Antivirulence+isoquinolone+mannosides%3A+Optimization+of+the+biaryl+aglycone+for+FimH+lectin+binding+affinity+and+efficacy+in+the+treatment+of+chronic+UTI&doi=10.1002%2Fcmdc.201600006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600006%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DJ.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DAntivirulence%2520isoquinolone%2520mannosides%253A%2520Optimization%2520of%2520the%2520biaryl%2520aglycone%2520for%2520FimH%2520lectin%2520binding%2520affinity%2520and%2520efficacy%2520in%2520the%2520treatment%2520of%2520chronic%2520UTI%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D367%26epage%3D373%26doi%3D10.1002%2Fcmdc.201600006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleeb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zihlmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abgottspon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smiesko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezencon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwardt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">FimH antagonists: Bioisosteres to improve the in vitro and in vivo PK/PD profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2239</span>, <span class="refDoi"> DOI: 10.1021/jm501524q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501524q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2221-2239&author=S.+Kleebauthor=L.+Pangauthor=K.+Mayerauthor=D.+Erisauthor=A.+Siglauthor=R.+C.+Prestonauthor=P.+Zihlmannauthor=T.+Sharpeauthor=R.+P.+Jakobauthor=D.+Abgottsponauthor=A.+S.+Hutterauthor=M.+Scharenbergauthor=X.+Jiangauthor=G.+Navarraauthor=S.+Rabbaniauthor=M.+Smieskoauthor=N.+Ludinauthor=J.+Bezenconauthor=O.+Schwardtauthor=T.+Maierauthor=B.+Ernst&title=FimH+antagonists%3A+Bioisosteres+to+improve+the+in+vitro+and+in+vivo+PK%2FPD+profile&doi=10.1021%2Fjm501524q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501524q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501524q%26sid%3Dliteratum%253Aachs%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DMayer%26aufirst%3DK.%26aulast%3DEris%26aufirst%3DD.%26aulast%3DSigl%26aufirst%3DA.%26aulast%3DPreston%26aufirst%3DR.%2BC.%26aulast%3DZihlmann%26aufirst%3DP.%26aulast%3DSharpe%26aufirst%3DT.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DHutter%26aufirst%3DA.%2BS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DNavarra%26aufirst%3DG.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DLudin%26aufirst%3DN.%26aulast%3DBezencon%26aufirst%3DJ.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%253A%2520Bioisosteres%2520to%2520improve%2520the%2520in%2520vitro%2520and%2520in%2520vivo%2520PK%252FPD%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2221%26epage%3D2239%26doi%3D10.1021%2Fjm501524q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abgottspon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleeb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwardt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">Antiadhesion therapy for urinary tract infections-a balanced PK/PD profile proved to be key for success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4700</span>– <span class="NLM_lpage">4713</span>, <span class="refDoi"> DOI: 10.1021/jm300192x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300192x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4700-4713&author=X.+Jiangauthor=D.+Abgottsponauthor=S.+Kleebauthor=S.+Rabbaniauthor=M.+Scharenbergauthor=M.+Wittwerauthor=M.+Haugauthor=O.+Schwardtauthor=B.+Ernst&title=Antiadhesion+therapy+for+urinary+tract+infections-a+balanced+PK%2FPD+profile+proved+to+be+key+for+success&doi=10.1021%2Fjm300192x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm300192x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300192x%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DHaug%26aufirst%3DM.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DAntiadhesion%2520therapy%2520for%2520urinary%2520tract%2520infections-a%2520balanced%2520PK%252FPD%2520profile%2520proved%2520to%2520be%2520key%2520for%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4700%26epage%3D4713%26doi%3D10.1021%2Fjm300192x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abgottspon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">In vivo evaluation of FimH antagonists - a novel class of antimicrobials for the treatment of urinary tract infection</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.2533/chimia.2012.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.2533%2Fchimia.2012.166" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=166-169&author=D.+Abgottsponauthor=B.+Ernst&title=In+vivo+evaluation+of+FimH+antagonists+-+a+novel+class+of+antimicrobials+for+the+treatment+of+urinary+tract+infection&doi=10.2533%2Fchimia.2012.166"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2012.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2012.166%26sid%3Dliteratum%253Aachs%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520FimH%2520antagonists%2520-%2520a%2520novel%2520class%2520of%2520antimicrobials%2520for%2520the%2520treatment%2520of%2520urinary%2520tract%2520infection%26jtitle%3DChimia%26date%3D2012%26volume%3D66%26spage%3D166%26epage%3D169%26doi%3D10.2533%2Fchimia.2012.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn’s disease</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1131266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1517%2F13543776.2016.1131266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=26651364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=175-197&author=L.+K.+Mydock-McGraneauthor=Z.+T.+Cusumanoauthor=J.+W.+Janetka&title=Mannose-derived+FimH+antagonists%3A+a+promising+anti-virulence+therapeutic+strategy+for+urinary+tract+infections+and+Crohn%E2%80%99s+disease&doi=10.1517%2F13543776.2016.1131266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease</span></div><div class="casAuthors">Mydock-McGrane, Laurel K.; Cusumano, Zachary T.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-197</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Type 1 pili are utilized by Gram-neg. bacteria to adhere to host tissue and thus are a key virulence factor in urinary tract infections (UTIs) and Crohn's disease (CD).  This adhesion is mediated through specific binding of the terminal adhesin, FimH, to mannosylated host glycoproteins.  FimH is essential for UTI pathogenesis and thus is a promising therapeutic target.: Herein, we review the structural frameworks of FimH antagonists disclosed in the patent literature.  X-ray crystallog. binding studies of D-mannose and early FimH antagonists have uncovered key mol. interactions.  Exploiting this knowledge, mannosides with extraordinarily high binding affinities have been designed.  Structure-activity relationships (SAR) and structure-property relationship (SPR) studies have resulted in the rapid development of orally bioavailable FimH antagonists with promising therapeutic potential for UTI and CD.: It is our opinion that biaryl or 'two-ring' mannosides, which represent the largest and most thoroughly tested class of FimH antagonists, also hold the most promise as a novel treatment for UTIs.  These antagonists have also been shown to have efficacy in treating CD.  Judging from the strong preclin. data, we predict that one or more FimH antagonists will be entering the clinic within the next 1-2 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_i0DZwcMRbVg90H21EOLACvtfcHk0lj9JKbkW65GBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D&md5=a28cd9875e0f5bf0c91f716c3d7b7653</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1131266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1131266%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%2BT.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DMannose-derived%2520FimH%2520antagonists%253A%2520a%2520promising%2520anti-virulence%2520therapeutic%2520strategy%2520for%2520urinary%2520tract%2520infections%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D175%26epage%3D197%26doi%3D10.1517%2F13543776.2016.1131266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1331216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1080%2F17460441.2017.1331216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=28506090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=711-731&author=L.+K.+Mydock-McGraneauthor=T.+J.+Hannanauthor=J.+W.+Janetka&title=Rational+design+strategies+for+FimH+antagonists%3A+new+drugs+on+the+horizon+for+urinary+tract+infection+and+Crohn%E2%80%99s+disease&doi=10.1080%2F17460441.2017.1331216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease</span></div><div class="casAuthors">Mydock-McGrane, Laurel K.; Hannan, Thomas J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">711-731</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: The bacterial adhesin FimH is a virulence factor and an attractive therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD).  Located on type 1 pili of uropathogenic E. coli (UPEC), the FimH adhesin plays an integral role in the pathogenesis of UPEC.  Recent efforts have culminated in the development of small-mol. mannoside FimH antagonists that target the mannose-binding lectin domain of FimH, inhibiting its function and preventing UPEC from binding mannosylated host cells in the bladder, thereby circumventing infection.: The authors describe the structure-guided design of mannoside ligands, and review the structural biol. of the FimH lectin domain.  Addnl., they discuss the lead optimization of mannosides for therapeutic application in UTI and CD, and describe various assays used to measure mannoside potency in vitro and mouse models used to det. efficacy in vivo.: To date, mannoside optimization has led to a diverse set of small-mol. FimH antagonists with oral bioavailability.  With clin. trials already initiated in CD and on the horizon for UTI, it is the authors, opinion that mannosides will be a 'first-in-class' treatment strategy for UTI and CD, and will pave the way for treatment of other Gram-neg. bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wDghfJfnIrVg90H21EOLACvtfcHk0lhmcjwN3LdXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSgs7s%253D&md5=48395bfe8cc540942a336e572b8dd667</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1331216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1331216%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DRational%2520design%2520strategies%2520for%2520FimH%2520antagonists%253A%2520new%2520drugs%2520on%2520the%2520horizon%2520for%2520urinary%2520tract%2520infection%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D711%26epage%3D731%26doi%3D10.1080%2F17460441.2017.1331216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, G.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis of quercetin 3-O-glycosides of 2-amino-2-deoxy-d-glucose under phase transfer catalytic conditions</span>. <i>J. Carbohydr. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1080/07328303.2014.996290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1080%2F07328303.2014.996290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1ejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=28-40&author=Z.+Caoauthor=Y.+Quauthor=J.+Zhouauthor=W.+Liuauthor=G.+Yao&title=Stereoselective+synthesis+of+quercetin+3-O-glycosides+of+2-amino-2-deoxy-d-glucose+under+phase+transfer+catalytic+conditions&doi=10.1080%2F07328303.2014.996290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective Synthesis of Quercetin 3-O-Glycosides of 2-Amino-2-Deoxy-D-Glucose Under Phase Transfer Catalytic Conditions</span></div><div class="casAuthors">Cao, Zhiling; Qu, Yingying; Zhou, Jiexing; Liu, Weiwei; Yao, Guowei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Carbohydrate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-40</span>CODEN:
                <span class="NLM_cas:coden">JCACDM</span>;
        ISSN:<span class="NLM_cas:issn">0732-8303</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">This article describes the stereoselective synthesis of quercetin 3-O-glycosides of 2-amino-2-deoxy-D-glucose.  Efficient 1,2-trans-glycosylation of protected quercetin with N-acetyl-protected 2-amino-2-deoxy-D-glucose chloride was achieved under phase transfer catalytic conditions in a 0.15 M aq. K2CO3/chloroform system using tetrabutylammonium bromide as the catalyst.  On the contrary, glycosylation with the N-phthalimido-protected bromide donor under the same conditions was found to give predominantly 1,2-cis-glycoside product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBVx4Nn6co7Vg90H21EOLACvtfcHk0lhmcjwN3LdXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1ejsrY%253D&md5=53cd23b2aec790db6805a80e98db2eaa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F07328303.2014.996290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328303.2014.996290%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DG.%26atitle%3DStereoselective%2520synthesis%2520of%2520quercetin%25203-O-glycosides%2520of%25202-amino-2-deoxy-d-glucose%2520under%2520phase%2520transfer%2520catalytic%2520conditions%26jtitle%3DJ.%2520Carbohydr.%2520Chem.%26date%3D2015%26volume%3D34%26spage%3D28%26epage%3D40%26doi%3D10.1080%2F07328303.2014.996290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropper, F.</span></span> <span> </span><span class="NLM_article-title">Stereospecific synthesis of aryl β-d-<i>N</i>-acetylglucopyranosides by phase transfer catalysis</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2097</span>– <span class="NLM_lpage">2102</span>, <span class="refDoi"> DOI: 10.1080/00397919008053144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1080%2F00397919008053144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADyaK3MXmt1Ggtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=2097-2102&author=R.+Royauthor=F.+Tropper&title=Stereospecific+synthesis+of+aryl+%CE%B2-d-N-acetylglucopyranosides+by+phase+transfer+catalysis&doi=10.1080%2F00397919008053144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecific synthesis of aryl β-D-N-acetylglucopyranosides by phase transfer catalysis</span></div><div class="casAuthors">Roy, Rene; Tropper, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2097-102</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Under phase transfer catalyzed conditions (Bu4N+ Br-, 1 M NaOH, CH2Cl2) 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chloride (I) reacts with ROH (R = 4-MeOC6H4, 4-Me3CC6H4, 3-MeC6H4, 4-PhC6H4, 1-naphthyl, 2-naphthyl) to afford high yields of acetylated aryl β-D-N-acetylglucopyranosides II (R1 = Ac).  Deprotection of the hydroxyl groups under Zemplen condition gave quant. yields of the free glycosides II (R1 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLE_NXDVsaFrVg90H21EOLACvtfcHk0lhmcjwN3LdXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmt1Ggtw%253D%253D&md5=6737c07f3e9eefc5acfac7f1d2462039</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00397919008053144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008053144%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DTropper%26aufirst%3DF.%26atitle%3DStereospecific%2520synthesis%2520of%2520aryl%2520%25CE%25B2-d-N-acetylglucopyranosides%2520by%2520phase%2520transfer%2520catalysis%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D2097%26epage%3D2102%26doi%3D10.1080%2F00397919008053144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleine, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, R. S.</span></span> <span> </span><span class="NLM_article-title">Phase-transfer-catalyzed synthesis of 2,3,4,6-tetra-O-acetyl-β-d-galactopyranosides</span>. <i>Carbohydr. Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/0008-6215(85)85036-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1016%2F0008-6215%2885%2985036-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADyaL28XhvVKktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1985&pages=333-337&author=H.+P.+Kleineauthor=D.+V.+Weinbergauthor=R.+J.+Kaufmanauthor=R.+S.+Sidhu&title=Phase-transfer-catalyzed+synthesis+of+2%2C3%2C4%2C6-tetra-O-acetyl-%CE%B2-d-galactopyranosides&doi=10.1016%2F0008-6215%2885%2985036-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phase-transfer-catalyzed synthesis of 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosides</span></div><div class="casAuthors">Kleine, Henry P.; Weinberg, David V.; Kaufman, Robert J.; Sidhu, Ravinder S.</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-7</span>CODEN:
                <span class="NLM_cas:coden">CRBRAT</span>;
        ISSN:<span class="NLM_cas:issn">0008-6215</span>.
    </div><div class="casAbstract">Forty-three aryl galactopyranosides I (R = 4-NO2, 3-NO2, 4-OMe, 3-Br, 2,4-Cl2, 4-cyano, H, 3-Me, 2,4,6-Me3, etc.) were prepd. in 29-86% yield by glycosidation of acetobromogalactose with the corresponding phenols in CHCl3-aq. NaOH in the presence of PhCH2N+Et3Br- 3 h at 60°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUAh6G69snbVg90H21EOLACvtfcHk0lgHw-bz8vVqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVKktrk%253D&md5=bd411a34b5e5c808457e1d4bbb0cd666</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0008-6215%2885%2985036-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0008-6215%252885%252985036-9%26sid%3Dliteratum%253Aachs%26aulast%3DKleine%26aufirst%3DH.%2BP.%26aulast%3DWeinberg%26aufirst%3DD.%2BV.%26aulast%3DKaufman%26aufirst%3DR.%2BJ.%26aulast%3DSidhu%26aufirst%3DR.%2BS.%26atitle%3DPhase-transfer-catalyzed%2520synthesis%2520of%25202%252C3%252C4%252C6-tetra-O-acetyl-%25CE%25B2-d-galactopyranosides%26jtitle%3DCarbohydr.%2520Res.%26date%3D1985%26volume%3D142%26spage%3D333%26epage%3D337%26doi%3D10.1016%2F0008-6215%2885%2985036-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Bruyne, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters-Leysen, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted phenyl β-d-galactopyranosides</span>. <i>Carbohydr. Res.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/S0008-6215(00)80264-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1016%2FS0008-6215%2800%2980264-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1971&pages=124-126&author=C.+K.+De%0ABruyneauthor=J.+Wouters-Leysen&title=Synthesis+of+substituted+phenyl+%CE%B2-d-galactopyranosides&doi=10.1016%2FS0008-6215%2800%2980264-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2800%2980264-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252800%252980264-5%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruyne%26aufirst%3DC.%2BK.%26aulast%3DWouters-Leysen%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520substituted%2520phenyl%2520%25CE%25B2-d-galactopyranosides%26jtitle%3DCarbohydr.%2520Res.%26date%3D1971%26volume%3D18%26spage%3D124%26epage%3D126%26doi%3D10.1016%2FS0008-6215%2800%2980264-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greig, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macauley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocadlo, D. J.</span></span> <span> </span><span class="NLM_article-title">Probing synergy between two catalytic strategies in the glycoside hydrolase O-glcNAcase using multiple linear free energy relationships</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">13415</span>– <span class="NLM_lpage">13422</span>, <span class="refDoi"> DOI: 10.1021/ja904506u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja904506u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGktbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=13415-13422&author=I.+R.+Greigauthor=M.+S.+Macauleyauthor=I.+H.+Williamsauthor=D.+J.+Vocadlo&title=Probing+synergy+between+two+catalytic+strategies+in+the+glycoside+hydrolase+O-glcNAcase+using+multiple+linear+free+energy+relationships&doi=10.1021%2Fja904506u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Probing Synergy between Two Catalytic Strategies in the Glycoside Hydrolase O-GlcNAcase Using Multiple Linear Free Energy Relationships</span></div><div class="casAuthors">Greig, Ian R.; Macauley, Matthew S.; Williams, Ian H.; Vocadlo, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13415-13422</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human O-GlcNAcase plays an important role in regulating the post-translational modification of serine and threonine residues with β-O-linked N-acetylglucosamine monosaccharide unit (O-GlcNAc).  The mechanism of O-GlcNAcase involves nucleophilic participation of the 2-acetamido group of the substrate to displace a glycosidically linked leaving group.  The tolerance of this enzyme for variation in substrate structure has enabled us to characterize O-GlcNAcase transition states using several series of substrates to generate multiple simultaneous free-energy relationships.  Patterns revealing changes in mechanism, transition state, and rate-detg. step upon concomitant variation of both nucleophilic strength and leaving group abilities are obsd.  The obsd. changes in mechanism reflect the roles played by the enzymic general acid and the catalytic nucleophile.  Significantly, these results illustrate how the enzyme synergistically harnesses both modes of catalysis; a feature that eludes many small mol. models of catalysis.  These studies also suggest the kinetic significance of an oxocarbenium ion intermediate in the O-GlcNAcase-catalyzed hydrolysis of glucosaminides, probing the limits of what may be learned using nonatomistic investigations of enzymic transition-state structure and offering general insights into how the superfamily of retaining glycoside hydrolases act as efficient catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFxM7cU-oUrVg90H21EOLACvtfcHk0lgHw-bz8vVqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGktbjM&md5=ee85b7c48919fb79ea68ea35aee3bcd7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja904506u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja904506u%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DI.%2BR.%26aulast%3DMacauley%26aufirst%3DM.%2BS.%26aulast%3DWilliams%26aufirst%3DI.%2BH.%26aulast%3DVocadlo%26aufirst%3DD.%2BJ.%26atitle%3DProbing%2520synergy%2520between%2520two%2520catalytic%2520strategies%2520in%2520the%2520glycoside%2520hydrolase%2520O-glcNAcase%2520using%2520multiple%2520linear%2520free%2520energy%2520relationships%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D13415%26epage%3D13422%26doi%3D10.1021%2Fja904506u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Selenenylsulfide-linked homogeneous glycopeptides and glycoproteins: Synthesis of human “Hepatic Se Metabolite A</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1002/anie.201106658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1002%2Fanie.201106658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1432-1436&author=O.+Boutureiraauthor=G.+J.+L.+Bernardesauthor=M.+Fern%C3%A1ndez-Gonz%C3%A1lezauthor=D.+C.+Anthonyauthor=B.+G.+Davis&title=Selenenylsulfide-linked+homogeneous+glycopeptides+and+glycoproteins%3A+Synthesis+of+human+%E2%80%9CHepatic+Se+Metabolite+A&doi=10.1002%2Fanie.201106658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selenenylsulfide-linked Homogeneous Glycopeptides and Glycoproteins: Synthesis of Human "Hepatic Se Metabolite A"</span></div><div class="casAuthors">Boutureira, Omar; Bernardes, Goncalo J. L.; Fernandez-Gonzalez, Marta; Anthony, Daniel C.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1432-1436, S1432/1-S1432/46</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors present the synthesis of selenenylsulfide-linked (glycosyl-SeS-Cys) glycopeptides and glycoproteins using a Cys-specific selenylation protocol of cysteine moiety in peptides and proteins, resp.  The first synthesis and full characterization of human hepatic Se metabolite A, 5, is also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaF7zi6kFErrVg90H21EOLACvtfcHk0lgHw-bz8vVqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVegsw%253D%253D&md5=2d183abedd5298ab09420005485ecf1c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.201106658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201106658%26sid%3Dliteratum%253Aachs%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26aulast%3DFern%25C3%25A1ndez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DAnthony%26aufirst%3DD.%2BC.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSelenenylsulfide-linked%2520homogeneous%2520glycopeptides%2520and%2520glycoproteins%253A%2520Synthesis%2520of%2520human%2520%25E2%2580%259CHepatic%2520Se%2520Metabolite%2520A%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1432%26epage%3D1436%26doi%3D10.1002%2Fanie.201106658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Lead optimization studies on FimH antagonists: Discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3945</span>– <span class="NLM_lpage">3959</span>, <span class="refDoi"> DOI: 10.1021/jm300165m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300165m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3945-3959&author=Z.+Hanauthor=J.+S.+Pinknerauthor=B.+Fordauthor=E.+Chorellauthor=J.+M.+Crowleyauthor=C.+K.+Cusumanoauthor=S.+Campbellauthor=J.+P.+Hendersonauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Lead+optimization+studies+on+FimH+antagonists%3A+Discovery+of+potent+and+orally+bioavailable+ortho-substituted+biphenyl+mannosides&doi=10.1021%2Fjm300165m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization Studies on FimH Antagonists: Discovery of Potent and Orally Bioavailable Ortho-Substituted Biphenyl Mannosides</span></div><div class="casAuthors">Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Chorell, Erik; Crowley, Jan M.; Cusumano, Corinne K.; Campbell, Scott; Henderson, Jeffrey P.; Hultgren, Scott J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3945-3959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we describe the X-ray structure-based design and optimization of biaryl mannoside FimH inhibitors.  Diverse modifications to the biaryl ring to improve druglike phys. and pharmacokinetic properties of mannosides were assessed for FimH binding affinity based on their effects on hemagglutination and biofilm formation along with direct FimH binding assays.  Substitution on the mannoside Ph ring ortho to the glycosidic bond results in large potency enhancements several-fold higher than those of corresponding unsubstituted matched pairs and can be rationalized from increased hydrophobic interactions with the FimH hydrophobic ridge (Ile13) or "tyrosine gate" (Tyr137 and Tyr48) also lined by Ile52.  The lead mannosides have increased metabolic stability and oral bioavailability as detd. from in vitro PAMPA predictive model of cellular permeability and in vivo pharmacokinetic studies in mice, thereby representing advanced preclin. candidates with promising potential as novel therapeutics for the clin. treatment and prevention of recurring urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBCwLuNdyjLVg90H21EOLACvtfcHk0ljnZa2qXfH25A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D&md5=2a9b4e564162f8c3292802826fa33974</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300165m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300165m%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DChorell%26aufirst%3DE.%26aulast%3DCrowley%26aufirst%3DJ.%2BM.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DLead%2520optimization%2520studies%2520on%2520FimH%2520antagonists%253A%2520Discovery%2520of%2520potent%2520and%2520orally%2520bioavailable%2520ortho-substituted%2520biphenyl%2520mannosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3945%26epage%3D3959%26doi%3D10.1021%2Fjm300165m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alteen, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemčovičová, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocadlo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloster, T. M.</span></span> <span> </span><span class="NLM_article-title">Mechanism of human nucleocytoplasmic hexosaminidase D</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2747</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b01285</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2735-2747&author=M.+G.+Alteenauthor=V.+Oehlerauthor=I.+Nem%C4%8Dovi%C4%8Dov%C3%A1author=I.+B.+H.+Wilsonauthor=D.+J.+Vocadloauthor=T.+M.+Gloster&title=Mechanism+of+human+nucleocytoplasmic+hexosaminidase+D&doi=10.1021%2Facs.biochem.5b01285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01285%26sid%3Dliteratum%253Aachs%26aulast%3DAlteen%26aufirst%3DM.%2BG.%26aulast%3DOehler%26aufirst%3DV.%26aulast%3DNem%25C4%258Dovi%25C4%258Dov%25C3%25A1%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DI.%2BB.%2BH.%26aulast%3DVocadlo%26aufirst%3DD.%2BJ.%26aulast%3DGloster%26aufirst%3DT.%2BM.%26atitle%3DMechanism%2520of%2520human%2520nucleocytoplasmic%2520hexosaminidase%2520D%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D2735%26epage%3D2747%26doi%3D10.1021%2Facs.biochem.5b01285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolfrom, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramp, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, D.</span></span> <span> </span><span class="NLM_article-title">3,4,6-Tri-O-acetyl-2-amino-2-deoxy-α-d-galactopyranosyl bromide hydrobromide1</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3232</span>, <span class="refDoi"> DOI: 10.1021/jo01046a519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01046a519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1963&pages=3231-3232&author=M.+L.+Wolfromauthor=W.+A.+Crampauthor=D.+Horton&title=3%2C4%2C6-Tri-O-acetyl-2-amino-2-deoxy-%CE%B1-d-galactopyranosyl+bromide+hydrobromide1&doi=10.1021%2Fjo01046a519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01046a519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01046a519%26sid%3Dliteratum%253Aachs%26aulast%3DWolfrom%26aufirst%3DM.%2BL.%26aulast%3DCramp%26aufirst%3DW.%2BA.%26aulast%3DHorton%26aufirst%3DD.%26atitle%3D3%252C4%252C6-Tri-O-acetyl-2-amino-2-deoxy-%25CE%25B1-d-galactopyranosyl%2520bromide%2520hydrobromide1%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1963%26volume%3D28%26spage%3D3231%26epage%3D3232%26doi%3D10.1021%2Fjo01046a519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Z.</span></span> <span> </span><span class="NLM_article-title">Copper-mediated one-pot synthesis of 2,2-difluoro-1,3-benzoxathioles from o-bromophenols and trifluoromethanethiolate</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b03877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b03877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=481-484&author=M.+Zhangauthor=S.+Chenauthor=Z.+Weng&title=Copper-mediated+one-pot+synthesis+of+2%2C2-difluoro-1%2C3-benzoxathioles+from+o-bromophenols+and+trifluoromethanethiolate&doi=10.1021%2Facs.orglett.7b03877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Mediated One-Pot Synthesis of 2,2-Difluoro-1,3-benzoxathioles from o-Bromophenols and Trifluoromethanethiolate</span></div><div class="casAuthors">Zhang, Mengjia; Chen, Shouxiong; Weng, Zhiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">481-484</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A Cu-mediated difluoromethylenation of o-bromophenols with trifluoromethanethiolate is described.  This 1-pot protocol proceeds through an intermol. addn. of S:CF2 (resulting from the decompn. of trifluoromethanethiolate) to o-bromophenols followed by intramol. C-S coupling to form 2,2-difluoro-1,3-benzoxathioles.  This method is compatible with a broad range of substrates and enables the late-stage difluoromethylenation of several functionally dense drug like o-bromophenols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOITyfE-6jmbVg90H21EOLACvtfcHk0lgEWBminKz4zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1ajsw%253D%253D&md5=ae16341912f0677bbafaa6a3a36dde3d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b03877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b03877%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWeng%26aufirst%3DZ.%26atitle%3DCopper-mediated%2520one-pot%2520synthesis%2520of%25202%252C2-difluoro-1%252C3-benzoxathioles%2520from%2520o-bromophenols%2520and%2520trifluoromethanethiolate%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D481%26epage%3D484%26doi%3D10.1021%2Facs.orglett.7b03877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgEWBminKz4zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lgEWBminKz4zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkóczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: A comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgEWBminKz4zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljAbXqKkKQ3Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Allison
C. Leonard, Laurenne E. Petrie, <span class="NLM_string-name hlFld-ContribAuthor">Georgina Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Bacterial Anti-adhesives: Inhibition of Staphylococcus aureus Nasal Colonization. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (10)
                                     , 1668-1681. <a href="https://doi.org/10.1021/acsinfecdis.9b00193" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DBacterial%252BAnti-adhesives%25253A%252BInhibition%252Bof%252BStaphylococcus%252Baureus%252BNasal%252BColonization%26aulast%3DLeonard%26aufirst%3DAllison%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22052019%26date%3D15082019%26date%3D02082019%26volume%3D5%26issue%3D10%26spage%3D1668%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishnu C.  Damalanka</span>, <span class="hlFld-ContribAuthor ">Amarendar Reddy  Maddirala</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 513-536. <a href="https://doi.org/10.1080/17460441.2021.1857721" title="DOI URL">https://doi.org/10.1080/17460441.2021.1857721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1857721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1857721%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bglycomimetic%252Bdesign%25253A%252Bdevelopment%252Bof%252Bsmall%252Bmolecular%252Bweight%252Blectin%252Bantagonists%26aulast%3DDamalanka%26aufirst%3DVishnu%2BC.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D5%26spage%3D513%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roland E.  Dolle</span>, <span class="hlFld-ContribAuthor ">Laurel K.  McGrane</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>, <span class="hlFld-ContribAuthor ">Jared T.  Hammill</span>, <span class="hlFld-ContribAuthor ">Rodney Kiplin  Guy</span>, <span class="hlFld-ContribAuthor ">Anjan  Debnath</span>, <span class="hlFld-ContribAuthor ">Peter M.  Cheuka</span>, <span class="hlFld-ContribAuthor ">Claire Le  Manach</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>, <span class="hlFld-ContribAuthor ">Ake  Elhammer</span>, <span class="hlFld-ContribAuthor ">Martin  Handfield</span>, <span class="hlFld-ContribAuthor ">Michael J.  Dawson</span>, <span class="hlFld-ContribAuthor ">Stefano  Donadio</span>, <span class="hlFld-ContribAuthor ">Jae H.  Park</span>, <span class="hlFld-ContribAuthor ">Alan  Joslyn</span>. </span><span class="cited-content_cbyCitation_article-title">Anti‐Infective Case Histories. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-95. <a href="https://doi.org/10.1002/0471266949.bmc288" title="DOI URL">https://doi.org/10.1002/0471266949.bmc288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc288%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590Infective%252BCase%252BHistories%26aulast%3DDolle%26aufirst%3DRoland%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D95%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Károly  Ágoston</span>, <span class="hlFld-ContribAuthor ">Gregory M.  Watt</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for O-Glycoside Synthesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 103-159. <a href="https://doi.org/10.1016/B978-0-12-819475-1.00017-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-819475-1.00017-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819475-1.00017-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819475-1.00017-1%26sid%3Dliteratum%253Aachs%26atitle%3DMethods%252Bfor%252BO-Glycoside%252BSynthesis%26aulast%3D%25C3%2581goston%26aufirst%3DK%25C3%25A1roly%26date%3D2021%26spage%3D103%26epage%3D159%26pub%3DElsevier%26atitle%3DComprehensive%252BGlycoscience%26date%3D2021%26volume%3Dvol.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meysam  Sarshar</span>, <span class="hlFld-ContribAuthor ">Payam  Behzadi</span>, <span class="hlFld-ContribAuthor ">Cecilia  Ambrosi</span>, <span class="hlFld-ContribAuthor ">Carlo  Zagaglia</span>, <span class="hlFld-ContribAuthor ">Anna Teresa  Palamara</span>, <span class="hlFld-ContribAuthor ">Daniela  Scribano</span>. </span><span class="cited-content_cbyCitation_article-title">FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2020,</strong> <em>9 </em>
                                    (7)
                                     , 397. <a href="https://doi.org/10.3390/antibiotics9070397" title="DOI URL">https://doi.org/10.3390/antibiotics9070397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics9070397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics9070397%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DFimH%252Band%252BAnti-Adhesive%252BTherapeutics%25253A%252BA%252BDisarming%252BStrategy%252BAgainst%252BUropathogens%26aulast%3DSarshar%26aufirst%3DMeysam%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D7%26spage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger D.  Klein</span>, <span class="hlFld-ContribAuthor ">Scott J.  Hultgren</span>. </span><span class="cited-content_cbyCitation_article-title">Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 211-226. <a href="https://doi.org/10.1038/s41579-020-0324-0" title="DOI URL">https://doi.org/10.1038/s41579-020-0324-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41579-020-0324-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41579-020-0324-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DUrinary%252Btract%252Binfections%25253A%252Bmicrobial%252Bpathogenesis%25252C%252Bhost%2525E2%252580%252593pathogen%252Binteractions%252Band%252Bnew%252Btreatment%252Bstrategies%26aulast%3DKlein%26aufirst%3DRoger%2BD.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D211%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joscha  Meiers</span>, <span class="hlFld-ContribAuthor ">Eike  Siebs</span>, <span class="hlFld-ContribAuthor ">Eva  Zahorska</span>, <span class="hlFld-ContribAuthor ">Alexander  Titz</span>. </span><span class="cited-content_cbyCitation_article-title">Lectin antagonists in infection, immunity, and inflammation. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>53 </em>, 51-67. <a href="https://doi.org/10.1016/j.cbpa.2019.07.005" title="DOI URL">https://doi.org/10.1016/j.cbpa.2019.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2019.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DLectin%252Bantagonists%252Bin%252Binfection%25252C%252Bimmunity%25252C%252Band%252Binflammation%26aulast%3DMeiers%26aufirst%3DJoscha%26date%3D2019%26volume%3D53%26spage%3D51%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ursula  Theuretzbacher</span>, <span class="hlFld-ContribAuthor ">Laura J.V.  Piddock</span>. </span><span class="cited-content_cbyCitation_article-title">Non-traditional Antibacterial Therapeutic Options and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Cell Host & Microbe</span><span> <strong>2019,</strong> <em>26 </em>
                                    (1)
                                     , 61-72. <a href="https://doi.org/10.1016/j.chom.2019.06.004" title="DOI URL">https://doi.org/10.1016/j.chom.2019.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chom.2019.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chom.2019.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Host%2520%2526%2520Microbe%26atitle%3DNon-traditional%252BAntibacterial%252BTherapeutic%252BOptions%252Band%252BChallenges%26aulast%3DTheuretzbacher%26aufirst%3DUrsula%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D61%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. FmlH bound to initial lead compound <b>1</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AS8">6AS8</a>). The COOH group on ring B engages in charge–charge interactions with guanidinium side chain of R142, while a series of direct and water-mediated H-bonds between the acetamide moiety and residue K132. Additionally, phenyl ring A forms edge-to-face π-stacking interactions with Y46.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Biphenyl Glycoside Compounds (<b>29</b>–<b>51</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCM, 1N NaOH, TBAB, 2-bromophenol, rt, 1 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water (5:1), 80 °C, 1 h; (c) NaOH, methanol/water (1:1), rt, overnight for <b>29</b>–<b>31</b> or 33% methylamine in absolute ethanol, rt, 1 h for <b>32</b>–<b>51</b>; (d) CHCl<sub>3</sub>, 1N NaOH, TEBAC, 2-bromophenol, rt, 1 h. See <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for identity of R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup>.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of FmlH<sup>LD</sup> in complex with (A) Gal <b>30</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAP">6MAP</a>) and (B) GalNAc <b>29</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAQ">6MAQ</a>) matched pairs. Direct and water-mediated interactions between the <i>N</i>-acetyl group on the galactose ring and the nitro group on the second phenyl ring result in decreased relative potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Biphenyl Glycosides to Explore A-Ring Substitution and B-Ring Sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DCM, 1N NaOH, TBAB, rt, 1 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water (5:1), 80 °C, 1 h; (c) DCM, cyclopropanesulfonyl chloride/TEA, rt, 2 h, (d) DMF, <i>N</i>,<i>N</i>-dimethylsulfonyl chloride/Cs<sub>2</sub>CO<sub>3</sub>, MW, 80 °C, 2 h; (e) 33% methylamine in absolute ethanol, rt, 1 h; (f) NaOH, methanol/water (1:1), rt, overnight.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Biphenyl Glycosides Evaluating Effect of <i>N</i>-Substitution of GalNAc Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN, 80 °C, 2 h; (b) DCM, (CF<sub>3</sub>CO)<sub>2</sub>O/TEA, rt, 1 h; (c) DCM, MsCl/TEA, rt, 3 h; (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/water (5:1), 80 °C, 1 h; (e) 33% methylamine in absolute ethanol, rt, 1 h.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of FmlH<sup>LD</sup> in complex with <b>90</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW">6MAW</a>). The sulfonyl oxygens form novel contacts with the backbone of S10 and I11 in loop 1 and the backbone of S2 in the <i>N</i>-terminus of the mature protein. Additionally, one fluorine in the trifluoromethyl group interacts with D45.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo pharmacokinetics (PK) of <b>86</b> and <b>90</b> in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Urinary excretion of compounds <b>86</b> and <b>90</b> in rats after (A) IV administration and (B) PO administration. R01–R12 rats used for the renal excretion studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/medium/jm-2018-01561p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo pharmacokinetic properties of <b>84</b> in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01561/20190116/images/large/jm-2018-01561p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01561&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adeyi, O. O.</span>; <span class="NLM_string-name">Baris, E.</span>; <span class="NLM_string-name">Jonas, O.
B.</span>; <span class="NLM_string-name">Irwin, A.</span>; <span class="NLM_string-name">Berthe, F. C. J.</span>; <span class="NLM_string-name">Le Gall, F. G.</span>; <span class="NLM_string-name">Marquez, P. V.</span>; <span class="NLM_string-name">Nikolic, I. A.</span>; <span class="NLM_string-name">Plante, C. A.</span>; <span class="NLM_string-name">Schneidman, M.</span>; <span class="NLM_string-name">Shriber, D. E.</span>; <span class="NLM_string-name">Thiebaud, A.</span></span> <span> </span><span class="NLM_article-title">Drug-resistant infections: a threat to our economic future</span>. <span class="NLM_publisher-name">The World Bank</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=O.+O.+Adeyi&author=E.+Baris&author=O.%0AB.+Jonas&author=A.+Irwin&author=F.+C.+J.+Berthe&author=F.+G.+Le+Gall&author=P.+V.+Marquez&author=I.+A.+Nikolic&author=C.+A.+Plante&author=M.+Schneidman&author=D.+E.+Shriber&author=A.+Thiebaud&title=Drug-resistant+infections%3A+a+threat+to+our+economic+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAdeyi%26aufirst%3DO.%2BO.%26atitle%3DDrug-resistant%2520infections%253A%2520a%2520threat%2520to%2520our%2520economic%2520future%26pub%3DThe%2520World%2520Bank%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebling, T. L.</span></span> <span> </span><span class="NLM_article-title">Urologic diseases in America project: trends in resource use for urinary tract infections in women</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1287</span>, <span class="refDoi"> DOI: 10.1097/01.ju.0000155596.98780.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1097%2F01.ju.0000155596.98780.82" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=15758783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A280%3ADC%252BD2M7isl2gsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2005&pages=1281-1287&author=T.+L.+Griebling&title=Urologic+diseases+in+America+project%3A+trends+in+resource+use+for+urinary+tract+infections+in+women&doi=10.1097%2F01.ju.0000155596.98780.82"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Urologic diseases in America project: trends in resource use for urinary tract infections in women</span></div><div class="casAuthors">Griebling Tomas L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1281-7</span>
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    </div><div class="casAbstract">PURPOSE:  Urinary tract infection (UTI) is one of the most common clinical diagnoses in women.  In this study we examined epidemiological, economic and health care use trends for UTI in women in the United States.  MATERIALS AND METHODS:  The analytical methods used to generate these results have been described previously.  RESULTS:  The lifetime risk for UTI in women is high (greater than 50%).  Between 1988 and 1994 the overall lifetime prevalence of UTI was estimated to be 53,067/100,000 women.  Prescribing patterns demonstrated an increase in the trend toward using fluoroquinolones as first line therapy for UTI, which was associated with increased costs.  Composite data revealed that overall expenditures for the treatment of UTIs in women in the United States, excluding spending on outpatient prescriptions, were approximately 2.47 billion dollars in 2000.  Diagnosis and treatment of UTI in women is performed in various clinical settings.  Inpatient hospitalization for UTI care has generally decreased in younger women but increased in elderly women.  There has been a sharp increase in emergency room use by younger women, which may reflect disparities in access to health insurance or primary care providers.  Most outpatient care of women with UTIs is performed in physician offices.  CONCLUSIONS:  Analysis of health care use and economic data on UTIs in women revealed various interesting trends.  These findings will help shape understanding of UTI treatment in relation to other urological disorders in women.  The results raise various important future research questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_KjH_H4Mito2y4bB4mnvYfW6udTcc2ebUaJDpiisbo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7isl2gsA%253D%253D&md5=39cb45fc4889b96a53683010c8801d5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F01.ju.0000155596.98780.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.ju.0000155596.98780.82%26sid%3Dliteratum%253Aachs%26aulast%3DGriebling%26aufirst%3DT.%2BL.%26atitle%3DUrologic%2520diseases%2520in%2520America%2520project%253A%2520trends%2520in%2520resource%2520use%2520for%2520urinary%2520tract%2520infections%2520in%2520women%26jtitle%3DJ.%2520Urol.%26date%3D2005%26volume%3D173%26spage%3D1281%26epage%3D1287%26doi%3D10.1097%2F01.ju.0000155596.98780.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schappert, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechtsteiner, E. A.</span></span> <span> </span><span class="NLM_article-title">Ambulatory medical care utilization estimates for 2007</span>. <i>Vital Health Stat.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1-38&author=S.+M.+Schappertauthor=E.+A.+Rechtsteiner&title=Ambulatory+medical+care+utilization+estimates+for+2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchappert%26aufirst%3DS.%2BM.%26aulast%3DRechtsteiner%26aufirst%3DE.%2BA.%26atitle%3DAmbulatory%2520medical%2520care%2520utilization%2520estimates%2520for%25202007%26jtitle%3DVital%2520Health%2520Stat.%26date%3D2011%26volume%3D13%26spage%3D1%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavia, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersh, A. L.</span></span> <span> </span><span class="NLM_article-title">Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1093/jac/dkt301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1093%2Fjac%2Fdkt301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=23887867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=234-240&author=D.+J.+Shapiroauthor=L.+A.+Hicksauthor=A.+T.+Paviaauthor=A.+L.+Hersh&title=Antibiotic+prescribing+for+adults+in+ambulatory+care+in+the+USA%2C+2007%E2%80%9309&doi=10.1093%2Fjac%2Fdkt301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09</span></div><div class="casAuthors">Shapiro, Daniel J.; Hicks, Lauri A.; Pavia, Andrew T.; Hersh, Adam L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">234-240</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives To det. patterns of ambulatory antibiotic prescribing in US adults, including the use of broad-spectrum vs. narrow-spectrum agents, to provide a description of the diagnoses for which antibiotics are prescribed and to identify patient and physician factors assocd. with broad-spectrum antibiotic prescribing.  Methods We used data for patients aged ≥18 years from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (2007-09).  These are nationally representative surveys of patient visits to offices, hospital outpatient departments and emergency departments (EDs) in the USA, collectively referred to as ambulatory visits.  We detd. the types of antibiotics prescribed, including the use of broad-spectrum vs. narrow-spectrum antibiotics, and examd. prescribing patterns by diagnoses.  We used multivariable logistic regression to identify factors assocd. with broad-spectrum antibiotic prescribing.  Results Antibiotics were prescribed during 101 million (95% CI: 91-111 million) ambulatory visits annually, representing 10% of all visits.  Broad-spectrum agents were prescribed during 61% of visits in which antibiotics were prescribed.  The most commonly prescribed antibiotics were quinolones (25% of antibiotics), macrolides (20%) and aminopenicillins (12%).  Antibiotics were most commonly prescribed for respiratory conditions (41% of antibiotics), skin/mucosal conditions (18%) and urinary tract infections (9%).  In multivariable anal., among patients prescribed antibiotics, broad-spectrum agents were more likely to be prescribed than narrow-spectrum antibiotics for respiratory infections for which antibiotics are rarely indicated (e.g. bronchitis), during visits to EDs and for patients ≥60 years.  Conclusions Broad-spectrum agents constitute the majority of antibiotics in ambulatory care.  More than 25% of prescriptions are for conditions for which antibiotics are rarely indicated.  Antibiotic stewardship interventions targeting respiratory and non-respiratory conditions are needed in ambulatory care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi7XJv16JahrVg90H21EOLACvtfcHk0ljqcAlOGEcmow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrjJ&md5=9ee4d6124a1852984ce9eef7052c9091</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt301%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DD.%2BJ.%26aulast%3DHicks%26aufirst%3DL.%2BA.%26aulast%3DPavia%26aufirst%3DA.%2BT.%26aulast%3DHersh%26aufirst%3DA.%2BL.%26atitle%3DAntibiotic%2520prescribing%2520for%2520adults%2520in%2520ambulatory%2520care%2520in%2520the%2520USA%252C%25202007%25E2%2580%259309%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D234%26epage%3D240%26doi%3D10.1093%2Fjac%2Fdkt301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fridkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malpiedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slayton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khader, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samore, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumyati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodds-Ashley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousey-Hindes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shehab, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, A.</span></span> <span> </span><span class="NLM_article-title">Vital signs: improving antibiotic use among hospitalized patients</span>. <i>Morb. Mortal. Wkly. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=24598596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A280%3ADC%252BC2crgs1Sjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=194-200&author=S.+Fridkinauthor=J.+Baggsauthor=R.+Faganauthor=S.+Magillauthor=L.+A.+Pollackauthor=P.+Malpiediauthor=R.+Slaytonauthor=K.+Khaderauthor=M.+A.+Rubinauthor=M.+Jonesauthor=M.+H.+Samoreauthor=G.+Dumyatiauthor=E.+Dodds-Ashleyauthor=J.+Meekauthor=K.+Yousey-Hindesauthor=J.+Jerniganauthor=N.+Shehabauthor=R.+Herreraauthor=C.+L.+McDonaldauthor=A.+Schneiderauthor=A.+Srinivasan&title=Vital+signs%3A+improving+antibiotic+use+among+hospitalized+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Vital signs: improving antibiotic use among hospitalized patients</span></div><div class="casAuthors">Fridkin Scott; Baggs James; Fagan Ryan; Magill Shelley; Pollack Lori A; Malpiedi Paul; Slayton Rachel; Khader Karim; Rubin Michael A; Jones Makoto; Samore Matthew H; Dumyati Ghinwa; Dodds-Ashley Elizabeth; Meek James; Yousey-Hindes Kimberly; Jernigan John; Shehab Nadine; Herrera Rosa; McDonald Clifford L; Schneider Amy; Srinivasan Arjun</div><div class="citationInfo"><span class="NLM_cas:title">MMWR. Morbidity and mortality weekly report</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">194-200</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Antibiotics are essential to effectively treat many hospitalized patients.  However, when antibiotics are prescribed incorrectly, they offer little benefit to patients and potentially expose them to risks for complications, including Clostridium difficile infection (CDI) and antibiotic-resistant infections.  Information is needed on the frequency of incorrect prescribing in hospitals and how improved prescribing will benefit patients.  METHODS:  A national administrative database (MarketScan Hospital Drug Database) and CDC's Emerging Infections Program (EIP) data were analyzed to assess the potential for improvement of inpatient antibiotic prescribing.  Variability in days of therapy for selected antibiotics reported to the National Healthcare Safety Network (NHSN) antimicrobial use option was computed.  The impact of reducing inpatient antibiotic exposure on incidence of CDI was modeled using data from two U.S. hospitals.  RESULTS:  In 2010, 55.7% of patients discharged from 323 hospitals received antibiotics during their hospitalization.  EIP reviewed patients' records from 183 hospitals to describe inpatient antibiotic use; antibiotic prescribing potentially could be improved in 37.2% of the most common prescription scenarios reviewed.  There were threefold differences in usage rates among 26 medical/surgical wards reporting to NHSN.  Models estimate that the total direct and indirect effects from a 30% reduction in use of broad-spectrum antibiotics will result in a 26% reduction in CDI.  CONCLUSIONS:  Antibiotic prescribing for inpatients is common, and there is ample opportunity to improve use and patient safety by reducing incorrect antibiotic prescribing.  Implications for Public Health: Hospital administrators and health-care providers can reduce potential harm and risk for antibiotic resistance by implementing formal programs to improve antibiotic prescribing in hospitals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiD0byK_MmNP3jf77P2BG3fW6udTcc2eapmRmeAXNqsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crgs1Sjug%253D%253D&md5=82865a2bdd6101314aec17865ca73936</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFridkin%26aufirst%3DS.%26aulast%3DBaggs%26aufirst%3DJ.%26aulast%3DFagan%26aufirst%3DR.%26aulast%3DMagill%26aufirst%3DS.%26aulast%3DPollack%26aufirst%3DL.%2BA.%26aulast%3DMalpiedi%26aufirst%3DP.%26aulast%3DSlayton%26aufirst%3DR.%26aulast%3DKhader%26aufirst%3DK.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DSamore%26aufirst%3DM.%2BH.%26aulast%3DDumyati%26aufirst%3DG.%26aulast%3DDodds-Ashley%26aufirst%3DE.%26aulast%3DMeek%26aufirst%3DJ.%26aulast%3DYousey-Hindes%26aufirst%3DK.%26aulast%3DJernigan%26aufirst%3DJ.%26aulast%3DShehab%26aufirst%3DN.%26aulast%3DHerrera%26aufirst%3DR.%26aulast%3DMcDonald%26aufirst%3DC.%2BL.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DA.%26atitle%3DVital%2520signs%253A%2520improving%2520antibiotic%2520use%2520among%2520hospitalized%2520patients%26jtitle%3DMorb.%2520Mortal.%2520Wkly.%2520Rep.%26date%3D2014%26volume%3D63%26spage%3D194%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Mireles, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caparon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Urinary tract infections: epidemiology, mechanisms of infection and treatment options</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1038%2Fnrmicro3432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=25853778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtVaqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=269-284&author=A.+L.+Flores-Mirelesauthor=J.+N.+Walkerauthor=M.+Caparonauthor=S.+J.+Hultgren&title=Urinary+tract+infections%3A+epidemiology%2C+mechanisms+of+infection+and+treatment+options&doi=10.1038%2Fnrmicro3432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary tract infections: epidemiology, mechanisms of infection and treatment options</span></div><div class="casAuthors">Flores-Mireles, Ana L.; Walker, Jennifer N.; Caparon, Michael; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-284</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus.  High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections.  In this Review, we discuss how basic science studies are elucidating the mol. details of the crosstalk that occurs at the host-pathogen interface, as well as the consequences of these interactions for the pathophysiol. of UTIs.  We also describe current efforts to translate this knowledge into new clin. treatments for UTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokqDEu5P1QX7Vg90H21EOLACvtfcHk0lgnUykEQEd_MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtVaqs78%253D&md5=b81a25f1f4ab04770982ee01b41b2427</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3432%26sid%3Dliteratum%253Aachs%26aulast%3DFlores-Mireles%26aufirst%3DA.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BN.%26aulast%3DCaparon%26aufirst%3DM.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DUrinary%2520tract%2520infections%253A%2520epidemiology%252C%2520mechanisms%2520of%2520infection%2520and%2520treatment%2520options%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2015%26volume%3D13%26spage%3D269%26epage%3D284%26doi%3D10.1038%2Fnrmicro3432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spaulding, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Adhesive pili in UTI pathogenesis and drug development</span>. <i>Pathogens</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30</span>, <span class="refDoi"> DOI: 10.3390/pathogens5010030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.3390%2Fpathogens5010030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=30&author=C.+N.+Spauldingauthor=S.+J.+Hultgren&title=Adhesive+pili+in+UTI+pathogenesis+and+drug+development&doi=10.3390%2Fpathogens5010030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fpathogens5010030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpathogens5010030%26sid%3Dliteratum%253Aachs%26aulast%3DSpaulding%26aufirst%3DC.%2BN.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DAdhesive%2520pili%2520in%2520UTI%2520pathogenesis%2520and%2520drug%2520development%26jtitle%3DPathogens%26date%3D2016%26volume%3D5%26spage%3D30%26doi%3D10.3390%2Fpathogens5010030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waksman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural biology of the chaperone-usher pathway of pilus biogenesis</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1038%2Fnrmicro2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=19820722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cmu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=765-774&author=G.+Waksmanauthor=S.+J.+Hultgren&title=Structural+biology+of+the+chaperone-usher+pathway+of+pilus+biogenesis&doi=10.1038%2Fnrmicro2220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of the chaperone-usher pathway of pilus biogenesis</span></div><div class="casAuthors">Waksman, Gabriel; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">765-774</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The chaperone-usher (CU) pathway of pilus biogenesis is the most widespread of the 5 pathways that assemble adhesive pili at the surface of Gram-neg. bacteria.  Recent progress in the study of the structural biol. of the CU pathway has unravelled the mol. basis of chaperone function and elucidated the mechanisms of fiber assembly at the outer membrane, leading to a comprehensive description of each step in the biogenesis pathway.  Other studies have provided the mol. basis of host recognition by CU pili.  The knowledge that has been gathered about both the assembly of and host recognition by CU pili has been harnessed to design promising antibiotic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEpAKySGeLiLVg90H21EOLACvtfcHk0ljURgPEDeZ0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cmu7%252FK&md5=2ee8b6520f089e50e037bf4addfa8a43</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2220%26sid%3Dliteratum%253Aachs%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520biology%2520of%2520the%2520chaperone-usher%2520pathway%2520of%2520pilus%2520biogenesis%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2009%26volume%3D7%26spage%3D765%26epage%3D774%26doi%3D10.1038%2Fnrmicro2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wurpel, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totsika, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petty, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schembri, M. A.</span></span> <span> </span><span class="NLM_article-title">Chaperone-usher fimbriae of Escherichia coli</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e52835</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0052835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1371%2Fjournal.pone.0052835" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=D.+J.+Wurpelauthor=S.+A.+Beatsonauthor=M.+Totsikaauthor=N.+K.+Pettyauthor=M.+A.+Schembri&title=Chaperone-usher+fimbriae+of+Escherichia+coli&doi=10.1371%2Fjournal.pone.0052835"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0052835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0052835%26sid%3Dliteratum%253Aachs%26aulast%3DWurpel%26aufirst%3DD.%2BJ.%26aulast%3DBeatson%26aufirst%3DS.%2BA.%26aulast%3DTotsika%26aufirst%3DM.%26aulast%3DPetty%26aufirst%3DN.%2BK.%26aulast%3DSchembri%26aufirst%3DM.%2BA.%26atitle%3DChaperone-usher%2520fimbriae%2520of%2520Escherichia%2520coli%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0052835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouckaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFusco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auguste, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waksman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02915.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1046%2Fj.1365-2958.2002.02915.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=12010488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2002&pages=903-915&author=C.+S.+Hungauthor=J.+Bouckaertauthor=D.+Hungauthor=J.+Pinknerauthor=C.+Widbergauthor=A.+DeFuscoauthor=C.+G.+Augusteauthor=R.+Strouseauthor=S.+Langermannauthor=G.+Waksmanauthor=S.+J.+Hultgren&title=Structural+basis+of+tropism+of+Escherichia+coli+to+the+bladder+during+urinary+tract+infection&doi=10.1046%2Fj.1365-2958.2002.02915.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span></div><div class="casAuthors">Hung, Chia-Suei; Bouckaert, Julie; Hung, Danielle; Pinkner, Jerome; Widberg, Charlotte; DeFusco, Anthony; Auguste, C. Gale; Strouse, Robert; Langermann, Solomon; Waksman, Gabriel; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">903-915</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The first step in the colonization of the human urinary tract by pathogenic Escherichia coli is the mannose-sensitive binding of FimH, the adhesin present at the tip of type 1 pili, to the bladder epithelium.  We elucidated crystallog. the interactions of FimH with D-mannose.  The unique site binding pocket occupied by D-mannose was probed using site-directed mutagenesis.  All but one of the mutants examd. had greatly diminished mannose-binding activity and had also lost the ability to bind human bladder cells.  The binding activity of the monosaccharide D-mannose was delineated from this of mannotriose (Man(α1-3)[Man(α1-6)]Man) by generating mutants that abolished D-mannose binding but retained mannotriose binding activity.  Our structure/function anal. demonstrated that the binding of the monosaccharide α-D-mannose is the primary bladder cell receptor for uropathogenic E. coli and that this event requires a highly conserved FimH binding pocket.  The residues in the FimH mannose-binding pocket were sequenced and found to be invariant in over 200 uropathogenic strains of E. coli.  Only enterohemorrhagic E. coli (EHEC) possess a sequence variation within the mannose-binding pocket of FimH, suggesting a naturally occurring mechanism of attenuation in EHEC bacteria that would prevent them from being targeted to the urinary tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoljy6DS5GA8bVg90H21EOLACvtfcHk0ljURgPEDeZ0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D&md5=b2d31ffbc2540d4be1bfff9d4036f5eb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02915.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02915.x%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DHung%26aufirst%3DD.%26aulast%3DPinkner%26aufirst%3DJ.%26aulast%3DWidberg%26aufirst%3DC.%26aulast%3DDeFusco%26aufirst%3DA.%26aulast%3DAuguste%26aufirst%3DC.%2BG.%26aulast%3DStrouse%26aufirst%3DR.%26aulast%3DLangermann%26aufirst%3DS.%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520tropism%2520of%2520Escherichia%2520coli%2520to%2520the%2520bladder%2520during%2520urinary%2520tract%2520infection%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D44%26spage%3D903%26epage%3D915%26doi%3D10.1046%2Fj.1365-2958.2002.02915.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conover, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taganna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Greve, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Inflammation-induced adhesin-receptor interaction provides a fitness advantage to uropathogenic E. coli during chronic infection</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2016.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1016%2Fj.chom.2016.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=27667696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGru7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=482-492&author=M.+S.+Conoverauthor=S.+Ruerauthor=J.+Tagannaauthor=V.+Kalasauthor=H.+De+Greveauthor=J.+S.+Pinknerauthor=K.+W.+Dodsonauthor=H.+Remautauthor=S.+J.+Hultgren&title=Inflammation-induced+adhesin-receptor+interaction+provides+a+fitness+advantage+to+uropathogenic+E.+coli+during+chronic+infection&doi=10.1016%2Fj.chom.2016.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection</span></div><div class="casAuthors">Conover, Matt S.; Ruer, Segolene; Taganna, Joemar; Kalas, Vasilios; De Greve, Henri; Pinkner, Jerome S.; Dodson, Karen W.; Remaut, Han; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-492</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Uropathogenic E. coli (UPEC) is the dominant cause of urinary tract infections, clin. described as cystitis.  UPEC express CUP pili, which are extracellular fibers tipped with adhesins that bind mucosal surfaces of the urinary tract.  Here we identify the role of the F9/Yde/Fml pilus for UPEC persistence in the inflamed urothelium.  The Fml adhesin FmlH binds galactose β1-3 N-acetylgalactosamine found in core-1 and -2 O-glycans.  Deletion of fmlH had no effect on UPEC virulence in an acute mouse model of cystitis.  However, FmlH provided a fitness advantage during chronic cystitis, which is manifested as persistent bacteriuria, high bladder bacterial burdens, and chronic inflammation.  In situ binding confirmed that FmlH bound avidly to the inflamed, but not the naive bladder.  In accordance with its pathogenic profile, vaccination with FmlH significantly protected mice from chronic cystitis.  Thus, UPEC employ sep. CUP pili to adapt to the rapidly changing niche during bladder infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8JDlQpjGVFLVg90H21EOLACvtfcHk0ljK6ivl0wkyxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGru7zJ&md5=35fb7d5f61cdb451f9104dcf4c3e072d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2016.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2016.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DConover%26aufirst%3DM.%2BS.%26aulast%3DRuer%26aufirst%3DS.%26aulast%3DTaganna%26aufirst%3DJ.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DDe%2BGreve%26aufirst%3DH.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DDodson%26aufirst%3DK.%2BW.%26aulast%3DRemaut%26aufirst%3DH.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DInflammation-induced%2520adhesin-receptor%2520interaction%2520provides%2520a%2520fitness%2520advantage%2520to%2520uropathogenic%2520E.%2520coli%2520during%2520chronic%2520infection%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2016%26volume%3D20%26spage%3D482%26epage%3D492%26doi%3D10.1016%2Fj.chom.2016.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbing, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddirala, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conover, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E2819</span>– <span class="NLM_lpage">E2828</span>, <span class="refDoi"> DOI: 10.1073/pnas.1720140115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1073%2Fpnas.1720140115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=29507247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Chs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E2819-E2828&author=V.+Kalasauthor=M.+E.+Hibbingauthor=A.+R.+Maddiralaauthor=R.+Chuganiauthor=J.+S.+Pinknerauthor=L.+K.+Mydock-McGraneauthor=M.+S.+Conoverauthor=J.+W.+Janetkaauthor=S.+J.+Hultgren&title=Structure-based+discovery+of+glycomimetic+FmlH+ligands+as+inhibitors+of+bacterial+adhesion+during+urinary+tract+infection&doi=10.1073%2Fpnas.1720140115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection</span></div><div class="casAuthors">Kalas, Vasilios; Hibbing, Michael E.; Maddirala, Amarendar Reddy; Chugani, Ryan; Pinkner, Jerome S.; Mydock-McGrane, Laurel K.; Conover, Matt S.; Janetka, James W.; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">E2819-E2828</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Treatment of bacterial infections is becoming a serious clin. challenge due to the global dissemination of multidrug antibiotic resistance, necessitating the search for alternative treatments to disarm the virulence mechanisms underlying these infections.  Uropathogenic Escherichia coli (UPEC) employs multiple chaperone-usher pathway pili tipped with adhesins with diverse receptor specificities to colonize various host tissues and habitats.  For example, UPEC F9 pili specifically bind galactose or N-acetylgalactosamine epitopes on the kidney and inflamed bladder.  Using x-ray structure-guided methods, virtual screening, and multiplex ELISA arrays, the authors rationally designed aryl galactosides and N-acetylgalactosaminosides that inhibit the F9 pilus adhesin FmlH.  The lead compd., 29β-NAc, is a biphenyl N-acetyl-β-galactosaminoside with a Ki of ∼90 nM, representing a major advancement in potency relative to the characteristically weak nature of most carbohydrate-lectin interactions. 29β-NAc binds tightly to FmlH by engaging the residues Y46 through edge-to-face p-stacking with its A-Ph ring, R142 in a salt-bridge interaction with its carboxylate group, and K132 through water-mediated hydrogen bonding with its N-acetyl group.  Administration of 29β-NAc in a mouse urinary tract infection (UTI) model significantly reduced bladder and kidney bacterial burdens, and coadministration of 29β-NAc and mannoside 4Z269, which targets the type 1 pilus adhesin FimH, resulted in greater elimination of bacteria from the urinary tract than either compd. alone.  Moreover, FmlH specifically binds healthy human kidney tissue in a 29β-NAc-inhibitable manner, suggesting a key role for F9 pili in human kidney colonization.  Thus, these glycoside antagonists of FmlH represent a rational antivirulence strategy for UPEC-mediated UTI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQALa-bUsUlrVg90H21EOLACvtfcHk0ljK6ivl0wkyxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Chs7nE&md5=e686b5b852add750b184b3f0ca8358d0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1720140115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1720140115%26sid%3Dliteratum%253Aachs%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DHibbing%26aufirst%3DM.%2BE.%26aulast%3DMaddirala%26aufirst%3DA.%2BR.%26aulast%3DChugani%26aufirst%3DR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DConover%26aufirst%3DM.%2BS.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructure-based%2520discovery%2520of%2520glycomimetic%2520FmlH%2520ligands%2520as%2520inhibitors%2520of%2520bacterial%2520adhesion%2520during%2520urinary%2520tract%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE2819%26epage%3DE2828%26doi%3D10.1073%2Fpnas.1720140115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">109ra115</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1126%2Fscitranslmed.3003021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=22089451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=109ra115&author=C.+K.+Cusumanoauthor=J.+S.+Pinknerauthor=Z.+Hanauthor=S.+E.+Greeneauthor=B.+A.+Fordauthor=J.+R.+Crowleyauthor=J.+P.+Hendersonauthor=J.+W.+Janetkaauthor=S.+J.+Hultgren&title=Treatment+and+prevention+of+urinary+tract+infection+with+orally+active+FimH+inhibitors&doi=10.1126%2Fscitranslmed.3003021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span></div><div class="casAuthors">Cusumano Corinne K; Pinkner Jerome S; Han Zhenfu; Greene Sarah E; Ford Bradley A; Crowley Jan R; Henderson Jeffrey P; Janetka James W; Hultgren Scott J</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">109</span>),
    <span class="NLM_cas:pages">109ra115</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic and recurrent urinary tract infections pose a serious medical problem because there are few effective treatment options.  Patients with chronic urinary tract infections are commonly treated with long-term prophylactic antibiotics that promote the development of antibiotic-resistant forms of uropathogenic Escherichia coli (UPEC), further complicating treatment.  We developed small-molecular weight compounds termed mannosides that specifically inhibit the FimH type 1 pilus lectin of UPEC, which mediates bacterial colonization, invasion, and formation of recalcitrant intracellular bacterial communities in the bladder epithelium.  Here, we optimized these compounds for oral bioavailability and demonstrated their fast-acting efficacy in treating chronic urinary tract infections in a preclinical murine model.  These compounds also prevented infection in vivo when given prophylactically and strongly potentiated the activity of the current standard of care therapy, trimethoprim-sulfamethoxazole, against clinically resistant PBC-1 UPEC bacteria.  These compounds have therapeutic efficacy after oral administration for the treatment of established urinary tract infections in vivo.  Their unique mechanism of action-targeting the pilus tip adhesin FimH-circumvents the conventional requirement for drug penetration of the outer membrane, minimizing the potential for the development of resistance.  The small-molecular weight compounds described herein promise to provide substantial benefit to women suffering from chronic and recurrent urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJjBsZZFqz29j_Vg2vObihfW6udTcc2ebMq1xzEchyFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D&md5=253b506b7485c2cf042cb5665c518277</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003021%26sid%3Dliteratum%253Aachs%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DGreene%26aufirst%3DS.%2BE.%26aulast%3DFord%26aufirst%3DB.%2BA.%26aulast%3DCrowley%26aufirst%3DJ.%2BR.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DTreatment%2520and%2520prevention%2520of%2520urinary%2520tract%2520infection%2520with%2520orally%2520active%2520FimH%2520inhibitors%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D109ra115%26doi%3D10.1126%2Fscitranslmed.3003021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostakioti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Antivirulence C-mannosides as antibiotic-sparing, oral therapeutics for urinary tract infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9390</span>– <span class="NLM_lpage">9408</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00948</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00948" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9390-9408&author=L.+Mydock-McGraneauthor=Z.+Cusumanoauthor=Z.+Hanauthor=J.+Binkleyauthor=M.+Kostakiotiauthor=T.+Hannanauthor=J.+S.+Pinknerauthor=R.+Kleinauthor=V.+Kalasauthor=J.+Crowleyauthor=N.+P.+Rathauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Antivirulence+C-mannosides+as+antibiotic-sparing%2C+oral+therapeutics+for+urinary+tract+infections&doi=10.1021%2Facs.jmedchem.6b00948"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00948%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DCusumano%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DBinkley%26aufirst%3DJ.%26aulast%3DKostakioti%26aufirst%3DM.%26aulast%3DHannan%26aufirst%3DT.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DCrowley%26aufirst%3DJ.%26aulast%3DRath%26aufirst%3DN.%2BP.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DAntivirulence%2520C-mannosides%2520as%2520antibiotic-sparing%252C%2520oral%2520therapeutics%2520for%2520urinary%2520tract%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9390%26epage%3D9408%26doi%3D10.1021%2Facs.jmedchem.6b00948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Antivirulence isoquinolone mannosides: Optimization of the biaryl aglycone for FimH lectin binding affinity and efficacy in the treatment of chronic UTI</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1002%2Fcmdc.201600006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=367-373&author=C.+Jarvisauthor=Z.+Hanauthor=V.+Kalasauthor=R.+Kleinauthor=J.+S.+Pinknerauthor=B.+Fordauthor=J.+Binkleyauthor=C.+K.+Cusumanoauthor=Z.+Cusumanoauthor=L.+Mydock-McGraneauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Antivirulence+isoquinolone+mannosides%3A+Optimization+of+the+biaryl+aglycone+for+FimH+lectin+binding+affinity+and+efficacy+in+the+treatment+of+chronic+UTI&doi=10.1002%2Fcmdc.201600006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600006%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DJ.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DAntivirulence%2520isoquinolone%2520mannosides%253A%2520Optimization%2520of%2520the%2520biaryl%2520aglycone%2520for%2520FimH%2520lectin%2520binding%2520affinity%2520and%2520efficacy%2520in%2520the%2520treatment%2520of%2520chronic%2520UTI%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D367%26epage%3D373%26doi%3D10.1002%2Fcmdc.201600006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleeb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zihlmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abgottspon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smiesko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezencon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwardt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">FimH antagonists: Bioisosteres to improve the in vitro and in vivo PK/PD profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2239</span>, <span class="refDoi"> DOI: 10.1021/jm501524q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501524q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2221-2239&author=S.+Kleebauthor=L.+Pangauthor=K.+Mayerauthor=D.+Erisauthor=A.+Siglauthor=R.+C.+Prestonauthor=P.+Zihlmannauthor=T.+Sharpeauthor=R.+P.+Jakobauthor=D.+Abgottsponauthor=A.+S.+Hutterauthor=M.+Scharenbergauthor=X.+Jiangauthor=G.+Navarraauthor=S.+Rabbaniauthor=M.+Smieskoauthor=N.+Ludinauthor=J.+Bezenconauthor=O.+Schwardtauthor=T.+Maierauthor=B.+Ernst&title=FimH+antagonists%3A+Bioisosteres+to+improve+the+in+vitro+and+in+vivo+PK%2FPD+profile&doi=10.1021%2Fjm501524q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm501524q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501524q%26sid%3Dliteratum%253Aachs%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DMayer%26aufirst%3DK.%26aulast%3DEris%26aufirst%3DD.%26aulast%3DSigl%26aufirst%3DA.%26aulast%3DPreston%26aufirst%3DR.%2BC.%26aulast%3DZihlmann%26aufirst%3DP.%26aulast%3DSharpe%26aufirst%3DT.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DHutter%26aufirst%3DA.%2BS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DNavarra%26aufirst%3DG.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DLudin%26aufirst%3DN.%26aulast%3DBezencon%26aufirst%3DJ.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%253A%2520Bioisosteres%2520to%2520improve%2520the%2520in%2520vitro%2520and%2520in%2520vivo%2520PK%252FPD%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2221%26epage%3D2239%26doi%3D10.1021%2Fjm501524q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abgottspon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleeb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwardt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">Antiadhesion therapy for urinary tract infections-a balanced PK/PD profile proved to be key for success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4700</span>– <span class="NLM_lpage">4713</span>, <span class="refDoi"> DOI: 10.1021/jm300192x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300192x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4700-4713&author=X.+Jiangauthor=D.+Abgottsponauthor=S.+Kleebauthor=S.+Rabbaniauthor=M.+Scharenbergauthor=M.+Wittwerauthor=M.+Haugauthor=O.+Schwardtauthor=B.+Ernst&title=Antiadhesion+therapy+for+urinary+tract+infections-a+balanced+PK%2FPD+profile+proved+to+be+key+for+success&doi=10.1021%2Fjm300192x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm300192x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300192x%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DHaug%26aufirst%3DM.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DAntiadhesion%2520therapy%2520for%2520urinary%2520tract%2520infections-a%2520balanced%2520PK%252FPD%2520profile%2520proved%2520to%2520be%2520key%2520for%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4700%26epage%3D4713%26doi%3D10.1021%2Fjm300192x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abgottspon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, B.</span></span> <span> </span><span class="NLM_article-title">In vivo evaluation of FimH antagonists - a novel class of antimicrobials for the treatment of urinary tract infection</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.2533/chimia.2012.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.2533%2Fchimia.2012.166" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=166-169&author=D.+Abgottsponauthor=B.+Ernst&title=In+vivo+evaluation+of+FimH+antagonists+-+a+novel+class+of+antimicrobials+for+the+treatment+of+urinary+tract+infection&doi=10.2533%2Fchimia.2012.166"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2012.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2012.166%26sid%3Dliteratum%253Aachs%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520FimH%2520antagonists%2520-%2520a%2520novel%2520class%2520of%2520antimicrobials%2520for%2520the%2520treatment%2520of%2520urinary%2520tract%2520infection%26jtitle%3DChimia%26date%3D2012%26volume%3D66%26spage%3D166%26epage%3D169%26doi%3D10.2533%2Fchimia.2012.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn’s disease</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1131266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1517%2F13543776.2016.1131266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=26651364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=175-197&author=L.+K.+Mydock-McGraneauthor=Z.+T.+Cusumanoauthor=J.+W.+Janetka&title=Mannose-derived+FimH+antagonists%3A+a+promising+anti-virulence+therapeutic+strategy+for+urinary+tract+infections+and+Crohn%E2%80%99s+disease&doi=10.1517%2F13543776.2016.1131266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease</span></div><div class="casAuthors">Mydock-McGrane, Laurel K.; Cusumano, Zachary T.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-197</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Type 1 pili are utilized by Gram-neg. bacteria to adhere to host tissue and thus are a key virulence factor in urinary tract infections (UTIs) and Crohn's disease (CD).  This adhesion is mediated through specific binding of the terminal adhesin, FimH, to mannosylated host glycoproteins.  FimH is essential for UTI pathogenesis and thus is a promising therapeutic target.: Herein, we review the structural frameworks of FimH antagonists disclosed in the patent literature.  X-ray crystallog. binding studies of D-mannose and early FimH antagonists have uncovered key mol. interactions.  Exploiting this knowledge, mannosides with extraordinarily high binding affinities have been designed.  Structure-activity relationships (SAR) and structure-property relationship (SPR) studies have resulted in the rapid development of orally bioavailable FimH antagonists with promising therapeutic potential for UTI and CD.: It is our opinion that biaryl or 'two-ring' mannosides, which represent the largest and most thoroughly tested class of FimH antagonists, also hold the most promise as a novel treatment for UTIs.  These antagonists have also been shown to have efficacy in treating CD.  Judging from the strong preclin. data, we predict that one or more FimH antagonists will be entering the clinic within the next 1-2 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_i0DZwcMRbVg90H21EOLACvtfcHk0lhqRgYIzVQauQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D&md5=a28cd9875e0f5bf0c91f716c3d7b7653</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1131266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1131266%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%2BT.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DMannose-derived%2520FimH%2520antagonists%253A%2520a%2520promising%2520anti-virulence%2520therapeutic%2520strategy%2520for%2520urinary%2520tract%2520infections%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D175%26epage%3D197%26doi%3D10.1517%2F13543776.2016.1131266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1331216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1080%2F17460441.2017.1331216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=28506090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=711-731&author=L.+K.+Mydock-McGraneauthor=T.+J.+Hannanauthor=J.+W.+Janetka&title=Rational+design+strategies+for+FimH+antagonists%3A+new+drugs+on+the+horizon+for+urinary+tract+infection+and+Crohn%E2%80%99s+disease&doi=10.1080%2F17460441.2017.1331216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease</span></div><div class="casAuthors">Mydock-McGrane, Laurel K.; Hannan, Thomas J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">711-731</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: The bacterial adhesin FimH is a virulence factor and an attractive therapeutic target for urinary tract infection (UTI) and Crohn's Disease (CD).  Located on type 1 pili of uropathogenic E. coli (UPEC), the FimH adhesin plays an integral role in the pathogenesis of UPEC.  Recent efforts have culminated in the development of small-mol. mannoside FimH antagonists that target the mannose-binding lectin domain of FimH, inhibiting its function and preventing UPEC from binding mannosylated host cells in the bladder, thereby circumventing infection.: The authors describe the structure-guided design of mannoside ligands, and review the structural biol. of the FimH lectin domain.  Addnl., they discuss the lead optimization of mannosides for therapeutic application in UTI and CD, and describe various assays used to measure mannoside potency in vitro and mouse models used to det. efficacy in vivo.: To date, mannoside optimization has led to a diverse set of small-mol. FimH antagonists with oral bioavailability.  With clin. trials already initiated in CD and on the horizon for UTI, it is the authors, opinion that mannosides will be a 'first-in-class' treatment strategy for UTI and CD, and will pave the way for treatment of other Gram-neg. bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wDghfJfnIrVg90H21EOLACvtfcHk0lhqRgYIzVQauQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSgs7s%253D&md5=48395bfe8cc540942a336e572b8dd667</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1331216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1331216%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DRational%2520design%2520strategies%2520for%2520FimH%2520antagonists%253A%2520new%2520drugs%2520on%2520the%2520horizon%2520for%2520urinary%2520tract%2520infection%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D711%26epage%3D731%26doi%3D10.1080%2F17460441.2017.1331216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, G.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis of quercetin 3-O-glycosides of 2-amino-2-deoxy-d-glucose under phase transfer catalytic conditions</span>. <i>J. Carbohydr. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1080/07328303.2014.996290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1080%2F07328303.2014.996290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1ejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=28-40&author=Z.+Caoauthor=Y.+Quauthor=J.+Zhouauthor=W.+Liuauthor=G.+Yao&title=Stereoselective+synthesis+of+quercetin+3-O-glycosides+of+2-amino-2-deoxy-d-glucose+under+phase+transfer+catalytic+conditions&doi=10.1080%2F07328303.2014.996290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective Synthesis of Quercetin 3-O-Glycosides of 2-Amino-2-Deoxy-D-Glucose Under Phase Transfer Catalytic Conditions</span></div><div class="casAuthors">Cao, Zhiling; Qu, Yingying; Zhou, Jiexing; Liu, Weiwei; Yao, Guowei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Carbohydrate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-40</span>CODEN:
                <span class="NLM_cas:coden">JCACDM</span>;
        ISSN:<span class="NLM_cas:issn">0732-8303</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">This article describes the stereoselective synthesis of quercetin 3-O-glycosides of 2-amino-2-deoxy-D-glucose.  Efficient 1,2-trans-glycosylation of protected quercetin with N-acetyl-protected 2-amino-2-deoxy-D-glucose chloride was achieved under phase transfer catalytic conditions in a 0.15 M aq. K2CO3/chloroform system using tetrabutylammonium bromide as the catalyst.  On the contrary, glycosylation with the N-phthalimido-protected bromide donor under the same conditions was found to give predominantly 1,2-cis-glycoside product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBVx4Nn6co7Vg90H21EOLACvtfcHk0ljxhMUL2CoKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1ejsrY%253D&md5=53cd23b2aec790db6805a80e98db2eaa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F07328303.2014.996290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328303.2014.996290%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DG.%26atitle%3DStereoselective%2520synthesis%2520of%2520quercetin%25203-O-glycosides%2520of%25202-amino-2-deoxy-d-glucose%2520under%2520phase%2520transfer%2520catalytic%2520conditions%26jtitle%3DJ.%2520Carbohydr.%2520Chem.%26date%3D2015%26volume%3D34%26spage%3D28%26epage%3D40%26doi%3D10.1080%2F07328303.2014.996290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropper, F.</span></span> <span> </span><span class="NLM_article-title">Stereospecific synthesis of aryl β-d-<i>N</i>-acetylglucopyranosides by phase transfer catalysis</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2097</span>– <span class="NLM_lpage">2102</span>, <span class="refDoi"> DOI: 10.1080/00397919008053144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1080%2F00397919008053144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADyaK3MXmt1Ggtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=2097-2102&author=R.+Royauthor=F.+Tropper&title=Stereospecific+synthesis+of+aryl+%CE%B2-d-N-acetylglucopyranosides+by+phase+transfer+catalysis&doi=10.1080%2F00397919008053144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecific synthesis of aryl β-D-N-acetylglucopyranosides by phase transfer catalysis</span></div><div class="casAuthors">Roy, Rene; Tropper, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2097-102</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Under phase transfer catalyzed conditions (Bu4N+ Br-, 1 M NaOH, CH2Cl2) 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chloride (I) reacts with ROH (R = 4-MeOC6H4, 4-Me3CC6H4, 3-MeC6H4, 4-PhC6H4, 1-naphthyl, 2-naphthyl) to afford high yields of acetylated aryl β-D-N-acetylglucopyranosides II (R1 = Ac).  Deprotection of the hydroxyl groups under Zemplen condition gave quant. yields of the free glycosides II (R1 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLE_NXDVsaFrVg90H21EOLACvtfcHk0ljxhMUL2CoKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmt1Ggtw%253D%253D&md5=6737c07f3e9eefc5acfac7f1d2462039</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00397919008053144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008053144%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DR.%26aulast%3DTropper%26aufirst%3DF.%26atitle%3DStereospecific%2520synthesis%2520of%2520aryl%2520%25CE%25B2-d-N-acetylglucopyranosides%2520by%2520phase%2520transfer%2520catalysis%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D2097%26epage%3D2102%26doi%3D10.1080%2F00397919008053144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleine, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, R. S.</span></span> <span> </span><span class="NLM_article-title">Phase-transfer-catalyzed synthesis of 2,3,4,6-tetra-O-acetyl-β-d-galactopyranosides</span>. <i>Carbohydr. Res.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/0008-6215(85)85036-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1016%2F0008-6215%2885%2985036-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADyaL28XhvVKktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1985&pages=333-337&author=H.+P.+Kleineauthor=D.+V.+Weinbergauthor=R.+J.+Kaufmanauthor=R.+S.+Sidhu&title=Phase-transfer-catalyzed+synthesis+of+2%2C3%2C4%2C6-tetra-O-acetyl-%CE%B2-d-galactopyranosides&doi=10.1016%2F0008-6215%2885%2985036-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phase-transfer-catalyzed synthesis of 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosides</span></div><div class="casAuthors">Kleine, Henry P.; Weinberg, David V.; Kaufman, Robert J.; Sidhu, Ravinder S.</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Research</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-7</span>CODEN:
                <span class="NLM_cas:coden">CRBRAT</span>;
        ISSN:<span class="NLM_cas:issn">0008-6215</span>.
    </div><div class="casAbstract">Forty-three aryl galactopyranosides I (R = 4-NO2, 3-NO2, 4-OMe, 3-Br, 2,4-Cl2, 4-cyano, H, 3-Me, 2,4,6-Me3, etc.) were prepd. in 29-86% yield by glycosidation of acetobromogalactose with the corresponding phenols in CHCl3-aq. NaOH in the presence of PhCH2N+Et3Br- 3 h at 60°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUAh6G69snbVg90H21EOLACvtfcHk0ljxhMUL2CoKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhvVKktrk%253D&md5=bd411a34b5e5c808457e1d4bbb0cd666</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0008-6215%2885%2985036-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0008-6215%252885%252985036-9%26sid%3Dliteratum%253Aachs%26aulast%3DKleine%26aufirst%3DH.%2BP.%26aulast%3DWeinberg%26aufirst%3DD.%2BV.%26aulast%3DKaufman%26aufirst%3DR.%2BJ.%26aulast%3DSidhu%26aufirst%3DR.%2BS.%26atitle%3DPhase-transfer-catalyzed%2520synthesis%2520of%25202%252C3%252C4%252C6-tetra-O-acetyl-%25CE%25B2-d-galactopyranosides%26jtitle%3DCarbohydr.%2520Res.%26date%3D1985%26volume%3D142%26spage%3D333%26epage%3D337%26doi%3D10.1016%2F0008-6215%2885%2985036-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Bruyne, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters-Leysen, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted phenyl β-d-galactopyranosides</span>. <i>Carbohydr. Res.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/S0008-6215(00)80264-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1016%2FS0008-6215%2800%2980264-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1971&pages=124-126&author=C.+K.+De%0ABruyneauthor=J.+Wouters-Leysen&title=Synthesis+of+substituted+phenyl+%CE%B2-d-galactopyranosides&doi=10.1016%2FS0008-6215%2800%2980264-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2800%2980264-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252800%252980264-5%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruyne%26aufirst%3DC.%2BK.%26aulast%3DWouters-Leysen%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520substituted%2520phenyl%2520%25CE%25B2-d-galactopyranosides%26jtitle%3DCarbohydr.%2520Res.%26date%3D1971%26volume%3D18%26spage%3D124%26epage%3D126%26doi%3D10.1016%2FS0008-6215%2800%2980264-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greig, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macauley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocadlo, D. J.</span></span> <span> </span><span class="NLM_article-title">Probing synergy between two catalytic strategies in the glycoside hydrolase O-glcNAcase using multiple linear free energy relationships</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">13415</span>– <span class="NLM_lpage">13422</span>, <span class="refDoi"> DOI: 10.1021/ja904506u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja904506u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGktbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=13415-13422&author=I.+R.+Greigauthor=M.+S.+Macauleyauthor=I.+H.+Williamsauthor=D.+J.+Vocadlo&title=Probing+synergy+between+two+catalytic+strategies+in+the+glycoside+hydrolase+O-glcNAcase+using+multiple+linear+free+energy+relationships&doi=10.1021%2Fja904506u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Probing Synergy between Two Catalytic Strategies in the Glycoside Hydrolase O-GlcNAcase Using Multiple Linear Free Energy Relationships</span></div><div class="casAuthors">Greig, Ian R.; Macauley, Matthew S.; Williams, Ian H.; Vocadlo, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13415-13422</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human O-GlcNAcase plays an important role in regulating the post-translational modification of serine and threonine residues with β-O-linked N-acetylglucosamine monosaccharide unit (O-GlcNAc).  The mechanism of O-GlcNAcase involves nucleophilic participation of the 2-acetamido group of the substrate to displace a glycosidically linked leaving group.  The tolerance of this enzyme for variation in substrate structure has enabled us to characterize O-GlcNAcase transition states using several series of substrates to generate multiple simultaneous free-energy relationships.  Patterns revealing changes in mechanism, transition state, and rate-detg. step upon concomitant variation of both nucleophilic strength and leaving group abilities are obsd.  The obsd. changes in mechanism reflect the roles played by the enzymic general acid and the catalytic nucleophile.  Significantly, these results illustrate how the enzyme synergistically harnesses both modes of catalysis; a feature that eludes many small mol. models of catalysis.  These studies also suggest the kinetic significance of an oxocarbenium ion intermediate in the O-GlcNAcase-catalyzed hydrolysis of glucosaminides, probing the limits of what may be learned using nonatomistic investigations of enzymic transition-state structure and offering general insights into how the superfamily of retaining glycoside hydrolases act as efficient catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFxM7cU-oUrVg90H21EOLACvtfcHk0lh_trJDVD51lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGktbjM&md5=ee85b7c48919fb79ea68ea35aee3bcd7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja904506u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja904506u%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DI.%2BR.%26aulast%3DMacauley%26aufirst%3DM.%2BS.%26aulast%3DWilliams%26aufirst%3DI.%2BH.%26aulast%3DVocadlo%26aufirst%3DD.%2BJ.%26atitle%3DProbing%2520synergy%2520between%2520two%2520catalytic%2520strategies%2520in%2520the%2520glycoside%2520hydrolase%2520O-glcNAcase%2520using%2520multiple%2520linear%2520free%2520energy%2520relationships%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D13415%26epage%3D13422%26doi%3D10.1021%2Fja904506u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boutureira, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardes, G. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. G.</span></span> <span> </span><span class="NLM_article-title">Selenenylsulfide-linked homogeneous glycopeptides and glycoproteins: Synthesis of human “Hepatic Se Metabolite A</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1002/anie.201106658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1002%2Fanie.201106658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1432-1436&author=O.+Boutureiraauthor=G.+J.+L.+Bernardesauthor=M.+Fern%C3%A1ndez-Gonz%C3%A1lezauthor=D.+C.+Anthonyauthor=B.+G.+Davis&title=Selenenylsulfide-linked+homogeneous+glycopeptides+and+glycoproteins%3A+Synthesis+of+human+%E2%80%9CHepatic+Se+Metabolite+A&doi=10.1002%2Fanie.201106658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selenenylsulfide-linked Homogeneous Glycopeptides and Glycoproteins: Synthesis of Human "Hepatic Se Metabolite A"</span></div><div class="casAuthors">Boutureira, Omar; Bernardes, Goncalo J. L.; Fernandez-Gonzalez, Marta; Anthony, Daniel C.; Davis, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1432-1436, S1432/1-S1432/46</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors present the synthesis of selenenylsulfide-linked (glycosyl-SeS-Cys) glycopeptides and glycoproteins using a Cys-specific selenylation protocol of cysteine moiety in peptides and proteins, resp.  The first synthesis and full characterization of human hepatic Se metabolite A, 5, is also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaF7zi6kFErrVg90H21EOLACvtfcHk0lh_trJDVD51lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVegsw%253D%253D&md5=2d183abedd5298ab09420005485ecf1c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.201106658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201106658%26sid%3Dliteratum%253Aachs%26aulast%3DBoutureira%26aufirst%3DO.%26aulast%3DBernardes%26aufirst%3DG.%2BJ.%2BL.%26aulast%3DFern%25C3%25A1ndez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DAnthony%26aufirst%3DD.%2BC.%26aulast%3DDavis%26aufirst%3DB.%2BG.%26atitle%3DSelenenylsulfide-linked%2520homogeneous%2520glycopeptides%2520and%2520glycoproteins%253A%2520Synthesis%2520of%2520human%2520%25E2%2580%259CHepatic%2520Se%2520Metabolite%2520A%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1432%26epage%3D1436%26doi%3D10.1002%2Fanie.201106658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusumano, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetka, J. W.</span></span> <span> </span><span class="NLM_article-title">Lead optimization studies on FimH antagonists: Discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3945</span>– <span class="NLM_lpage">3959</span>, <span class="refDoi"> DOI: 10.1021/jm300165m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300165m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3945-3959&author=Z.+Hanauthor=J.+S.+Pinknerauthor=B.+Fordauthor=E.+Chorellauthor=J.+M.+Crowleyauthor=C.+K.+Cusumanoauthor=S.+Campbellauthor=J.+P.+Hendersonauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Lead+optimization+studies+on+FimH+antagonists%3A+Discovery+of+potent+and+orally+bioavailable+ortho-substituted+biphenyl+mannosides&doi=10.1021%2Fjm300165m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization Studies on FimH Antagonists: Discovery of Potent and Orally Bioavailable Ortho-Substituted Biphenyl Mannosides</span></div><div class="casAuthors">Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Chorell, Erik; Crowley, Jan M.; Cusumano, Corinne K.; Campbell, Scott; Henderson, Jeffrey P.; Hultgren, Scott J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3945-3959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we describe the X-ray structure-based design and optimization of biaryl mannoside FimH inhibitors.  Diverse modifications to the biaryl ring to improve druglike phys. and pharmacokinetic properties of mannosides were assessed for FimH binding affinity based on their effects on hemagglutination and biofilm formation along with direct FimH binding assays.  Substitution on the mannoside Ph ring ortho to the glycosidic bond results in large potency enhancements several-fold higher than those of corresponding unsubstituted matched pairs and can be rationalized from increased hydrophobic interactions with the FimH hydrophobic ridge (Ile13) or "tyrosine gate" (Tyr137 and Tyr48) also lined by Ile52.  The lead mannosides have increased metabolic stability and oral bioavailability as detd. from in vitro PAMPA predictive model of cellular permeability and in vivo pharmacokinetic studies in mice, thereby representing advanced preclin. candidates with promising potential as novel therapeutics for the clin. treatment and prevention of recurring urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBCwLuNdyjLVg90H21EOLACvtfcHk0lh_trJDVD51lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D&md5=2a9b4e564162f8c3292802826fa33974</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300165m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300165m%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DChorell%26aufirst%3DE.%26aulast%3DCrowley%26aufirst%3DJ.%2BM.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DLead%2520optimization%2520studies%2520on%2520FimH%2520antagonists%253A%2520Discovery%2520of%2520potent%2520and%2520orally%2520bioavailable%2520ortho-substituted%2520biphenyl%2520mannosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3945%26epage%3D3959%26doi%3D10.1021%2Fjm300165m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alteen, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemčovičová, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocadlo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloster, T. M.</span></span> <span> </span><span class="NLM_article-title">Mechanism of human nucleocytoplasmic hexosaminidase D</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2747</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b01285</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2735-2747&author=M.+G.+Alteenauthor=V.+Oehlerauthor=I.+Nem%C4%8Dovi%C4%8Dov%C3%A1author=I.+B.+H.+Wilsonauthor=D.+J.+Vocadloauthor=T.+M.+Gloster&title=Mechanism+of+human+nucleocytoplasmic+hexosaminidase+D&doi=10.1021%2Facs.biochem.5b01285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01285%26sid%3Dliteratum%253Aachs%26aulast%3DAlteen%26aufirst%3DM.%2BG.%26aulast%3DOehler%26aufirst%3DV.%26aulast%3DNem%25C4%258Dovi%25C4%258Dov%25C3%25A1%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DI.%2BB.%2BH.%26aulast%3DVocadlo%26aufirst%3DD.%2BJ.%26aulast%3DGloster%26aufirst%3DT.%2BM.%26atitle%3DMechanism%2520of%2520human%2520nucleocytoplasmic%2520hexosaminidase%2520D%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D2735%26epage%3D2747%26doi%3D10.1021%2Facs.biochem.5b01285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolfrom, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramp, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, D.</span></span> <span> </span><span class="NLM_article-title">3,4,6-Tri-O-acetyl-2-amino-2-deoxy-α-d-galactopyranosyl bromide hydrobromide1</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3232</span>, <span class="refDoi"> DOI: 10.1021/jo01046a519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01046a519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1963&pages=3231-3232&author=M.+L.+Wolfromauthor=W.+A.+Crampauthor=D.+Horton&title=3%2C4%2C6-Tri-O-acetyl-2-amino-2-deoxy-%CE%B1-d-galactopyranosyl+bromide+hydrobromide1&doi=10.1021%2Fjo01046a519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01046a519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01046a519%26sid%3Dliteratum%253Aachs%26aulast%3DWolfrom%26aufirst%3DM.%2BL.%26aulast%3DCramp%26aufirst%3DW.%2BA.%26aulast%3DHorton%26aufirst%3DD.%26atitle%3D3%252C4%252C6-Tri-O-acetyl-2-amino-2-deoxy-%25CE%25B1-d-galactopyranosyl%2520bromide%2520hydrobromide1%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1963%26volume%3D28%26spage%3D3231%26epage%3D3232%26doi%3D10.1021%2Fjo01046a519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Z.</span></span> <span> </span><span class="NLM_article-title">Copper-mediated one-pot synthesis of 2,2-difluoro-1,3-benzoxathioles from o-bromophenols and trifluoromethanethiolate</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b03877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b03877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=481-484&author=M.+Zhangauthor=S.+Chenauthor=Z.+Weng&title=Copper-mediated+one-pot+synthesis+of+2%2C2-difluoro-1%2C3-benzoxathioles+from+o-bromophenols+and+trifluoromethanethiolate&doi=10.1021%2Facs.orglett.7b03877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Mediated One-Pot Synthesis of 2,2-Difluoro-1,3-benzoxathioles from o-Bromophenols and Trifluoromethanethiolate</span></div><div class="casAuthors">Zhang, Mengjia; Chen, Shouxiong; Weng, Zhiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">481-484</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A Cu-mediated difluoromethylenation of o-bromophenols with trifluoromethanethiolate is described.  This 1-pot protocol proceeds through an intermol. addn. of S:CF2 (resulting from the decompn. of trifluoromethanethiolate) to o-bromophenols followed by intramol. C-S coupling to form 2,2-difluoro-1,3-benzoxathioles.  This method is compatible with a broad range of substrates and enables the late-stage difluoromethylenation of several functionally dense drug like o-bromophenols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOITyfE-6jmbVg90H21EOLACvtfcHk0lj8ZKYgIFi2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1ajsw%253D%253D&md5=ae16341912f0677bbafaa6a3a36dde3d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b03877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b03877%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWeng%26aufirst%3DZ.%26atitle%3DCopper-mediated%2520one-pot%2520synthesis%2520of%25202%252C2-difluoro-1%252C3-benzoxathioles%2520from%2520o-bromophenols%2520and%2520trifluoromethanethiolate%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D481%26epage%3D484%26doi%3D10.1021%2Facs.orglett.7b03877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lj8ZKYgIFi2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lghCM3BOrIl-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkóczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: A comprehensive python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+comprehensive+python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lghCM3BOrIl-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520comprehensive%2520python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liaZ6bDrA9xNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AS8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AS8','PDB','6AS8'); return false;">PDB: 6AS8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAP','PDB','6MAP'); return false;">PDB: 6MAP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAQ','PDB','6MAQ'); return false;">PDB: 6MAQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW','PDB','6MAW'); return false;">PDB: 6MAW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AOW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AOW','PDB','6AOW'); return false;">PDB: 6AOW</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01561">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68863"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01561">10.1021/acs.jmedchem.8b01561</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC, MS, <sup>1</sup>H, and <sup>13</sup>C NMR spectra of all final tested compounds and intermediates as well as the detailed protocol and data for the rat and mouse pharmacokinetic studies performed by WuXi AppTec (Shanghai) Co., Ltd. (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_001.pdf">jm8b01561_si_001.pdf (7.03 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01561/suppl_file/jm8b01561_si_002.csv">jm8b01561_si_002.csv (3.27 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB IDs of X-ray structures/homology models: novel protein structures have been deposited into the PDB; FmlH-30, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAP">6MAP</a>; FmlH-29, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAQ">6MAQ</a>; FmlH-90, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MAW">6MAW</a>.  Authors will release the atomic coordinates upon article publication. Homology modeling was performed using the apo FimHLD structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AOW">6AOW</a>) as a search model.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01561&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01561%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01561" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a16fca212410","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
